{"meta":{"query_hash":"7ee8ea7c73fd","filters":{"venue":"Human Psychopharmacology Clinical and Experimental"},"cohort_total":104,"direct_labels_cover":1,"predictions_cover":104,"exported":104,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7ee8ea7c73fd","api":"https://metacan.xera.ac/api/v1/cohort?venue=Human+Psychopharmacology+Clinical+and+Experimental"},"results":[{"id":"W1481698373","doi":"10.1002/hup.1199","title":"Clinical and functional outcomes in patients with major depressive disorder and painful physical symptoms switched to treatment with duloxetine","year":2011,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Treatment of Major Depression","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Alberta","funders":"Eli Lilly Australia","keywords":"Duloxetine; Anxiety; Hamilton Anxiety Rating Scale; Mood; Population; Psychology; Hamd; Depression (economics); Rating scale; Internal medicine; Psychiatry; Physical therapy; Medicine","score_opus":0.03702081680045414,"score_gpt":0.3827842841808541,"score_spread":0.3457634673803999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1481698373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978488,0.00024616922,0.0000055617916,0.00032586354,0.00017174464,0.0011306598,0.000010850296,0.000045881396,0.00021446023],"genre_scores_gemma":[0.99798185,0.000030209481,0.00043767356,0.0008753979,0.00014963432,0.00023393567,0.000029991721,0.000035131532,0.00022616818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796855,0.00016341984,0.000538675,0.000830688,0.00019870764,0.0002999687],"domain_scores_gemma":[0.9989126,0.00021901864,0.00012308969,0.00020180868,0.000039668303,0.00050387136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013059731,0.00036342235,0.0007870903,0.00009416707,0.00013378807,0.000012676717,0.000048646154,0.00015466569,0.00022092654],"category_scores_gemma":[0.000013407469,0.00021583578,0.000081075064,0.00006482404,0.0007060225,0.000091879636,0.00009679221,0.00026588177,0.000011089093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022740416,0.0105621265,0.9594831,0.000010334712,0.00048488847,0.000068650814,0.00051538646,1.4451469e-7,0.00033156405,0.000019224108,0.00009736571,0.005686802],"study_design_scores_gemma":[0.08830156,0.015862422,0.8946834,0.00004557197,0.0002946159,0.000013885852,0.00013767184,0.000011657274,0.0002813639,0.000027463906,0.00011361646,0.00022676126],"about_ca_topic_score_codex":0.000038049588,"about_ca_topic_score_gemma":0.000024359177,"teacher_disagreement_score":0.065561146,"about_ca_system_score_codex":0.000027227516,"about_ca_system_score_gemma":0.000023726314,"threshold_uncertainty_score":0.88015276},"labels":[],"label_agreement":null},{"id":"W1499518160","doi":"10.1002/hup.2233","title":"Association study of <i>GRIK1</i> gene polymorphisms in schizophrenia: case–control and family‐based studies","year":2012,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; AstraZeneca; Eli Lilly and Company; American Foundation for Suicide Prevention","keywords":"Single-nucleotide polymorphism; Schizophrenia (object-oriented programming); Haplotype; Dorsolateral prefrontal cortex; Genetic association; Case-control study; Genetics; Glutamatergic; DISC1; Linkage disequilibrium; Association (psychology); Gene; Prefrontal cortex; Glutamate receptor; Biology; Medicine; Allele; Internal medicine; Psychology; Neuroscience; Genotype; Psychiatry; Receptor; Cognition","score_opus":0.13824270185541165,"score_gpt":0.47621105967673233,"score_spread":0.3379683578213207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1499518160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959861,0.0016013408,4.2403911e-7,0.00026314598,0.0013002102,0.0007467612,0.000013906705,0.000031446376,0.000056649602],"genre_scores_gemma":[0.99556386,0.00023539017,0.000009861145,0.0037426536,0.00023193526,0.00012584594,1.9041785e-7,0.000017805418,0.00007246093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963074,0.001471923,0.0007348105,0.00065951154,0.00028299508,0.0005433925],"domain_scores_gemma":[0.9979361,0.001399945,0.00022984312,0.00014968241,0.000030151436,0.00025423584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012002402,0.0002255992,0.0005442416,0.00021053385,0.00033897193,0.00001855128,0.00018659352,0.000130048,0.00005470301],"category_scores_gemma":[0.00018320158,0.00019981466,0.000067345325,0.00026819383,0.00082608016,0.00024191989,0.00016765046,0.0005427126,0.000009793099],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012921466,0.003270638,0.16177268,0.0000048183447,0.00003539262,0.000409481,0.000527108,0.0000014251309,0.83198214,0.000014565481,0.00043779632,0.00025179196],"study_design_scores_gemma":[0.07766441,0.0062808674,0.15371948,0.000015126644,0.00022166588,0.0003277553,0.001668564,0.00028466698,0.75901943,0.000060890965,0.0001605565,0.0005765813],"about_ca_topic_score_codex":0.000015454756,"about_ca_topic_score_gemma":0.000005102722,"teacher_disagreement_score":0.07637227,"about_ca_system_score_codex":0.000036526173,"about_ca_system_score_gemma":0.000022695076,"threshold_uncertainty_score":0.8148205},"labels":[],"label_agreement":null},{"id":"W1501567039","doi":"10.1002/hup.2394","title":"Evaluation of the safety, pharmacodynamic, and pharmacokinetic effects following oral coadministration of immediate‐release morphine with ethanol in healthy male participants","year":2014,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Pharmacodynamics; Pharmacokinetics; Pharmacology; Morphine; Ethanol; Medicine; Chemistry","score_opus":0.056784689675123935,"score_gpt":0.4447436207714164,"score_spread":0.3879589310962924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1501567039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671686,0.00068268203,0.000010161892,0.0005754698,0.00037378902,0.0011413321,0.0000025245704,0.000010828373,0.00048635036],"genre_scores_gemma":[0.9985968,0.00011852133,0.00006926857,0.00096961285,0.00009749864,0.00008094083,0.000011167639,0.000014119188,0.000042065894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977417,0.0007150928,0.0006426386,0.00031351973,0.0003620206,0.00022501133],"domain_scores_gemma":[0.9992143,0.00022611608,0.00022169667,0.00013661523,0.0000490885,0.0001521673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002026657,0.00016124512,0.00044205974,0.000080984944,0.00007253439,0.000004530064,0.00008118097,0.00007975174,0.00016482272],"category_scores_gemma":[0.00006714863,0.0001154475,0.00007966267,0.00012198822,0.00038012234,0.00005929476,0.000058596223,0.00022842924,0.0000019031121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01413324,0.0027879628,0.6403382,0.00033808127,0.00046650373,0.00002491321,0.00066469016,0.00005143661,0.32937288,0.0000968803,0.00044384124,0.011281356],"study_design_scores_gemma":[0.11245626,0.005166607,0.7872484,0.00025529094,0.0019525072,0.000009896501,0.00022535144,0.047385883,0.044771317,0.00013663716,0.00011309581,0.0002788065],"about_ca_topic_score_codex":0.00001988344,"about_ca_topic_score_gemma":0.0000119544775,"teacher_disagreement_score":0.28460157,"about_ca_system_score_codex":0.000027044836,"about_ca_system_score_gemma":0.00005302242,"threshold_uncertainty_score":0.47078127},"labels":[],"label_agreement":null},{"id":"W1521700621","doi":"10.1002/hup.2418","title":"Modulation of auditory deviance detection by acute nicotine is baseline and deviant dependent in healthy nonsmokers: a mismatch negativity study","year":2014,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neuroscience and Music Perception","field":"Neuroscience","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Mismatch negativity; Nicotine; Psychology; Nicotinic agonist; Auditory cortex; Audiology; Stimulus (psychology); Nicotinic acetylcholine receptor; Cognition; Neuroscience; Electroencephalography; Medicine; Cognitive psychology; Internal medicine; Receptor","score_opus":0.05457024941184346,"score_gpt":0.42269098333835525,"score_spread":0.3681207339265118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1521700621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794036,0.00003757729,0.00020083514,0.00030705146,0.0009203702,0.0005228433,0.000011169537,0.000025394622,0.000034390556],"genre_scores_gemma":[0.9961309,0.00010581958,0.00002890237,0.003463498,0.00016539828,0.000056426405,0.0000016314884,0.000010586614,0.0000368703],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99755305,0.00067116454,0.0006196974,0.0007369355,0.00019343286,0.00022573135],"domain_scores_gemma":[0.9992638,0.00022078649,0.00020548556,0.00014980634,0.00001676408,0.00014331826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007652446,0.00016447062,0.00031703166,0.00008613965,0.00020011452,0.000017937751,0.00011834787,0.00009573059,0.00007504158],"category_scores_gemma":[0.000060053575,0.00015466829,0.00004262956,0.0001407997,0.00043355842,0.00021299034,0.00008127022,0.00026888837,0.0000064997967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010364574,0.0015988267,0.0061809225,0.000008856004,0.0000047582835,0.0000033319693,0.00054124004,0.0000020601155,0.9838131,0.0000035581313,0.00047663608,0.006330223],"study_design_scores_gemma":[0.03593922,0.011863146,0.19254673,0.000044610086,0.00008325084,0.00005662448,0.00085258146,0.020581268,0.73605686,0.0002920388,0.0009773697,0.00070628215],"about_ca_topic_score_codex":0.00004371129,"about_ca_topic_score_gemma":0.000041916188,"teacher_disagreement_score":0.24775624,"about_ca_system_score_codex":0.000025550968,"about_ca_system_score_gemma":0.000012244185,"threshold_uncertainty_score":0.630719},"labels":[],"label_agreement":null},{"id":"W1558149471","doi":"10.1002/hup.2294","title":"Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression","year":2013,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Treatment of Major Depression","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Agomelatine; Antidepressant; Depression (economics); Anxiety; Psychology; Psychiatry; Medicine; Clinical psychology; Psychotherapist","score_opus":0.038699610096068586,"score_gpt":0.41239357314812736,"score_spread":0.37369396305205876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1558149471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99558264,0.000933237,0.000008691406,0.00047135295,0.00056006515,0.0018360766,0.000008863182,0.000029153245,0.00056989846],"genre_scores_gemma":[0.99799824,0.0000388866,0.0005122911,0.000635209,0.00019800504,0.0002581939,0.000013718706,0.000023988798,0.0003214432],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99836737,0.00008114413,0.00070132094,0.0004518342,0.00015338023,0.00024497477],"domain_scores_gemma":[0.999095,0.00025468523,0.00018914488,0.00027796725,0.00003404307,0.00014913187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019170737,0.00019189388,0.00045582184,0.00006213168,0.00011178336,0.000008203693,0.00014724016,0.00019650099,0.0004854867],"category_scores_gemma":[0.00003958576,0.00011902575,0.00021502769,0.000074925774,0.00040554398,0.00007803221,0.00014572304,0.00026734715,0.00000966398],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021258213,0.0031357063,0.46062475,0.000027436896,0.00010150976,0.000001801788,0.00011420998,0.0000015762597,0.52771395,0.000033108463,0.0029383812,0.0031817285],"study_design_scores_gemma":[0.05720992,0.0006388971,0.8529889,0.00012866932,0.00011257187,0.00002223387,0.000056068766,0.00020654991,0.08782901,0.00006564081,0.00061675487,0.0001247798],"about_ca_topic_score_codex":0.000033574248,"about_ca_topic_score_gemma":0.000001882559,"teacher_disagreement_score":0.43988493,"about_ca_system_score_codex":0.000020051428,"about_ca_system_score_gemma":0.000018269135,"threshold_uncertainty_score":0.5315739},"labels":[],"label_agreement":null},{"id":"W1571005844","doi":"10.1002/hup.2413","title":"Is environmental temperature related to renal symptoms, serum lithium levels, and other laboratory test results in current lithium users?","year":2014,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Victoria Hospital; Ontario Shores Centre for Mental Health Sciences; University of Toronto; McGill University","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Lithium (medication); Nephrogenic diabetes insipidus; Urine osmolality; Mood; Urine specific gravity; Renal function; Medicine; Bipolar disorder; Internal medicine; Endocrinology; Diabetes insipidus; Urine; Psychiatry","score_opus":0.030003125700162513,"score_gpt":0.3886337448856706,"score_spread":0.3586306191855081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1571005844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885071,0.00672977,2.049424e-7,0.0021769432,0.0005548617,0.00056445046,0.00035825174,0.000048771344,0.0010596323],"genre_scores_gemma":[0.99373674,0.00018881682,0.00006107921,0.004863188,0.0002437686,0.000058349102,0.000044353055,0.000037198188,0.00076649955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770916,0.00021638536,0.0007363488,0.000808076,0.00017282477,0.00035720138],"domain_scores_gemma":[0.99903375,0.00014047709,0.0000979134,0.0002533995,0.0000134736665,0.00046101178],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042014776,0.00032142503,0.00048620938,0.000114513714,0.0001587578,0.000024955249,0.00009064473,0.00031906998,0.00047308745],"category_scores_gemma":[0.000024248806,0.00027182393,0.00009083761,0.000115618204,0.0004069891,0.000068604626,0.00010911293,0.00069135474,0.000082669205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022525594,0.0041985842,0.8669661,0.000034325018,0.00020503157,0.000024845327,0.0026605492,2.5325602e-7,0.110331565,0.00009694139,0.010063154,0.0031660423],"study_design_scores_gemma":[0.032825362,0.0032062577,0.88117695,0.00013206927,0.00012539775,0.00004472772,0.00031211777,0.000025890397,0.009425139,0.000097800665,0.07223416,0.00039410562],"about_ca_topic_score_codex":0.000010084903,"about_ca_topic_score_gemma":0.000013570834,"teacher_disagreement_score":0.100906424,"about_ca_system_score_codex":0.00005373051,"about_ca_system_score_gemma":0.00002705358,"threshold_uncertainty_score":0.9999734},"labels":[],"label_agreement":null},{"id":"W1578387912","doi":"10.1002/hup.2325","title":"The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder","year":2013,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"START Clinic; University of Toronto; University Health Network","funders":"","keywords":"Internal medicine; Bipolar disorder; Resistin; Medicine; Body mass index; Adjunctive treatment; Clinical endpoint; Adiponectin; Major depressive disorder; Metabolic syndrome; Gastroenterology; Endocrinology; Randomized controlled trial; Obesity; Insulin resistance; Lithium (medication)","score_opus":0.009754570716360532,"score_gpt":0.33546367876504635,"score_spread":0.3257091080486858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1578387912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97932774,0.018421382,0.0000017433962,0.00055297586,0.00022001954,0.0012802234,0.000005238793,0.000028072194,0.00016258017],"genre_scores_gemma":[0.9976141,0.0017327691,0.000034198878,0.00010465328,0.00004150152,0.0003330868,0.000023535056,0.000026770796,0.00008938252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998084,0.0003989583,0.0005338856,0.00051790406,0.00014105941,0.00032418588],"domain_scores_gemma":[0.99894047,0.0004903463,0.00015589847,0.0002267727,0.000024319603,0.00016218587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024561145,0.00030748826,0.0007012195,0.00009968092,0.00027525082,0.00001386022,0.000079236364,0.00017521562,0.00010262],"category_scores_gemma":[0.000017493407,0.00017423005,0.000119944074,0.000107456384,0.0007565611,0.00009766777,0.00007932503,0.00038881905,0.000015016224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004264412,0.0020240562,0.9811773,0.000039575025,0.0004107011,0.000006219487,0.00009108874,3.4464887e-7,0.0042068465,0.00013424354,0.000029903347,0.0076153167],"study_design_scores_gemma":[0.031654958,0.009775883,0.95589703,0.000063158666,0.00027252853,0.0000569609,0.00012954592,0.00020688189,0.0009588491,0.00002200358,0.0007780421,0.00018417319],"about_ca_topic_score_codex":0.00024890483,"about_ca_topic_score_gemma":0.00010036807,"teacher_disagreement_score":0.027390543,"about_ca_system_score_codex":0.000009711189,"about_ca_system_score_gemma":0.000010341466,"threshold_uncertainty_score":0.7104896},"labels":[],"label_agreement":null},{"id":"W1608528568","doi":"10.1002/hup.2326","title":"Patterns of atypical antipsychotic therapy use in adults with bipolar I disorder in the USA","year":2013,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Discontinuation; Bipolar disorder; Antipsychotic; Concomitant; Medicine; Bipolar I disorder; Internal medicine; Persistence (discontinuity); Psychiatry; Pediatrics; Schizophrenia (object-oriented programming); Mood; Mania","score_opus":0.04820522135731387,"score_gpt":0.39684679873718615,"score_spread":0.3486415773798723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608528568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945791,0.0037843331,0.0000018830008,0.00045259862,0.000111940695,0.0009774601,0.0000040381688,0.000008593774,0.00008009494],"genre_scores_gemma":[0.9975241,0.0009381597,0.000051348685,0.0011974606,0.000056538946,0.00016545854,0.000013402888,0.000014843586,0.000038687045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985962,0.00020512831,0.00048923667,0.00034600386,0.0001316645,0.00023177931],"domain_scores_gemma":[0.99947566,0.00014554331,0.00006909943,0.00019549982,0.000018995765,0.000095216485],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015320869,0.00017665733,0.0003662019,0.00008553326,0.000046395082,0.000011971742,0.00010323973,0.00012360659,0.0010617559],"category_scores_gemma":[0.000003998118,0.00010144068,0.000081125814,0.00010762514,0.00028092274,0.00009125717,0.00002123228,0.00035198254,0.000024274757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045425557,0.0056721177,0.9838336,0.000016035834,0.00007494026,0.000019520472,0.00099133,1.8922361e-7,0.0014099405,0.000056880817,0.00012689405,0.0032559645],"study_design_scores_gemma":[0.030085757,0.002483154,0.96563286,0.00006251638,0.000020665397,0.000027820053,0.0005813007,0.000016091337,0.00024642266,0.00003181288,0.00070528383,0.00010630653],"about_ca_topic_score_codex":0.0008371203,"about_ca_topic_score_gemma":0.001018648,"teacher_disagreement_score":0.025543202,"about_ca_system_score_codex":0.000009410905,"about_ca_system_score_gemma":0.000013043641,"threshold_uncertainty_score":0.9998514},"labels":[],"label_agreement":null},{"id":"W1622313911","doi":"10.1002/hup.2383","title":"Positive perception of pharmacogenetic testing for psychotropic medications","year":2014,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto; Centre for Addiction and Mental Health; Western University","funders":"Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research; University of Toronto","keywords":"Pharmacogenetics; Medicine; Perception; Psychology; Pharmacology; Biology; Genetics; Neuroscience; Genotype; Gene","score_opus":0.1763177381488729,"score_gpt":0.5428489992395906,"score_spread":0.36653126109071776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1622313911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886736,0.0015538041,0.0004596099,0.0007335217,0.0030103542,0.00088927534,0.0000930852,0.00007627041,0.0045104558],"genre_scores_gemma":[0.98963237,0.00027861728,0.0020905153,0.005871002,0.0015045822,0.0002832534,0.000051573017,0.00004387007,0.000244217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99676776,0.0007859264,0.001105429,0.0006853123,0.00016477406,0.00049078604],"domain_scores_gemma":[0.9976151,0.0011411652,0.00037652336,0.00019989381,0.00016190429,0.00050543575],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012985639,0.00033170715,0.0005915019,0.00015040638,0.0004846523,0.000013763422,0.0003484286,0.00036740178,0.0014795014],"category_scores_gemma":[0.000072610244,0.00032640743,0.00023312077,0.00015243204,0.0011525714,0.000076787815,0.00010089045,0.00058874115,0.000046805173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00119968,0.0014877305,0.013520987,0.000044253018,0.00035662323,0.0000018970478,0.00064485776,0.000028209482,0.91959965,0.0009967615,0.0074738082,0.054645568],"study_design_scores_gemma":[0.11720138,0.008285607,0.09681841,0.00010398753,0.003697312,0.0001360416,0.0015255663,0.02573957,0.45845264,0.012130544,0.27332935,0.00257959],"about_ca_topic_score_codex":0.0000055745454,"about_ca_topic_score_gemma":7.9594014e-7,"teacher_disagreement_score":0.46114698,"about_ca_system_score_codex":0.00001968068,"about_ca_system_score_gemma":0.000044335553,"threshold_uncertainty_score":0.9999188},"labels":[],"label_agreement":null},{"id":"W1749705612","doi":"10.1002/hup.2477","title":"Detecting a signal in the noise: monitoring the global spread of novel psychoactive substances using media and other open‐source information","year":2015,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Forensic Toxicology and Drug Analysis","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Carleton University; Canadian Centre on Substance Use and Addiction","funders":"Health Canada; Government of Canada; Public Health Agency; Public Health Agency of Canada","keywords":"Law enforcement; Public health; Relevance (law); Enforcement; Agency (philosophy); Psychoactive substance; Computer security; Computer science; Psychology; Medicine; Internet privacy; Political science; Psychiatry; Sociology; Law","score_opus":0.2633703388882517,"score_gpt":0.5339977098763229,"score_spread":0.2706273709880712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1749705612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944356,0.0016050023,0.00008492995,0.00054119836,0.0011790559,0.00048234395,0.00002769703,0.000018873176,0.001625296],"genre_scores_gemma":[0.9959655,0.000039493883,0.00025257893,0.0032990617,0.00036342136,0.00005661828,0.0000032386292,0.000009265863,0.000010832286],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9975196,0.0008654304,0.00079406705,0.00032037933,0.00017087323,0.00032961107],"domain_scores_gemma":[0.9983376,0.0008930361,0.00037066205,0.00015455631,0.00006050899,0.00018361576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025020246,0.00023270403,0.00041458398,0.00007320592,0.00040320505,0.000049323546,0.000495535,0.00034253075,0.0001314673],"category_scores_gemma":[0.000075716045,0.00015579241,0.000090639376,0.0002817166,0.0015743134,0.00031989193,0.0001965971,0.00080977916,0.000005783254],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0139837535,0.0033766024,0.8667662,0.000037999027,0.0011304761,0.000025928228,0.05742487,0.0011896162,0.029417627,0.0028615266,0.0017868147,0.021998568],"study_design_scores_gemma":[0.22717792,0.0064550755,0.2452343,0.00034584044,0.0038372716,0.0012095345,0.26721314,0.058474686,0.09068747,0.010597922,0.0849874,0.0037794472],"about_ca_topic_score_codex":0.00018769561,"about_ca_topic_score_gemma":0.00006786818,"teacher_disagreement_score":0.6215319,"about_ca_system_score_codex":0.000050119066,"about_ca_system_score_gemma":0.000054273813,"threshold_uncertainty_score":0.63530296},"labels":[],"label_agreement":null},{"id":"W1894568551","doi":"10.1002/hup.1243","title":"The effects of agomelatine on sexual function in depressed patients and healthy volunteers","year":2011,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Fowler Kennedy Sport Medicine Clinic; University Health Network","funders":"","keywords":"Agomelatine; Sexual function; Psychology; Internal medicine; Medicine; Clinical psychology; Antidepressant","score_opus":0.09401394231628969,"score_gpt":0.46807398319986937,"score_spread":0.3740600408835797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1894568551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19150102,0.803871,6.920649e-7,0.000020584193,0.0030466255,0.0010327869,0.000003886237,0.000023428762,0.0005000221],"genre_scores_gemma":[0.033044044,0.964206,0.0000047346493,0.0012978212,0.00034286076,0.00024911616,0.00003762598,0.00003387933,0.00078393007],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977889,0.00034173773,0.0010038398,0.00051557337,0.00013244744,0.00021752289],"domain_scores_gemma":[0.99845034,0.0008820237,0.00029106566,0.00016512444,0.00003834387,0.00017310116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029746015,0.00031119926,0.0012421208,0.00014902672,0.00019881174,0.000006940606,0.000058456324,0.00030691165,0.00010890999],"category_scores_gemma":[0.00008682157,0.00019596826,0.00014616823,0.000105712956,0.0005463885,0.000028231636,0.00007576698,0.00061176735,0.000024989979],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019742886,0.005668711,0.025922643,0.0075576366,0.0016239542,0.00001969991,0.0005910933,3.3629902e-8,0.000099114484,0.0003658801,0.023651801,0.91475654],"study_design_scores_gemma":[0.028682763,0.02256893,0.020155732,0.0012880231,0.0011004618,0.000015275893,0.00033893363,0.0000030241672,0.000010117288,0.000019611845,0.9254526,0.0003645553],"about_ca_topic_score_codex":0.000021435828,"about_ca_topic_score_gemma":0.0000048821294,"teacher_disagreement_score":0.914392,"about_ca_system_score_codex":0.000032019227,"about_ca_system_score_gemma":0.000032165077,"threshold_uncertainty_score":0.7991354},"labels":[],"label_agreement":null},{"id":"W1933977529","doi":"10.1002/hup.2243","title":"Effects of anxiolytic treatment on potentiated startle during aversive image anticipation","year":2012,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Drug Abuse; National Institute of Mental Health","keywords":"Anticipation (artificial intelligence); Psychology; Anxiety; Anxiolytic; Aversive Stimulus; Functional magnetic resonance imaging; Arousal; Audiology; Neuroscience; Developmental psychology; Medicine; Psychiatry","score_opus":0.05165671553649838,"score_gpt":0.4510372539875754,"score_spread":0.399380538451077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1933977529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98625004,0.0039861538,0.00001854181,0.00004019574,0.0048668967,0.00071089447,0.000022589662,0.000074037824,0.004030637],"genre_scores_gemma":[0.99567765,0.0017438357,0.000075794145,0.0002884703,0.00074647955,0.00021037944,0.000034549234,0.00004230598,0.0011805579],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976371,0.0004111147,0.0006185403,0.00062538724,0.00017473479,0.00053310796],"domain_scores_gemma":[0.99865115,0.00040638357,0.0003244679,0.00022044449,0.000072451,0.00032510076],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019606309,0.00035453393,0.0005094108,0.0002599638,0.00025514344,0.0000146166,0.00013808334,0.00024749327,0.0021391679],"category_scores_gemma":[0.000044291475,0.00030374457,0.0002013993,0.00022095602,0.0005215228,0.0001872312,0.0000659264,0.0002405577,0.0002965507],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013881296,0.044055164,0.32601014,0.00017961644,0.0028733169,0.00012726802,0.010038467,9.643924e-7,0.5654745,0.00039811232,0.016082214,0.0208789],"study_design_scores_gemma":[0.03554696,0.0047728918,0.55256665,0.000062524676,0.00049973716,0.000022335944,0.0013815291,0.0000064787882,0.4018703,0.00012641074,0.002636169,0.0005079929],"about_ca_topic_score_codex":0.000030754185,"about_ca_topic_score_gemma":5.9469374e-7,"teacher_disagreement_score":0.22655651,"about_ca_system_score_codex":0.000074379284,"about_ca_system_score_gemma":0.000012620114,"threshold_uncertainty_score":0.99994147},"labels":[],"label_agreement":null},{"id":"W1937837739","doi":"10.1002/hup.1219","title":"Genetic interactions in the adrenergic system genes: analysis of antipsychotic‐induced weight gain","year":2011,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Adrenergic; Adrenergic receptor; Receptor; Biology; Weight gain; Monoamine oxidase A; Antipsychotic; Endocrinology; Monoamine oxidase; Phenotype; Internal medicine; Gene; Genetics; Pharmacology; Medicine; Schizophrenia (object-oriented programming); Enzyme; Serotonin; Body weight; Biochemistry; Psychiatry","score_opus":0.16291012432290258,"score_gpt":0.44180190072836045,"score_spread":0.27889177640545787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1937837739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642974,0.00010915697,0.000008236548,0.00003397111,0.0010846698,0.0003902249,0.000010346801,0.000038224385,0.00189544],"genre_scores_gemma":[0.9984638,0.000048833703,0.00007449796,0.0011425517,0.000090003385,0.00013566611,0.0000014185025,0.000016688957,0.000026516871],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970405,0.00086812326,0.00096169824,0.00065547397,0.00019332036,0.00028085787],"domain_scores_gemma":[0.99905896,0.00023774004,0.0002224473,0.00034492058,0.000017343065,0.00011859426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029821793,0.00021272148,0.00045841906,0.00033880412,0.00014641632,0.000018133689,0.00052989146,0.000083694125,0.00089647656],"category_scores_gemma":[0.00000861785,0.00016111752,0.00026511142,0.00063337514,0.0005464684,0.00010793989,0.00004794975,0.00036410213,0.00003488127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004596454,0.001554358,0.059243694,0.000008673959,0.00007267406,0.000076985554,0.0017416482,0.0000037707698,0.93579406,0.0003840577,0.00013836518,0.00052204385],"study_design_scores_gemma":[0.006834678,0.00088584155,0.3476253,0.000034182118,0.00086168636,0.000111163055,0.001562374,0.00055345386,0.64073485,0.00005216856,0.00028267977,0.00046163556],"about_ca_topic_score_codex":0.000052368454,"about_ca_topic_score_gemma":0.000016858547,"teacher_disagreement_score":0.29505923,"about_ca_system_score_codex":0.000017346003,"about_ca_system_score_gemma":0.000011853259,"threshold_uncertainty_score":0.981579},"labels":[],"label_agreement":null},{"id":"W1949474745","doi":"10.1002/hup.2258","title":"Methylphenidate‐mediated reduction in prefrontal hemodynamic responses to working memory task: a functional near‐infrared spectroscopy study","year":2012,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Optical Imaging and Spectroscopy Techniques","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Placebo; Functional near-infrared spectroscopy; Prefrontal cortex; Crossover study; Methylphenidate; Working memory; Cognition; Anesthesia; Audiology; Psychology; Elementary cognitive task; Effects of sleep deprivation on cognitive performance; Medicine; Internal medicine; Cardiology; Neuroscience; Psychiatry; Attention deficit hyperactivity disorder; Pathology","score_opus":0.06063489954899019,"score_gpt":0.4540011986362789,"score_spread":0.3933662990872887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1949474745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939101,0.0006353318,0.00004604821,0.0005038121,0.0012727601,0.0011392615,0.000004149998,0.00021141158,0.0022771421],"genre_scores_gemma":[0.992738,0.000021669515,0.004241722,0.0011106468,0.00072773255,0.00023863737,0.000028678123,0.000037767444,0.00085513893],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974866,0.00037276596,0.0007442458,0.00061109266,0.00023936068,0.00054596993],"domain_scores_gemma":[0.99900067,0.00015478014,0.00009137998,0.00023172729,0.000029143284,0.00049232645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00091303466,0.00027881225,0.00057026296,0.00021215378,0.00021201166,0.000037588397,0.000098519806,0.0001789036,0.0006526758],"category_scores_gemma":[0.00006688337,0.0002568661,0.00011649512,0.00022494102,0.00043775284,0.0001594487,0.00011242512,0.0007203381,0.000067342546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01365375,0.0064066234,0.15997858,0.0000086058435,0.00013692428,0.00004528383,0.0017461455,5.531294e-7,0.81273574,0.000032175452,0.0048529417,0.00040269087],"study_design_scores_gemma":[0.03277369,0.010048671,0.8558219,0.00011862148,0.00031664452,0.00028334674,0.0053146537,0.0003657845,0.09174753,0.0002575106,0.0020770452,0.0008746083],"about_ca_topic_score_codex":0.00003405806,"about_ca_topic_score_gemma":0.000003523289,"teacher_disagreement_score":0.7209882,"about_ca_system_score_codex":0.00016037375,"about_ca_system_score_gemma":0.000052220064,"threshold_uncertainty_score":0.9999884},"labels":[],"label_agreement":null},{"id":"W1953092902","doi":"10.1002/hup.2421","title":"A review on schizophrenia and relapse—a quest for user‐friendly psychopharmacotherapy","year":2014,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Schizophrenia (object-oriented programming); User Friendly; Psychiatry; Psychology; Medicine; Psychotherapist; Computer science; Operating system","score_opus":0.1041482483956502,"score_gpt":0.5287976079021227,"score_spread":0.42464935950647253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1953092902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010816263,0.99090064,0.000002804736,0.0005727238,0.00083410606,0.0050342623,0.00007008283,0.00012607797,0.0013776604],"genre_scores_gemma":[0.00013232435,0.987384,0.0010500359,0.0049359477,0.0014471038,0.0021548348,0.00017209996,0.00021860926,0.002505012],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957388,0.0005405076,0.0014326276,0.0014735514,0.00024010827,0.00057441357],"domain_scores_gemma":[0.99741006,0.000633211,0.00043429053,0.00051328045,0.000049331953,0.0009598473],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007602355,0.0008457885,0.0033646943,0.0002593843,0.00027077788,0.000038412953,0.00023016463,0.00054376986,0.0013462617],"category_scores_gemma":[0.000059919632,0.0006074226,0.00092402386,0.0001545887,0.0007271391,0.000044709806,0.000090114176,0.0009882719,0.00026443778],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016218686,0.0020422693,0.000018300952,0.017266799,0.0015988869,0.00008147968,0.000009823078,2.608178e-9,0.000036343987,0.0014282776,0.26473692,0.69656223],"study_design_scores_gemma":[0.033800505,0.00623162,0.000017505981,0.017483994,0.0016918544,0.00022690416,0.0000036490712,0.0000015876263,0.000012226442,0.00007764668,0.939978,0.00047448184],"about_ca_topic_score_codex":0.0000039734073,"about_ca_topic_score_gemma":0.000002732984,"teacher_disagreement_score":0.6960877,"about_ca_system_score_codex":0.000065177555,"about_ca_system_score_gemma":0.00015566098,"threshold_uncertainty_score":0.9996377},"labels":[],"label_agreement":null},{"id":"W1970434963","doi":"10.1002/hup.530","title":"Donepezil in a chronic drug user—a potential treatment?","year":2003,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Donepezil; Dysexecutive syndrome; Psychology; Neuropsychology; MDMA; Wechsler Adult Intelligence Scale; Clinical psychology; Cognition; Neuropsychological test; Psychiatry; Cognitive psychology; Developmental psychology; Medicine; Dementia; Internal medicine","score_opus":0.06629194327758388,"score_gpt":0.43210154173832144,"score_spread":0.3658095984607376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970434963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962296,0.00034729586,0.000001421562,0.00017912356,0.0013963301,0.00058257044,0.000007335697,0.000082057704,0.0011742649],"genre_scores_gemma":[0.99648154,0.0002117505,0.00004522497,0.0019574168,0.0002077024,0.00021073822,0.0000014890613,0.000033423406,0.00085071573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705786,0.00067882973,0.0006778051,0.0009400645,0.00015894469,0.00048651264],"domain_scores_gemma":[0.9992928,0.00012111932,0.000101444886,0.0002246676,0.0000075383773,0.00025246778],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019952192,0.0003011368,0.00038956405,0.0001210484,0.00021475994,0.000044793178,0.00023483153,0.00013464164,0.002599579],"category_scores_gemma":[0.000014509986,0.00027475282,0.00016711434,0.00015503945,0.0007809831,0.00019758288,0.000039642804,0.0003789666,0.00023824086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045381614,0.0014173588,0.0070675067,0.000003935768,0.0000077475925,0.00026276225,0.00023853162,0.0000043507835,0.9884024,0.00044534696,0.0007366863,0.0009595499],"study_design_scores_gemma":[0.027584417,0.001295419,0.003519253,0.000012717062,0.000032815384,0.00011802702,0.00008736088,0.000021452388,0.9503781,0.0001973626,0.016325438,0.00042762136],"about_ca_topic_score_codex":0.000021320944,"about_ca_topic_score_gemma":0.000011819267,"teacher_disagreement_score":0.03802429,"about_ca_system_score_codex":0.000118127115,"about_ca_system_score_gemma":0.000055973087,"threshold_uncertainty_score":0.99997044},"labels":[],"label_agreement":null},{"id":"W1971912227","doi":"10.1002/hup.226","title":"Self‐report of memory and affective dysfunction in association with medication use in a sample of individuals with chronic sleep disturbance","year":2000,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sleep and related disorders","field":"Psychology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; University Health Network","funders":"","keywords":"Association (psychology); Sleep disorder; Disturbance (geology); Sleep (system call); Psychology; Clinical psychology; Sample (material); Psychiatry; Medicine; Audiology; Cognition; Psychotherapist; Computer science; Biology","score_opus":0.017569865354006897,"score_gpt":0.36063283140744673,"score_spread":0.34306296605343983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971912227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99696964,0.0011732815,0.000007822677,0.000092434115,0.00022302954,0.0004891981,0.0000075694875,0.000017388944,0.001019653],"genre_scores_gemma":[0.9992938,0.00018056922,0.00011526255,0.0001120888,0.00004824274,0.000109049244,0.000025261863,0.000012366943,0.00010337401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984241,0.00029513997,0.0005644835,0.00039358315,0.00014200632,0.00018067083],"domain_scores_gemma":[0.99906933,0.00042057995,0.0003098418,0.00011618283,0.000022783155,0.000061302584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050636276,0.0001355435,0.00034607496,0.000114785944,0.00004091871,0.000004618398,0.000055785233,0.00024648305,0.0007172835],"category_scores_gemma":[0.000017242506,0.0001087417,0.0000308275,0.00016778558,0.00036020819,0.000109571076,0.000013231556,0.0003017076,0.0000028786549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022986177,0.002224668,0.9873276,0.000016013275,0.00049562246,0.00002582691,0.0034162742,0.000018788862,0.00061813387,0.000056844947,0.00029140324,0.0032102556],"study_design_scores_gemma":[0.02861903,0.001987218,0.967151,0.000047259095,0.000136295,0.000029203744,0.0008289339,0.00005664008,0.0006616366,0.00007049966,0.0002518518,0.00016045703],"about_ca_topic_score_codex":0.00050819427,"about_ca_topic_score_gemma":0.00022295004,"teacher_disagreement_score":0.026320413,"about_ca_system_score_codex":0.000065516855,"about_ca_system_score_gemma":0.000023387935,"threshold_uncertainty_score":0.7853751},"labels":[],"label_agreement":null},{"id":"W1973189506","doi":"10.1002/hup.665","title":"Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation","year":2005,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Dextroamphetamine; Lithium (medication); Placebo; Psychology; Neuroscience; Pharmacology; Anesthesia; Medicine; Psychiatry; Amphetamine; Pathology","score_opus":0.0868604780322,"score_gpt":0.46082887580146226,"score_spread":0.3739683977692623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973189506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802597,0.00062783936,0.0000016362774,0.017122712,0.0002413384,0.000572661,0.0000020724256,0.000054479562,0.0011175422],"genre_scores_gemma":[0.9809812,0.00022764159,0.00010810375,0.017335748,0.0007296734,0.000108261855,0.000006434312,0.00001549625,0.00048744903],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99847853,0.0001848529,0.00041656915,0.00050141563,0.00010982696,0.00030878428],"domain_scores_gemma":[0.99928963,0.000279877,0.00009122823,0.00008670134,0.000021922699,0.00023063587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004619565,0.00021655213,0.00049363205,0.00009823854,0.00015253785,0.000014109444,0.000056180488,0.00017988036,0.00028058275],"category_scores_gemma":[0.0000499266,0.00017129147,0.000064108564,0.00008939148,0.00036466998,0.00008775777,0.0001067909,0.00042618267,0.000016437973],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020738598,0.0014289327,0.022869432,0.00003158706,0.00012991353,0.000043231885,0.00053977326,4.5747524e-7,0.94941956,0.0000692904,0.0047200476,0.018673899],"study_design_scores_gemma":[0.061172947,0.0067180437,0.593297,0.00012541335,0.00018292617,0.00010029753,0.00059420324,0.00096974743,0.3179661,0.00022060426,0.017958695,0.00069401175],"about_ca_topic_score_codex":0.000012655129,"about_ca_topic_score_gemma":0.000018901746,"teacher_disagreement_score":0.63145345,"about_ca_system_score_codex":0.000035163797,"about_ca_system_score_gemma":0.000010932414,"threshold_uncertainty_score":0.6985063},"labels":[],"label_agreement":null},{"id":"W1979260280","doi":"10.1002/hup.676","title":"A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis","year":2005,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; The Scarborough Hospital","funders":"","keywords":"Galantamine; Donepezil; Meta-analysis; Cognition; Disease; Alzheimer's disease; Psychology; Dementia; Medicine; Intervention (counseling); Psychiatry; Pharmacology; Internal medicine","score_opus":0.3437238473383894,"score_gpt":0.5819603609728178,"score_spread":0.23823651363442838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979260280","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37338144,0.62556803,1.2237184e-7,0.000020825848,0.000030539613,0.0007428707,0.00022474569,0.0000026985767,0.000028770024],"genre_scores_gemma":[0.46684676,0.5325713,0.0000044911335,0.000110105306,0.00008800431,0.00017280683,0.00018041508,0.000010716647,0.000015405123],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967876,0.0006663644,0.0017165851,0.00050204137,0.00018332202,0.00014409193],"domain_scores_gemma":[0.9980166,0.0008581939,0.00067967834,0.00022448716,0.000051653682,0.00016941054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019434966,0.00037831865,0.004869149,0.00026270165,0.00003689289,0.000004308247,0.00008796291,0.00014035712,0.00038866812],"category_scores_gemma":[0.000013538803,0.00021265786,0.0019505078,0.00024907713,0.00081112236,0.000024238003,0.000032397893,0.0001763046,9.551966e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0126877,0.097005144,0.04856342,0.0039163763,0.60089827,0.0003269361,0.005429597,0.0000021529527,0.0005095527,0.000064689826,0.0009804566,0.2296157],"study_design_scores_gemma":[0.013783339,0.005913207,0.008851049,0.00055206264,0.9567469,0.000018877405,0.0003591839,0.000019761648,0.00053363875,0.0000026488722,0.0128983995,0.00032097558],"about_ca_topic_score_codex":0.000011145611,"about_ca_topic_score_gemma":0.000005846778,"teacher_disagreement_score":0.35584858,"about_ca_system_score_codex":0.000008601028,"about_ca_system_score_gemma":0.00005195605,"threshold_uncertainty_score":0.8671936},"labels":[],"label_agreement":null},{"id":"W1982900708","doi":"10.1002/hup.480","title":"Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers","year":2003,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Amphetamine; Mania; Stimulant; Placebo; Metabolite; Internal medicine; Endocrinology; Crossover study; Plasma concentration; Psychology; Pharmacology; Medicine; Dopamine; Bipolar disorder; Lithium (medication)","score_opus":0.17859813782405698,"score_gpt":0.45509106250014364,"score_spread":0.27649292467608666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982900708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853104,0.00011088633,0.0000048947345,0.0001367667,0.00029149512,0.0006140359,0.000020896565,0.000027477981,0.00026251565],"genre_scores_gemma":[0.9973078,0.000022425576,0.000099511875,0.0023758693,0.000032706695,0.00011453912,0.000001096797,0.000015331852,0.000030730756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975182,0.0006493603,0.00063884194,0.0007440488,0.00015316154,0.00029641576],"domain_scores_gemma":[0.9989181,0.00060249236,0.000096340525,0.00009990636,0.000028572076,0.0002545709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029949046,0.00019851307,0.00038918617,0.00012063615,0.00012582331,0.000012357075,0.0001270854,0.00015554766,0.0002780708],"category_scores_gemma":[0.00038570864,0.00018677433,0.00006850806,0.00020880508,0.0011671556,0.00009217315,0.00004857566,0.00041134277,0.000021408556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015143213,0.0008755131,0.0878195,0.000007654636,0.0000044928433,0.00001117187,0.00036629828,8.0282115e-7,0.9087882,0.00027372784,0.00014343201,0.00019485876],"study_design_scores_gemma":[0.008288908,0.0018288104,0.26496297,0.000022259326,0.000015459926,0.000023069906,0.00021973549,0.0000057458815,0.72416544,0.00016742003,0.00007639291,0.00022380525],"about_ca_topic_score_codex":0.000006454513,"about_ca_topic_score_gemma":0.0000031406423,"teacher_disagreement_score":0.18462281,"about_ca_system_score_codex":0.000021912105,"about_ca_system_score_gemma":0.000023696548,"threshold_uncertainty_score":0.7616436},"labels":[],"label_agreement":null},{"id":"W1985931523","doi":"10.1002/hup.1146","title":"Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response","year":2010,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Clozapine; Schizophrenia (object-oriented programming); Neurexin; Neuroscience; Medicine; Internal medicine; Biology; Psychiatry; Receptor; Postsynaptic potential","score_opus":0.07579218702771681,"score_gpt":0.47543872277325483,"score_spread":0.399646535745538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985931523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973272,0.00007923696,1.516147e-7,0.0008784605,0.0010492485,0.00039387366,0.00000931313,0.000045939265,0.00021655498],"genre_scores_gemma":[0.9938216,0.00012990042,0.000013184193,0.0055268886,0.0001375484,0.00006167748,2.7877908e-7,0.000021886808,0.0002870232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964643,0.0010197138,0.0008229699,0.00091241393,0.00027334967,0.0005072649],"domain_scores_gemma":[0.9980864,0.0011172428,0.00016872353,0.00028972412,0.000025738951,0.00031219106],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0010906948,0.0002260616,0.00040787592,0.00029091717,0.00021789465,0.000019808433,0.00062056567,0.00019443924,0.0006055046],"category_scores_gemma":[0.0004555446,0.00020889608,0.00010020596,0.0004095984,0.0033133246,0.00023067847,0.00029675843,0.001283724,0.00006026471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006047663,0.0010819124,0.016338801,0.0000038876387,0.0000027667343,0.00025433605,0.00013548226,0.0000089543455,0.9751545,0.0002616198,0.00045249076,0.00025755158],"study_design_scores_gemma":[0.006935281,0.001229403,0.07411958,0.0000055510586,0.0000055628343,0.000097197124,0.0000145866015,0.000086211105,0.9156787,0.00016851621,0.0014767996,0.0001826438],"about_ca_topic_score_codex":0.000010985647,"about_ca_topic_score_gemma":0.000003550762,"teacher_disagreement_score":0.05947587,"about_ca_system_score_codex":0.00000827558,"about_ca_system_score_gemma":0.00006859467,"threshold_uncertainty_score":0.99939907},"labels":[],"label_agreement":null},{"id":"W1991293593","doi":"10.1002/hup.1170","title":"The acute effect of Swedish‐style snus on cigarette craving and self‐administration in male and female smokers","year":2011,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Snus; Placebo; Lozenge; Craving; Nicotine; Medicine; Smoking cessation; Harm reduction; Randomized controlled trial; Psychology; Clinical psychology; Physical therapy; Psychiatry; Internal medicine; Smokeless tobacco; Addiction; Environmental health; Tobacco use; Public health; Population; Alternative medicine","score_opus":0.050760917946429174,"score_gpt":0.4256653895921206,"score_spread":0.3749044716456914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991293593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769336,0.00019252635,2.637005e-7,0.00011361875,0.0003511193,0.0003348107,0.0000022546049,0.00001667363,0.0012953562],"genre_scores_gemma":[0.9993071,0.00016438353,0.000013517262,0.0002744827,0.000081389706,0.000044323806,0.000005928176,0.000009681973,0.000099206525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990155,0.0001317939,0.00034820562,0.00026903566,0.000096827,0.0001386321],"domain_scores_gemma":[0.999522,0.00017855714,0.000092337745,0.000097481105,0.000011391173,0.00009824608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004524386,0.00012207468,0.0002468477,0.000044056087,0.00013668402,0.000011209899,0.000042011165,0.00011473532,0.00013572809],"category_scores_gemma":[0.000011299613,0.00008701489,0.00004390297,0.00003960844,0.0004040535,0.000046901554,0.000030130144,0.00024246842,6.6501394e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005465769,0.0007578612,0.96138513,0.000029595632,0.00012409671,0.000083879786,0.0015528965,1.5998841e-8,0.027609358,0.00009445364,0.0004711322,0.0024258338],"study_design_scores_gemma":[0.012375496,0.0065261014,0.91161007,0.000048421323,0.0002496448,0.00010323177,0.0004649586,0.000015459114,0.06835879,0.00002292736,0.00010190511,0.00012302866],"about_ca_topic_score_codex":0.000013058181,"about_ca_topic_score_gemma":0.000003122432,"teacher_disagreement_score":0.04977507,"about_ca_system_score_codex":0.000013003132,"about_ca_system_score_gemma":0.000009857074,"threshold_uncertainty_score":0.3548364},"labels":[],"label_agreement":null},{"id":"W1991510272","doi":"10.1002/hup.467","title":"Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review","year":2002,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Paroxetine; Panic disorder; Anxiety; Generalized anxiety disorder; Psychiatry; Anxiety disorder; Panic; Depression (economics); Psychology; Tolerability; Social anxiety; Adverse effect; Antidepressant; Medicine; Internal medicine","score_opus":0.22065676671635012,"score_gpt":0.5230055692913864,"score_spread":0.30234880257503627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991510272","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006046455,0.98779255,0.0000075134967,0.00014803802,0.0010583177,0.004453618,0.0001377526,0.000016116053,0.00033966],"genre_scores_gemma":[0.008975353,0.9867102,0.00006544848,0.00032613613,0.00032039938,0.003230812,0.00006320103,0.0000538779,0.00025460147],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99563324,0.0011122593,0.0016961572,0.0009966199,0.00018809743,0.00037364016],"domain_scores_gemma":[0.9944457,0.00382349,0.0010004903,0.0005537657,0.00006121223,0.00011537294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006698656,0.0006085896,0.0020254864,0.00019103954,0.00020723227,0.000019716404,0.00040527858,0.00043749015,0.0006758137],"category_scores_gemma":[0.000089967725,0.0003165349,0.0007145836,0.00040938632,0.0010941682,0.00007109194,0.00007681375,0.00037991814,0.000007661975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004388613,0.0050793607,0.0030019653,0.0023266352,0.0006886496,0.0000024792032,0.00061504566,2.633852e-8,0.000002463907,0.000033460576,0.012801824,0.9750092],"study_design_scores_gemma":[0.0058631967,0.0028266325,0.0006718651,0.002388428,0.0019174884,0.000028115399,0.0002520452,0.0000016559098,0.000004764873,0.00005902681,0.98570347,0.00028332585],"about_ca_topic_score_codex":0.000049887112,"about_ca_topic_score_gemma":0.000012459307,"teacher_disagreement_score":0.9747259,"about_ca_system_score_codex":0.000025679241,"about_ca_system_score_gemma":0.000023799495,"threshold_uncertainty_score":0.99992865},"labels":[],"label_agreement":null},{"id":"W1992505607","doi":"10.1002/hup.1161","title":"Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective","year":2011,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Tardive dyskinesia; Antipsychotic; Biomarker; Schizophrenia (object-oriented programming); Prolactin; Dyskinesia; Allele; Internal medicine; Pharmacogenetics; Medicine; Endocrinology; Genotype; Psychology; Oncology; Psychiatry; Genetics; Biology; Parkinson's disease; Hormone; Gene; Disease","score_opus":0.058328678059480554,"score_gpt":0.4136569510773177,"score_spread":0.35532827301783715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992505607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497396,0.0035878925,0.00002610049,0.00018252543,0.00022242701,0.00076837925,0.000047272177,0.000012451688,0.00017899231],"genre_scores_gemma":[0.9950998,0.00044688917,0.0028192592,0.0006821474,0.00033465936,0.0003311331,0.000049457758,0.000023434,0.000213208],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977904,0.0006011832,0.00050634105,0.0007736064,0.00004426831,0.0002842279],"domain_scores_gemma":[0.9992742,0.00017176452,0.00015758442,0.00019039633,0.000050042,0.00015600443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041648207,0.00024412051,0.00041831256,0.00007131583,0.00014436082,0.000011233395,0.00010144388,0.00031507207,0.00009584471],"category_scores_gemma":[0.00011906221,0.00021268106,0.00012976408,0.00005638198,0.00032699938,0.000005399316,0.00007923741,0.00008801448,0.000008172237],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.121485785,0.0020066502,0.22164208,0.000008840192,0.00082833617,0.000047187576,0.0027317435,0.0000011109879,0.6466656,0.00012663499,0.002652264,0.001803821],"study_design_scores_gemma":[0.019753931,0.004463517,0.96123934,0.000011859105,0.00010875969,0.000019390292,0.00097301794,0.00010916897,0.009941359,0.0013291774,0.0017162273,0.0003342696],"about_ca_topic_score_codex":0.00015237991,"about_ca_topic_score_gemma":0.000057735033,"teacher_disagreement_score":0.73959726,"about_ca_system_score_codex":0.000038757837,"about_ca_system_score_gemma":0.00004457135,"threshold_uncertainty_score":0.8672882},"labels":[],"label_agreement":null},{"id":"W1993289280","doi":"10.1002/hup.1111","title":"Association study of polymorphisms in Insulin Induced Gene 2 (INSIG2) with antipsychotic‐induced weight gain in European and African‐American schizophrenia patients","year":2010,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Clozapine; Olanzapine; Risperidone; Antipsychotic; Weight gain; Haloperidol; Allele; Internal medicine; Medicine; Genotype; Schizophrenia (object-oriented programming); Oncology; Endocrinology; Genetics; Psychiatry; Biology; Gene; Dopamine; Body weight","score_opus":0.03299244179103093,"score_gpt":0.37749372504611367,"score_spread":0.3445012832550827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993289280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979318,0.00008773454,9.869643e-8,0.00026985686,0.0002644454,0.0010821244,0.0000062909075,0.00002146142,0.00033622008],"genre_scores_gemma":[0.9991816,0.000044846394,0.000260824,0.00021328809,0.00015697525,0.00007060995,0.000016814229,0.000032409636,0.000022606615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740237,0.0005255677,0.00077142374,0.00062279444,0.00031591894,0.0003619354],"domain_scores_gemma":[0.9989361,0.00016673387,0.0002775418,0.0002216254,0.000058543854,0.00033946108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006012609,0.00025553445,0.0006517095,0.00032140478,0.00008488783,0.000016316406,0.00011375625,0.00011795479,0.000093680515],"category_scores_gemma":[0.000054763907,0.00020385617,0.000051847102,0.00033058916,0.0002695293,0.0000755789,0.000085632506,0.00083657,0.000008340792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039987188,0.011558937,0.8491236,0.0000048963666,0.00018755802,0.00016078206,0.0010691588,9.237825e-8,0.093356706,0.000011790959,0.000048025227,0.0044912887],"study_design_scores_gemma":[0.087837115,0.011092172,0.89544505,0.000021314112,0.00005970038,0.0000074232057,0.0004619755,0.000017938895,0.004860461,0.000019224544,0.000008210917,0.00016943733],"about_ca_topic_score_codex":0.00028062687,"about_ca_topic_score_gemma":0.0006980101,"teacher_disagreement_score":0.088496245,"about_ca_system_score_codex":0.000060518276,"about_ca_system_score_gemma":0.00005604705,"threshold_uncertainty_score":0.83130133},"labels":[],"label_agreement":null},{"id":"W2000906264","doi":"10.1002/hup.873","title":"The neuropsychology of ecstasy (MDMA) use: a quantitative review","year":2007,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Forensic Toxicology and Drug Analysis","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital; University of Toronto","funders":"","keywords":"Ecstasy; MDMA; Neuropsychology; Psychology; Psychiatry; Cognition","score_opus":0.4500235545481315,"score_gpt":0.6435152760980752,"score_spread":0.19349172154994376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000906264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020093827,0.9879996,0.000005444319,0.00034835952,0.005277949,0.0016600225,0.00013124813,0.00008487036,0.0024831023],"genre_scores_gemma":[0.0006623836,0.9901427,0.0001104694,0.006530129,0.00053911714,0.000277508,0.000109554756,0.00009257254,0.0015355829],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98822576,0.0054541244,0.0037508777,0.0013223751,0.00027172145,0.0009751146],"domain_scores_gemma":[0.98863655,0.008064518,0.0018503269,0.00070035685,0.00017100442,0.0005772664],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.004633213,0.00096678396,0.0038948418,0.00030067266,0.0009988031,0.000030130432,0.0010136861,0.0019035551,0.0021724917],"category_scores_gemma":[0.00038113754,0.0006696698,0.0016269308,0.0006148486,0.0070048743,0.00012756416,0.00040787173,0.0039898464,0.00029692752],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028731707,0.0024803858,0.00016975479,0.0061213546,0.005429382,0.0003403283,0.00016679392,7.8224866e-7,0.00011420274,0.008984214,0.17991325,0.79340637],"study_design_scores_gemma":[0.0032220746,0.001419164,0.000032063428,0.0016488257,0.0040419777,0.00020411769,0.00006618258,0.000008840953,0.000030885527,0.00012859411,0.9886146,0.0005826348],"about_ca_topic_score_codex":0.000010209242,"about_ca_topic_score_gemma":0.000016290938,"teacher_disagreement_score":0.8087014,"about_ca_system_score_codex":0.00005679046,"about_ca_system_score_gemma":0.00017719387,"threshold_uncertainty_score":0.99957544},"labels":[],"label_agreement":null},{"id":"W2003064473","doi":"10.1002/hup.1084","title":"Lorazepam modulates orbitofrontal signal changes during emotional processing in catatonia","year":2009,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Electroconvulsive Therapy Studies","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Lorazepam; Catatonia; Orbitofrontal cortex; Psychology; Psychomotor learning; Functional magnetic resonance imaging; Neuroscience; Prefrontal cortex; Schizophrenia (object-oriented programming); Psychiatry; Cognition","score_opus":0.03797315505347342,"score_gpt":0.42542834760681386,"score_spread":0.38745519255334043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003064473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920147,0.0050397073,0.0000016847648,0.001838551,0.00016665192,0.00038253237,0.000002324118,0.00006729611,0.00048657565],"genre_scores_gemma":[0.9960247,0.00018277591,0.00017840453,0.0026268067,0.0006592595,0.00004166921,0.0000143259895,0.00001776817,0.00025425287],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984622,0.00007885898,0.00045379452,0.0004901462,0.0001440651,0.0003709485],"domain_scores_gemma":[0.99959373,0.000026351569,0.000092214636,0.00008379466,0.000035741385,0.00016814364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017256694,0.0002272166,0.00047485952,0.00012805869,0.00021683794,0.000014442531,0.0000782664,0.00013179088,0.00038116128],"category_scores_gemma":[0.0000055348723,0.00020504644,0.00007918858,0.00010157798,0.00038226732,0.00008604605,0.000037614685,0.00041096474,0.000013980752],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004292391,0.0019316237,0.06668459,0.000032874632,0.00008844502,0.00020088146,0.0010616204,0.000001366926,0.92060626,0.000057333596,0.0007219865,0.0043206443],"study_design_scores_gemma":[0.031577375,0.0045510526,0.838635,0.00015303907,0.00007651415,0.00029529398,0.00066258735,0.00023202687,0.12264912,0.0004466598,0.0002650338,0.00045626043],"about_ca_topic_score_codex":0.0000065465197,"about_ca_topic_score_gemma":0.000011583789,"teacher_disagreement_score":0.7979571,"about_ca_system_score_codex":0.000064884385,"about_ca_system_score_gemma":0.000027732462,"threshold_uncertainty_score":0.83615506},"labels":[],"label_agreement":null},{"id":"W2003829755","doi":"10.1002/hup.317","title":"Fluvoxamine in obsessive‐compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine","year":2001,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Clomipramine; Fluvoxamine; Tolerability; Clinical Global Impression; Psychology; Adverse effect; Rating scale; Psychiatry; Internal medicine; Anesthesia; Medicine; Fluoxetine; Serotonin; Placebo","score_opus":0.039236521161719974,"score_gpt":0.4226257529002544,"score_spread":0.3833892317385344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003829755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98946,0.0034116136,0.00001617544,0.0011376888,0.0013182065,0.0013819629,0.000017600449,0.00010713513,0.0031496054],"genre_scores_gemma":[0.9973829,0.00011783719,0.00016718033,0.0013072483,0.00030980402,0.0002874525,0.00006389083,0.00007135794,0.0002923597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943337,0.0010409579,0.0017651872,0.0016192583,0.0002552343,0.0009856927],"domain_scores_gemma":[0.9979368,0.0007816477,0.00033446524,0.0005323109,0.000051355615,0.00036344098],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005300637,0.00064269156,0.0014491694,0.00033234002,0.00022564261,0.000044262848,0.00050113816,0.0004299863,0.004356826],"category_scores_gemma":[0.00005134848,0.0005894132,0.00019206293,0.00053004856,0.0017586134,0.0001971827,0.00019295033,0.0013217259,0.0001382028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010029842,0.012969154,0.9613434,0.000014836144,0.00018210051,0.00062901987,0.0033681602,0.000068708156,0.004189889,0.00031592796,0.00078336627,0.0061056023],"study_design_scores_gemma":[0.060236935,0.0030269541,0.92413896,0.00005018535,0.000056452765,0.00007188503,0.008145021,0.00028756997,0.00034797838,0.0001725267,0.0027000657,0.00076547597],"about_ca_topic_score_codex":0.00050544995,"about_ca_topic_score_gemma":0.0007936096,"teacher_disagreement_score":0.050207093,"about_ca_system_score_codex":0.00011620236,"about_ca_system_score_gemma":0.000045556826,"threshold_uncertainty_score":0.9996557},"labels":[],"label_agreement":null},{"id":"W2005015693","doi":"10.1002/1099-1077(200010)15:7<559::aid-hup230>3.0.co;2-j","title":"Hallucinogenic drugs attenuate the subjective response to alcohol in humans","year":2000,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Psilocybin; Hallucinogen; Lysergic acid diethylamide; Serotonergic; Alcohol; Antagonism; Psychology; Pharmacology; Alcohol addiction; Medicine; Addiction; Psychiatry; Chemistry; Receptor; Internal medicine; Serotonin","score_opus":0.07015782356166694,"score_gpt":0.47569956591512885,"score_spread":0.4055417423534619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005015693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9609694,0.0017112839,6.9496735e-7,0.0043760943,0.0014251701,0.00068850355,0.00001348455,0.00005842952,0.030756954],"genre_scores_gemma":[0.98150814,0.00008224124,0.000017511791,0.010324777,0.0004802718,0.0004392135,0.0000033327294,0.00003380049,0.0071107326],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9965102,0.0010262921,0.00081788475,0.0008990387,0.00015872315,0.00058784324],"domain_scores_gemma":[0.99869114,0.0005484003,0.00008589868,0.00041082024,0.000027010206,0.00023672848],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0014884055,0.00031142548,0.0004715687,0.00012529813,0.00044302177,0.000030947638,0.00039667886,0.00020013808,0.007899135],"category_scores_gemma":[0.000016303964,0.00023910891,0.00018933493,0.000232034,0.00074064784,0.000054538712,0.00011839345,0.0005565536,0.0013550405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14762992,0.012468092,0.15840636,0.000016337088,0.0022133798,0.0006258045,0.17658374,0.000029002618,0.10901666,0.00522148,0.33892593,0.048863295],"study_design_scores_gemma":[0.032549746,0.00260116,0.8405704,0.000030777624,0.000090709604,0.000036631678,0.011673507,0.000014332842,0.0009693046,0.0013035542,0.10926936,0.0008905426],"about_ca_topic_score_codex":0.0001408681,"about_ca_topic_score_gemma":0.00006350425,"teacher_disagreement_score":0.682164,"about_ca_system_score_codex":0.000041119747,"about_ca_system_score_gemma":0.00001781869,"threshold_uncertainty_score":0.9994225},"labels":[],"label_agreement":null},{"id":"W2008459739","doi":"10.1002/hup.189","title":"Antidepressants in clinical practice: limitations of assessment methods and drug response","year":2001,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Treatment of Major Depression","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Clinical Practice; Drug trial; Clinical trial; Medicine; Outcome (game theory); Randomized controlled trial; Drug response; Intensive care medicine; Psychology; Drug; Psychiatry; Internal medicine; Physical therapy","score_opus":0.18107087704164163,"score_gpt":0.6059506347499309,"score_spread":0.42487975770828934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008459739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99014634,0.0031236075,0.0000246505,0.002562712,0.0005704446,0.0005398723,0.000003351967,0.00003359209,0.0029954095],"genre_scores_gemma":[0.96875376,0.0026992462,0.026579317,0.0013916503,0.00014960622,0.00005362579,0.000008027095,0.000019865995,0.00034493065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955693,0.0021739746,0.0012842068,0.0005699182,0.00018098624,0.0002216369],"domain_scores_gemma":[0.9945788,0.004560361,0.0002863289,0.00024045339,0.00005640119,0.0002777009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033910563,0.00018823904,0.00064605434,0.00014496835,0.00009816678,0.000011137718,0.000080959326,0.00020060435,0.0001921506],"category_scores_gemma":[0.00064974633,0.0001598918,0.00012938266,0.00011300303,0.0007276732,0.00015635845,0.00012776193,0.000528109,0.0000058525875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033940382,0.011240392,0.75673217,0.000021128624,0.00036065254,0.0005143547,0.0006492557,7.553388e-7,0.12639324,0.00017219954,0.0052719633,0.06470348],"study_design_scores_gemma":[0.03198903,0.0023772405,0.94839203,0.00007427039,0.00023657897,0.00017989769,0.0009798472,0.000103622704,0.0032525738,0.00016631345,0.012084301,0.00016430697],"about_ca_topic_score_codex":0.0000146697175,"about_ca_topic_score_gemma":0.0000028769448,"teacher_disagreement_score":0.19165982,"about_ca_system_score_codex":0.000025388279,"about_ca_system_score_gemma":0.000059886574,"threshold_uncertainty_score":0.65201986},"labels":[],"label_agreement":null},{"id":"W2018350887","doi":"10.1002/hup.866","title":"Relationship between the cardiac response to acute intoxication and alcohol‐induced subjective effects throughout the blood alcohol concentration curve","year":2007,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McGill University; University of New Brunswick","funders":"Canadian Institutes of Health Research","keywords":"Alcohol; Stimulant; Sedative; Blood alcohol; Ethanol; Medicine; Area under the curve; Ingestion; Anesthesia; Internal medicine; Poison control; Injury prevention; Chemistry; Biochemistry; Emergency medicine","score_opus":0.16209001834767195,"score_gpt":0.5408834831316449,"score_spread":0.37879346478397297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018350887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902287,0.0008073889,0.000030670748,0.0054257843,0.00078895467,0.002319441,0.000007954437,0.000061349005,0.0003297719],"genre_scores_gemma":[0.9915938,0.000055974408,0.00006552508,0.007179329,0.0007540797,0.00017230962,0.000024565552,0.000021060887,0.00013334776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726343,0.0010827202,0.0006146571,0.0004902713,0.00020855456,0.0003403492],"domain_scores_gemma":[0.9949724,0.004163301,0.00016975202,0.00026104006,0.000064246015,0.00036922822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030267208,0.00021583219,0.00039553957,0.00006268314,0.0007791162,0.000033172593,0.00010713951,0.00024979972,0.000033909368],"category_scores_gemma":[0.00027270144,0.00014051104,0.00011517082,0.00016893104,0.0005625956,0.00008982075,0.00007185981,0.0006868037,0.000048904305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008524823,0.0002861767,0.7697189,0.000024555738,0.0003494985,0.00001962677,0.0032863736,6.2975154e-8,0.2145058,0.00073399994,0.0012388851,0.0013113302],"study_design_scores_gemma":[0.009171419,0.0016905479,0.9584495,0.000024945362,0.00049539964,0.000026677106,0.00025760673,0.0000044736057,0.02896491,0.000106319625,0.00066170935,0.00014652222],"about_ca_topic_score_codex":0.00001767234,"about_ca_topic_score_gemma":0.0000036195731,"teacher_disagreement_score":0.1887306,"about_ca_system_score_codex":0.00005501789,"about_ca_system_score_gemma":0.000058696343,"threshold_uncertainty_score":0.5992411},"labels":[],"label_agreement":null},{"id":"W2024344447","doi":"10.1002/hup.1076","title":"Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects","year":2009,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Clozapine; GPX1; Internal medicine; Oxidative stress; Schizophrenia (object-oriented programming); Glutathione peroxidase; Medicine; Antioxidant; Lipid peroxidation; Endocrinology; Psychiatry; Superoxide dismutase; Biology; Biochemistry","score_opus":0.05336549478538501,"score_gpt":0.41203768746196734,"score_spread":0.35867219267658235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024344447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838424,0.00048576156,4.93268e-7,0.0005654275,0.00008099474,0.00032320444,0.0000118273465,0.000014249117,0.0001337997],"genre_scores_gemma":[0.99833137,0.00034216125,0.000113571674,0.0010088996,0.00003307338,0.000014257696,9.873773e-7,0.000006457152,0.00014924986],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986567,0.00032006012,0.00037055963,0.00038551434,0.00010230523,0.00016484682],"domain_scores_gemma":[0.9993201,0.0003306367,0.00013269414,0.000085583,0.000012874579,0.00011812891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025854137,0.0001394168,0.0003394249,0.000100764875,0.000072161405,0.000011129954,0.000062681815,0.00009655768,0.000039076887],"category_scores_gemma":[0.000049988976,0.00011447161,0.000033084314,0.00013634418,0.00027134747,0.00006172766,0.000031714542,0.000091851674,0.0000011513113],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0206079,0.0011859633,0.023297118,0.000007718568,0.000019048479,0.000012345319,0.0009530368,0.0000010850559,0.9492799,0.000090033,0.00018740744,0.0043584406],"study_design_scores_gemma":[0.027939446,0.00663465,0.4994596,0.000026660122,0.000020930718,0.000012717583,0.00027237413,0.00003026517,0.4647369,0.00023556112,0.0004209922,0.0002098774],"about_ca_topic_score_codex":0.000015011363,"about_ca_topic_score_gemma":0.000020296662,"teacher_disagreement_score":0.484543,"about_ca_system_score_codex":0.00002788221,"about_ca_system_score_gemma":0.000021974314,"threshold_uncertainty_score":0.46680167},"labels":[],"label_agreement":null},{"id":"W2028184718","doi":"10.1002/hup.868","title":"HTR2C haplotypes and antipsychotics‐induced weight gain: X‐linked multimarker analysis","year":2007,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Health Canada; National Alliance for Research on Schizophrenia and Depression","keywords":"Haplotype; Weight gain; Clozapine; Confounding; Antipsychotic; Internal medicine; Medicine; Polymorphism (computer science); Obesity; Genetics; Oncology; Gene; Body weight; Schizophrenia (object-oriented programming); Biology; Genotype; Psychiatry","score_opus":0.06937529939051093,"score_gpt":0.4694765214319927,"score_spread":0.4001012220414818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028184718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951844,0.0018865307,0.000023930275,0.000792257,0.00042637798,0.0004897942,0.000005789382,0.00007335533,0.0011175376],"genre_scores_gemma":[0.996003,0.00035067822,0.0012116551,0.0014421686,0.0004980353,0.000027569591,0.000029877203,0.000025901489,0.00041114655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977641,0.000135529,0.00067089667,0.0007080349,0.0002384388,0.00048296587],"domain_scores_gemma":[0.99851066,0.00030103163,0.000101263584,0.00025088352,0.000056208548,0.0007799598],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071773626,0.0002727953,0.0006583927,0.00029819427,0.0002565869,0.000027306049,0.00008957659,0.00023838408,0.0012383043],"category_scores_gemma":[0.000027787042,0.0002157843,0.00026869474,0.00026956157,0.0006029741,0.00006611812,0.000080059115,0.0004559282,0.000057023837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1030628,0.006308733,0.7182628,0.00003927063,0.007461261,0.0011159385,0.0004963818,3.391657e-7,0.13877605,0.0006250293,0.004812858,0.01903857],"study_design_scores_gemma":[0.045119945,0.0023639307,0.939912,0.000018267605,0.0012168817,0.00006606384,0.00027095174,0.00039543633,0.0092797,0.00021720285,0.000827961,0.00031162862],"about_ca_topic_score_codex":0.000020874157,"about_ca_topic_score_gemma":0.000034166518,"teacher_disagreement_score":0.22164926,"about_ca_system_score_codex":0.000036859634,"about_ca_system_score_gemma":0.000035083314,"threshold_uncertainty_score":0.9996747},"labels":[],"label_agreement":null},{"id":"W2031176566","doi":"10.1002/hup.852","title":"Do formulation switches exacerbate existing medical illness? Results of an open‐label transition to orally disintegrating risperidone tablets","year":2007,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Risperidone; Medicine; Clinical Global Impression; Adverse effect; Schizophrenia (object-oriented programming); Side effect (computer science); Psychiatry; Internal medicine; Alternative medicine","score_opus":0.19966845533366856,"score_gpt":0.5499176975775033,"score_spread":0.35024924224383475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031176566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903718,0.000531811,0.00020090437,0.002427026,0.000546091,0.0006815673,0.00001789768,0.000043411885,0.005179452],"genre_scores_gemma":[0.9928033,0.00011507007,0.0019529841,0.0043327645,0.00061529997,0.000028396984,0.000052150586,0.000022497486,0.00007754559],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972672,0.000167238,0.0012508002,0.0005796306,0.00035747903,0.0003776732],"domain_scores_gemma":[0.9982792,0.0005194667,0.0002603308,0.00016469785,0.00009737418,0.0006788995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002892426,0.0002249422,0.0005921596,0.0000707758,0.00038506906,0.000042223175,0.00020645926,0.00021850967,0.0006192024],"category_scores_gemma":[0.00026826575,0.0001801821,0.00006349366,0.00017061635,0.00029661384,0.00032649972,0.00017254338,0.00050170644,0.000009864438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.074179806,0.007670749,0.002390876,0.000105426145,0.00041178562,0.00023735991,0.0057828794,0.0000037557375,0.76526517,0.00067115104,0.002794945,0.14048612],"study_design_scores_gemma":[0.32162216,0.042938627,0.054552905,0.0014733399,0.0014403171,0.0006658539,0.023243422,0.007747758,0.47288457,0.0016339517,0.069068395,0.00272869],"about_ca_topic_score_codex":0.00012020744,"about_ca_topic_score_gemma":0.000052637875,"teacher_disagreement_score":0.29238057,"about_ca_system_score_codex":0.00003490536,"about_ca_system_score_gemma":0.00003571016,"threshold_uncertainty_score":0.7347613},"labels":[],"label_agreement":null},{"id":"W2039846441","doi":"10.1002/(sici)1099-1077(200004)15:3<199::aid-hup163>3.0.co;2-t","title":"The interaction between cytokines and neurotransmitters in depression and stress: possible mechanism of antidepressant treatments","year":2000,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Antidepressant; Mechanism (biology); Depression (economics); Animal models of depression; Psychology; Stress (linguistics); Chronic stress; Neuroscience; Pharmacology; Psychotherapist; Medicine; Hippocampus; Philosophy","score_opus":0.0501237004069989,"score_gpt":0.399544832697158,"score_spread":0.34942113229015914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039846441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99836296,0.0005406206,0.0000011422223,0.00014620538,0.00017305436,0.0002636632,0.000014062738,0.000017548326,0.00048075453],"genre_scores_gemma":[0.9977266,0.0016846801,0.000012191041,0.0004146959,0.00005031874,0.000025010695,0.0000018362989,0.000010055812,0.00007460456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987068,0.00023108034,0.00038544709,0.0004161915,0.000083412,0.00017706888],"domain_scores_gemma":[0.9993801,0.00036023054,0.00007521709,0.00009198547,0.000003852354,0.00008862747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010890548,0.0001393373,0.00021181234,0.00004783125,0.00021836405,0.000029689843,0.0001032379,0.00007711672,0.000112319365],"category_scores_gemma":[0.000010340643,0.00009814751,0.000039673025,0.000056363777,0.00055490766,0.00012919563,0.000046953264,0.00017786688,0.000002045233],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022208064,0.00087694207,0.24161384,0.000021542744,0.000042421518,0.000032035685,0.00096735184,0.0000024935707,0.6976944,0.00024440934,0.00016458836,0.05611915],"study_design_scores_gemma":[0.016277075,0.0010479967,0.40063843,0.00007273183,0.00003920018,0.00003052906,0.00061341864,0.0002880791,0.5785677,0.0016401629,0.0005090677,0.00027563304],"about_ca_topic_score_codex":0.00002696997,"about_ca_topic_score_gemma":0.0000063374328,"teacher_disagreement_score":0.15902461,"about_ca_system_score_codex":0.0000041065664,"about_ca_system_score_gemma":0.0000039340857,"threshold_uncertainty_score":0.40023392},"labels":[],"label_agreement":null},{"id":"W2046097935","doi":"10.1002/hup.994","title":"St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double‐blind placebo‐controlled pilot trial","year":2008,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Natural Compound Pharmacology Studies","field":"Agricultural and Biological Sciences","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Placebo; Kava; Anxiety; Major depressive disorder; Beck Anxiety Inventory; Randomized controlled trial; Depression (economics); Antidepressant; Psychiatry; Double blind; Crossover study; Medicine; Hypericum; Psychology; Beck Depression Inventory; Internal medicine; Traditional medicine; Alternative medicine","score_opus":0.07076856362050964,"score_gpt":0.38460027298227434,"score_spread":0.3138317093617647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046097935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99126774,0.003445714,1.6171454e-7,0.00072638877,0.000483281,0.002870288,0.000011914044,0.00006459009,0.0011299057],"genre_scores_gemma":[0.99652576,0.0006727711,0.000047422942,0.0009265092,0.00064678566,0.00081800437,0.000027452117,0.000004981106,0.00033029122],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972968,0.00043274582,0.0008272125,0.00079556624,0.00018236514,0.00046532007],"domain_scores_gemma":[0.9982905,0.0010955211,0.00027137762,0.00006171531,0.000041805994,0.00023911521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005081887,0.00039085464,0.0010162463,0.000042469805,0.00085648475,0.00003476493,0.00020906584,0.00019117456,0.0006087658],"category_scores_gemma":[0.000023657412,0.00016612823,0.00015022456,0.00017985718,0.0011128032,0.00014301855,0.0001647144,0.0006004878,0.000005722557],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90416706,0.0016536225,0.049519602,0.000004478875,0.0003451674,0.00009512847,0.00025038343,0.0000013905914,0.041372944,0.000027559701,0.0015950394,0.00096762576],"study_design_scores_gemma":[0.97175246,0.004769372,0.020370165,0.000016109007,0.00014529677,0.00007397744,0.00034598084,0.000029875158,0.00074527203,0.00006210695,0.0012670873,0.00042231393],"about_ca_topic_score_codex":0.00015722572,"about_ca_topic_score_gemma":0.00045481464,"teacher_disagreement_score":0.06758539,"about_ca_system_score_codex":0.00002170555,"about_ca_system_score_gemma":0.000014607589,"threshold_uncertainty_score":0.67745125},"labels":[],"label_agreement":null},{"id":"W2046149237","doi":"10.1002/hup.1073","title":"Augmentation of atypical antipsychotics with valproic acid. An open‐label study for most difficult patients with schizophrenia","year":2009,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Astellas Pharma; Asahi Kasei Pharma Corporation; GlaxoSmithKline; Dainippon Sumitomo Pharma; Pfizer","keywords":"Brief Psychiatric Rating Scale; Risperidone; Clozapine; Polypharmacy; Olanzapine; Schizophrenia (object-oriented programming); Clinical Global Impression; Medicine; Valproic Acid; Sedation; Internal medicine; Adverse effect; Global Assessment of Functioning; Positive and Negative Syndrome Scale; Psychiatry; Pediatrics; Psychosis; Anesthesia; Epilepsy","score_opus":0.08173536920673692,"score_gpt":0.4752615703145118,"score_spread":0.3935262011077749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046149237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956774,0.00011830826,0.000017982667,0.00026124963,0.00012799598,0.003688294,0.000028135237,0.00003404862,0.00004657824],"genre_scores_gemma":[0.9934614,0.00001223078,0.0053228233,0.0005971516,0.00014586093,0.00020474257,0.00018449106,0.000026465377,0.000044834782],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9980174,0.00014252157,0.0005717517,0.0006535409,0.00030421017,0.00031060577],"domain_scores_gemma":[0.9987712,0.000071912014,0.0001698628,0.00027313153,0.00019393314,0.00051994406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021374424,0.00026831936,0.00058594067,0.00008615218,0.00023380184,0.000040988678,0.00019982885,0.000105395455,0.00013103457],"category_scores_gemma":[0.000016263404,0.00017470622,0.00004019219,0.00016953704,0.0003630027,0.00017398971,0.000047915124,0.0002500908,0.000004421065],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7376043,0.07249626,0.16532744,0.000017925737,0.00062472525,0.000040625306,0.0003368259,4.689539e-7,0.012743487,0.00024117192,0.0008851306,0.009681582],"study_design_scores_gemma":[0.2565444,0.094050445,0.6454819,0.000034106266,0.0002773359,0.000010156047,0.00036324665,0.0000375533,0.0028872616,0.0001142714,0.00001557057,0.00018375235],"about_ca_topic_score_codex":0.000005077816,"about_ca_topic_score_gemma":0.000020401,"teacher_disagreement_score":0.48105994,"about_ca_system_score_codex":0.00003270284,"about_ca_system_score_gemma":0.00009938215,"threshold_uncertainty_score":0.7124313},"labels":[],"label_agreement":null},{"id":"W2052521137","doi":"10.1002/hup.932","title":"Adverse events in children and adolescents treated with antipsychotic medications","year":2008,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Antipsychotic; Odds ratio; Adverse effect; Psychiatry; Pediatrics; Retrospective cohort study; Internal medicine; Schizophrenia (object-oriented programming)","score_opus":0.03767934550095657,"score_gpt":0.41470536717201223,"score_spread":0.37702602167105564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052521137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980984,0.0006806487,6.983272e-7,0.00030577654,0.00005715325,0.0006867823,0.00000531054,0.00003252322,0.00013275117],"genre_scores_gemma":[0.998382,0.00056853273,0.00018544884,0.0004902306,0.00010730933,0.00007284666,0.000040845935,0.000015634954,0.00013720673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986974,0.00010658598,0.00033998126,0.00043992707,0.00016371913,0.0002523678],"domain_scores_gemma":[0.9993389,0.000032573527,0.000053226384,0.00014190872,0.00001895019,0.0004144025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111496745,0.00016694436,0.00032226118,0.00012195339,0.00015889428,0.0000015546898,0.000058265294,0.000100571466,0.00021323304],"category_scores_gemma":[0.000005713077,0.00012301454,0.000051239,0.00011399167,0.0006472371,0.000053421023,0.000034411274,0.00029386103,0.00002962723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013582809,0.0026130131,0.981603,0.000005753019,0.00021458385,0.00014794893,0.00008469163,8.534364e-8,0.0010262083,0.000015495178,0.00033718836,0.00036918314],"study_design_scores_gemma":[0.055708118,0.0014523107,0.94160473,0.000060862483,0.000070964285,0.00051239156,0.000041448904,0.000013153782,0.00039339552,0.000024366223,0.000012203854,0.00010605801],"about_ca_topic_score_codex":0.000036693033,"about_ca_topic_score_gemma":0.000010995962,"teacher_disagreement_score":0.042125307,"about_ca_system_score_codex":0.000025079058,"about_ca_system_score_gemma":0.000045939512,"threshold_uncertainty_score":0.50163877},"labels":[],"label_agreement":null},{"id":"W2058705456","doi":"10.1002/hup.883","title":"Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users","year":2007,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Methylphenidate; Medical prescription; Stimulant; Psychiatry; Prescription Drug Misuse; Medicine; Compliance (psychology); Substance misuse; Substance abuse; Attention deficit hyperactivity disorder; Psychology; Mental health; Pharmacology","score_opus":0.05042384498019385,"score_gpt":0.4307247282445931,"score_spread":0.38030088326439926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058705456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974395,0.0011569478,0.0000062189984,0.0003757405,0.00032484496,0.00047910798,0.000014483703,0.000020959418,0.00018218711],"genre_scores_gemma":[0.9976758,0.001170405,0.00020825205,0.0007498551,0.00007915415,0.000020711486,0.0000355349,0.000011825791,0.000048508795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986638,0.00007464906,0.00055758667,0.0003826306,0.00012988907,0.0001914716],"domain_scores_gemma":[0.99935186,0.00013342375,0.00011959655,0.00011622009,0.00003381975,0.0002450753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028907557,0.0001502864,0.00036318024,0.000103334394,0.000062032144,0.0000044951566,0.000052673415,0.00013223037,0.0001368553],"category_scores_gemma":[0.000018658424,0.00013045988,0.000042695796,0.000055596072,0.0004473452,0.00005996003,0.00007665527,0.00018714592,0.0000022290046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002292443,0.0012829398,0.9704042,0.00008673966,0.00015025731,0.000031147127,0.0019543725,5.689841e-8,0.0216708,0.000041222385,0.0008479389,0.0012378739],"study_design_scores_gemma":[0.023209687,0.0010783549,0.9636165,0.000104059385,0.00013669053,0.000012823356,0.001959631,0.000033302615,0.0094542345,0.000036430774,0.00024120031,0.00011706988],"about_ca_topic_score_codex":0.000099553225,"about_ca_topic_score_gemma":0.000020083056,"teacher_disagreement_score":0.020917244,"about_ca_system_score_codex":0.000019313737,"about_ca_system_score_gemma":0.000012876647,"threshold_uncertainty_score":0.532},"labels":[],"label_agreement":null},{"id":"W2058914162","doi":"10.1002/hup.417","title":"Acute cholecystokinin effects on event‐related potentials in healthy volunteers","year":2002,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neuroscience and Music Perception","field":"Neuroscience","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre; University of Ottawa","funders":"","keywords":"N100; Cholecystokinin; Placebo; Mood; Psychology; Audiology; Panic disorder; Event-related potential; Electroencephalography; Medicine; Internal medicine; Anxiety; Neuroscience; Psychiatry","score_opus":0.0659935334473063,"score_gpt":0.4351830708851802,"score_spread":0.3691895374378739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058914162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931834,0.00007741518,0.0000015321427,0.0010598113,0.003103083,0.00048342344,0.000004707023,0.00008140279,0.0020052737],"genre_scores_gemma":[0.9757177,0.00027655956,0.0000069756356,0.022986274,0.00020881275,0.00007580177,0.0000017819955,0.000019304744,0.00070678693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972212,0.00051803316,0.00064546755,0.000934411,0.00022121053,0.00045970437],"domain_scores_gemma":[0.9992271,0.00021025048,0.00011431702,0.00018708575,0.000006479361,0.00025474915],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029236748,0.00022543233,0.00034331778,0.00017580592,0.00028731805,0.000031596952,0.0002486509,0.00017919698,0.0012608949],"category_scores_gemma":[0.000049619266,0.00020911699,0.00012528639,0.00023595216,0.000567512,0.00017639365,0.000078322366,0.0005459093,0.0004816481],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080949307,0.0012708353,0.0002908202,0.0000051281077,0.0000069949792,0.00017872274,0.00043437254,0.0000034924465,0.9885414,0.00016950237,0.0055417046,0.0027475064],"study_design_scores_gemma":[0.101946056,0.022713425,0.052546337,0.00016771776,0.00012257308,0.0004423545,0.00031017952,0.003985227,0.8066841,0.0011692253,0.008116925,0.0017959204],"about_ca_topic_score_codex":0.0000054745387,"about_ca_topic_score_gemma":0.0000012516005,"teacher_disagreement_score":0.18185736,"about_ca_system_score_codex":0.000039534956,"about_ca_system_score_gemma":0.000007975574,"threshold_uncertainty_score":0.9996521},"labels":[],"label_agreement":null},{"id":"W2062291045","doi":"10.1002/hup.453","title":"Cognitive effects of long‐term benzodiazepine use in older adults","year":2002,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sleep and related disorders","field":"Psychology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Benzodiazepine; Cognition; Discontinuation; Effects of sleep deprivation on cognitive performance; Audiology; Sedative; Psychology; Medicine; Affect (linguistics); Working memory; Psychiatry; Internal medicine","score_opus":0.04135031935559214,"score_gpt":0.4171162764878241,"score_spread":0.375765957132232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062291045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850196,0.00906341,0.0000033638996,0.00006231528,0.0021683462,0.0007010277,0.000006838842,0.00004069942,0.0029343723],"genre_scores_gemma":[0.99730164,0.00043016666,0.000011829837,0.0012865432,0.00016073983,0.00012704691,0.00001554709,0.000027297961,0.000639202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978624,0.000345561,0.000731502,0.00059285463,0.00010018609,0.0003675142],"domain_scores_gemma":[0.9988603,0.00060259865,0.0001625902,0.00015897083,0.000027034052,0.00018850647],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013676636,0.00023835784,0.00045618828,0.000157815,0.00007619071,0.000009460947,0.00013585089,0.00039531357,0.007516762],"category_scores_gemma":[0.000027592521,0.00021912342,0.00015404863,0.00015377508,0.0007534387,0.00009634327,0.00006107596,0.0004946309,0.00020123628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007880281,0.032370728,0.8690258,0.00011704516,0.0017578901,0.0011655808,0.016621301,4.5230226e-7,0.0061817933,0.0002731015,0.01922418,0.0453818],"study_design_scores_gemma":[0.100315325,0.0020926301,0.8922322,0.00025639412,0.00021961122,0.000035729823,0.0010392428,0.000022796354,0.0032315974,0.00003027897,0.00007682272,0.00044738795],"about_ca_topic_score_codex":0.000043081054,"about_ca_topic_score_gemma":0.00001251909,"teacher_disagreement_score":0.09243505,"about_ca_system_score_codex":0.000009854746,"about_ca_system_score_gemma":0.0000032349908,"threshold_uncertainty_score":0.9933905},"labels":[],"label_agreement":null},{"id":"W2070405109","doi":"10.1002/hup.454","title":"Adverse effects of temazepam in older adults with chronic insomnia","year":2003,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sleep and related disorders","field":"Psychology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Mental Health","keywords":"Temazepam; Insomnia; Adverse effect; Medicine; Placebo; Hypnotic; Anesthesia; Benzodiazepine; Internal medicine; Psychiatry","score_opus":0.012341032773999706,"score_gpt":0.3767591763358378,"score_spread":0.36441814356183805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070405109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97926104,0.00827337,0.0000023189198,0.00003440122,0.0016508452,0.0007250083,0.0000013362725,0.00003500933,0.010016658],"genre_scores_gemma":[0.9986355,0.00019237548,0.000040230923,0.0004906547,0.000087894245,0.00016549804,0.0000043440946,0.000027780292,0.00035577398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795985,0.00039648378,0.0006213416,0.00055873505,0.0001015223,0.00036209007],"domain_scores_gemma":[0.9992335,0.0002212232,0.00015563202,0.00020950758,0.000017901595,0.00016227741],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021313933,0.0002325734,0.00043065805,0.00013590805,0.000074033145,0.0000032715354,0.00013052195,0.00033406905,0.0027017149],"category_scores_gemma":[0.000011208459,0.0001873248,0.00010655512,0.00017239769,0.00072968594,0.00005474554,0.000026624846,0.00045311096,0.00008543144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023097964,0.044505958,0.82394314,0.0004666156,0.003785921,0.0013135582,0.025186352,0.000020426382,0.03097578,0.01002993,0.022407493,0.0142668765],"study_design_scores_gemma":[0.411547,0.0128958635,0.53894514,0.0008104416,0.0005743996,0.0001529571,0.008993557,0.000031612533,0.018959034,0.0003659685,0.005215617,0.0015083877],"about_ca_topic_score_codex":0.000041872838,"about_ca_topic_score_gemma":0.000021650103,"teacher_disagreement_score":0.38844904,"about_ca_system_score_codex":0.00002403894,"about_ca_system_score_gemma":0.000027071297,"threshold_uncertainty_score":0.99820995},"labels":[],"label_agreement":null},{"id":"W2072357163","doi":"10.1002/hup.648","title":"Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder","year":2004,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; St. Joseph’s Healthcare Hamilton; University of Toronto; McMaster University; St. Joseph's Hospital","funders":"Pfizer","keywords":"Sertraline; Placebo; Clinical Global Impression; Psychology; Anxiety; Internal medicine; Depression (economics); Generalized anxiety disorder; Medicine; Psychiatry; Antidepressant","score_opus":0.13531036234617175,"score_gpt":0.504781174446511,"score_spread":0.3694708121003393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072357163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895528,0.0067101484,0.00008034226,0.0005159781,0.0017044103,0.000937316,0.000035815385,0.000046532037,0.0004166742],"genre_scores_gemma":[0.9884765,0.008839091,0.0007087075,0.0007763803,0.00039974393,0.00036384616,0.000023893494,0.000033943244,0.0003778897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960236,0.00097650226,0.0013283541,0.0010832635,0.00018134883,0.00040695255],"domain_scores_gemma":[0.9984662,0.0005570296,0.00026932085,0.000262585,0.00007151678,0.0003733289],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000648065,0.00037340284,0.00077761186,0.0003118239,0.00014616064,0.00002342058,0.00016741421,0.00033104414,0.00086982374],"category_scores_gemma":[0.000077160636,0.00030687306,0.00018319777,0.0003397422,0.00075003103,0.000112178925,0.00008654855,0.00022445945,0.000036603487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021488858,0.010649391,0.9249216,0.0000120115365,0.00038829417,0.000027063372,0.005528851,0.0000023438056,0.006115522,0.00027427546,0.000770177,0.029821659],"study_design_scores_gemma":[0.04491996,0.004948917,0.9411459,0.000018444545,0.00010493043,0.000018816565,0.0021117057,0.0000065268596,0.0014299363,0.0009979615,0.003954318,0.00034256483],"about_ca_topic_score_codex":0.0002050107,"about_ca_topic_score_gemma":0.000039957,"teacher_disagreement_score":0.029479094,"about_ca_system_score_codex":0.000053876618,"about_ca_system_score_gemma":0.000044939177,"threshold_uncertainty_score":0.9999383},"labels":[],"label_agreement":null},{"id":"W2077355116","doi":"10.1002/hup.816","title":"Effects of alternative reinforcer and craving on the choice to smoke cigarettes in the laboratory","year":2006,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Behavioral and Psychological Studies","field":"Psychology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Institute on Drug Abuse","keywords":"Craving; Reinforcement; Nicotine; Psychology; Smoke; Anticipation (artificial intelligence); Smoking cessation; Psychological intervention; Clinical psychology; Addiction; Medicine; Social psychology; Psychiatry; Chemistry; Computer science","score_opus":0.13438987261527538,"score_gpt":0.4556974017737499,"score_spread":0.3213075291584745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077355116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896648,0.0014569658,6.5292807e-7,0.0021809642,0.00079307787,0.0005744847,0.0000073270917,0.000016555825,0.005305206],"genre_scores_gemma":[0.9879875,0.000031129744,0.000005471153,0.0111013455,0.00039732634,0.0002523934,0.0000014364432,0.000009556441,0.00021380903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982199,0.00052534544,0.00047147283,0.00040440777,0.00012424804,0.00025459798],"domain_scores_gemma":[0.9980901,0.001556435,0.00011300738,0.00015654003,0.00002072976,0.00006318562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051350065,0.00019023016,0.0002974238,0.000047319125,0.00020273376,0.000017622298,0.00024769994,0.00013155087,0.00043391308],"category_scores_gemma":[0.000027756296,0.00010291536,0.00006764526,0.00013571292,0.00073356286,0.000029326835,0.000080753125,0.00042481336,0.000017942068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056108497,0.009091028,0.6040739,0.00004425832,0.0005008303,0.00032589075,0.019163057,0.000005328701,0.081057526,0.059385117,0.20646304,0.014279211],"study_design_scores_gemma":[0.0041313586,0.0014454909,0.9835207,0.00002526002,0.00003296417,0.00000307916,0.0008471339,0.0000010382608,0.003328016,0.0005959541,0.0058987387,0.00017027966],"about_ca_topic_score_codex":0.0002500935,"about_ca_topic_score_gemma":0.000015141272,"teacher_disagreement_score":0.3794468,"about_ca_system_score_codex":0.000008629363,"about_ca_system_score_gemma":0.0000025150018,"threshold_uncertainty_score":0.4751044},"labels":[],"label_agreement":null},{"id":"W2082771012","doi":"10.1002/hup.1135","title":"Protracted, dose‐dependent weight loss after addition of ziprasidone to a stable regimen of clozapine","year":2010,"lang":"en","type":"letter","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Ziprasidone; Olanzapine; Citation; Psychology; Medicine; Library science; Schizophrenia (object-oriented programming); Psychiatry; Computer science","score_opus":0.04178586303216055,"score_gpt":0.42338770986154084,"score_spread":0.3816018468293803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082771012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9248949,0.001657114,0.000001567414,0.06942115,0.00090222317,0.0022657125,0.00033935191,0.000035983034,0.0004819936],"genre_scores_gemma":[0.8958121,0.00059103104,0.0014103035,0.09177689,0.005069221,0.0016090921,0.00079071714,0.0001003674,0.0028403068],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99654925,0.00025129484,0.0012426238,0.0008597723,0.0005799383,0.00051712204],"domain_scores_gemma":[0.99826413,0.00020200716,0.00039553104,0.0005133858,0.00017654689,0.0004483669],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00037465445,0.00044557473,0.0012559359,0.0003004849,0.000078602534,0.000012318738,0.00021524215,0.0013847908,0.009856876],"category_scores_gemma":[0.000031500662,0.00035887104,0.00034456557,0.00012981369,0.00084463495,0.000071492264,0.00017599172,0.0029729307,0.00009175877],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.112374075,0.0049532535,0.0032738862,0.0004423822,0.0015130071,0.0023735878,0.0001985567,6.168989e-8,0.095095724,0.000026713287,0.7769417,0.0028070223],"study_design_scores_gemma":[0.1538624,0.025034744,0.038116302,0.0009954342,0.0016371838,0.0006564806,0.00010742273,0.000007127186,0.20704536,0.0006096221,0.5705817,0.001346226],"about_ca_topic_score_codex":0.000060931154,"about_ca_topic_score_gemma":0.000014263053,"teacher_disagreement_score":0.20636004,"about_ca_system_score_codex":0.000063035644,"about_ca_system_score_gemma":0.00018341147,"threshold_uncertainty_score":0.9999116},"labels":[],"label_agreement":null},{"id":"W2083693117","doi":"10.1002/hup.710","title":"Differential effects of chronic lithium and valproate on brain activation in healthy volunteers","year":2005,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Lithium (medication); Medicine; Neuroscience; Internal medicine; Pharmacology; Psychology","score_opus":0.026072353661381064,"score_gpt":0.4145243416145304,"score_spread":0.38845198795314934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083693117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99432874,0.0019143405,0.0000045391052,0.0025995413,0.00026844302,0.0005271109,0.0000015630433,0.00001786654,0.0003378759],"genre_scores_gemma":[0.99757373,0.00022088818,0.000029173912,0.0016800386,0.0002897381,0.00005326892,0.000014336011,0.00001261921,0.00012619565],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989363,0.000110339904,0.00037030314,0.00031844655,0.000086422304,0.0001781812],"domain_scores_gemma":[0.99951607,0.00018455833,0.00006344464,0.0000893545,0.000008706633,0.00013786205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008183811,0.00014136263,0.0003344309,0.000085203974,0.00005828991,0.0000040880955,0.000029091529,0.00012953526,0.00018941276],"category_scores_gemma":[0.000011567016,0.000118098425,0.00006477768,0.000043182707,0.0002495316,0.00004003218,0.000027890512,0.0002578317,0.000007526822],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023096329,0.019084739,0.15774934,0.0004501067,0.0005184623,0.000016370808,0.0021258534,0.0000018857364,0.7241932,0.00073767954,0.0038159706,0.068210036],"study_design_scores_gemma":[0.10664298,0.023896433,0.71550316,0.00021828491,0.00015245864,0.000018650995,0.00014130787,0.0004448163,0.14928333,0.000120832774,0.0032699492,0.00030779262],"about_ca_topic_score_codex":0.000025528065,"about_ca_topic_score_gemma":0.000020798692,"teacher_disagreement_score":0.57490987,"about_ca_system_score_codex":0.0000543645,"about_ca_system_score_gemma":0.00002251906,"threshold_uncertainty_score":0.4815914},"labels":[],"label_agreement":null},{"id":"W2084291311","doi":"10.1002/hup.747","title":"Diazepam-induced prospective memory impairment and its relation to retrospective memory, attention, and arousal","year":2005,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Cognitive Functions and Memory","field":"Psychology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto; York University","funders":"","keywords":"Arousal; Psychology; Recall; Prospective memory; Audiology; Retrospective memory; Diazepam; Cognitive psychology; Developmental psychology; Cognition; Explicit memory; Episodic memory; Psychiatry; Neuroscience; Medicine","score_opus":0.04416885291669423,"score_gpt":0.42300482590563016,"score_spread":0.3788359729889359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084291311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98507625,0.0012916009,0.000012259571,0.0009668755,0.0018633872,0.0012376813,0.000018387074,0.000100851255,0.009432735],"genre_scores_gemma":[0.99266666,0.000059229013,0.000085753774,0.0019968192,0.001246896,0.00039040556,0.000010780951,0.000034488523,0.003508972],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975343,0.00028391194,0.00061963784,0.001029458,0.00014761917,0.0003851145],"domain_scores_gemma":[0.9990316,0.0001347048,0.0001477026,0.00017021921,0.00009632598,0.0004194478],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005374448,0.00030501458,0.00043017644,0.0001661792,0.0004670927,0.000036784444,0.00008280603,0.00024775718,0.0017233937],"category_scores_gemma":[0.00002969149,0.00029733262,0.00009751707,0.00012810541,0.0003181616,0.0001817176,0.00014868031,0.00046734372,0.00020921373],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015955403,0.0114734825,0.31407496,0.00005395636,0.0021017708,0.00018882845,0.026688378,0.0000024779388,0.51713794,0.010709245,0.044492513,0.057121035],"study_design_scores_gemma":[0.0150820315,0.0035027508,0.9729648,0.000022199962,0.00014172192,0.00010785514,0.0031526086,0.00003448979,0.0029724156,0.0004038036,0.001162856,0.00045247184],"about_ca_topic_score_codex":0.000021546872,"about_ca_topic_score_gemma":0.00001798973,"teacher_disagreement_score":0.65888983,"about_ca_system_score_codex":0.00009067746,"about_ca_system_score_gemma":0.000017413007,"threshold_uncertainty_score":0.9999479},"labels":[],"label_agreement":null},{"id":"W2089644403","doi":"10.1002/hup.435","title":"Pharmacotherapy of anxious disorders","year":2002,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Panic disorder; Anxiety; Pharmacotherapy; Social anxiety; Psychiatry; Anxiety disorder; Psychology; Panic; Clinical psychology; Epidemiology; Psychotherapist; Medicine; Internal medicine","score_opus":0.16020570993694463,"score_gpt":0.5426876525794043,"score_spread":0.3824819426424597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089644403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028049215,0.9705752,0.000010060402,0.000030164507,0.008207258,0.001570805,0.00012487214,0.00014876384,0.01652795],"genre_scores_gemma":[0.008827807,0.9844975,0.00007507462,0.0005423738,0.001734365,0.0008768737,0.00011217255,0.000195781,0.0031380728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936312,0.0011754432,0.0022962133,0.0018305954,0.00031561838,0.0007509725],"domain_scores_gemma":[0.9967041,0.00086428097,0.0012983803,0.0005793671,0.00008286342,0.00047099395],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050519203,0.0010769998,0.00301018,0.00066733145,0.00029202402,0.00003357393,0.000768408,0.0010741472,0.021391215],"category_scores_gemma":[0.000029629742,0.0009119172,0.0011924028,0.00066156953,0.0017720971,0.000118219265,0.00019564325,0.0012002259,0.00066501874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043239546,0.0057569165,0.00077329355,0.0007056835,0.0019976895,0.00002574267,0.00047367153,1.9206912e-8,0.000020081532,0.00013227318,0.06094851,0.9287337],"study_design_scores_gemma":[0.010653863,0.0012443509,0.00007814991,0.00057281327,0.0011357431,0.000052935033,0.00020335759,7.460631e-7,0.00001999802,0.00020271151,0.98504245,0.0007929007],"about_ca_topic_score_codex":0.000024581097,"about_ca_topic_score_gemma":0.0000019234278,"teacher_disagreement_score":0.92794085,"about_ca_system_score_codex":0.000053918877,"about_ca_system_score_gemma":0.00004866917,"threshold_uncertainty_score":0.99933314},"labels":[],"label_agreement":null},{"id":"W2092531023","doi":"10.1002/hup.445","title":"Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement","year":2003,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sleep and related disorders","field":"Psychology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Zopiclone; Library science; Medicine; Psychiatry; Insomnia","score_opus":0.11872431532709739,"score_gpt":0.49614200888124904,"score_spread":0.37741769355415167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092531023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1461551,0.84738624,3.6062758e-8,0.00016634072,0.0017728641,0.0013756355,0.000060295628,0.000012302898,0.0030711752],"genre_scores_gemma":[0.011846973,0.9862431,0.000015910076,0.00079145184,0.00017342668,0.00043220952,0.00006613974,0.000039973464,0.000390775],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960085,0.0011917687,0.0014874453,0.0007242652,0.0001058146,0.00048220827],"domain_scores_gemma":[0.9985799,0.00046046678,0.00034790195,0.00031330404,0.000017318132,0.0002810671],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042374915,0.00049659784,0.0015502521,0.0002847204,0.000172952,0.000017282802,0.00020435036,0.00068012584,0.0012639108],"category_scores_gemma":[0.000005587764,0.00032673823,0.0003045546,0.0001741669,0.0009534256,0.00001673873,0.000021145703,0.00047782893,0.000050095012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001466451,0.018405473,0.0048896843,0.0011924527,0.0072157276,0.0011872898,0.013256351,3.0484438e-7,0.000011706541,0.0027701652,0.057897344,0.89170706],"study_design_scores_gemma":[0.011743287,0.0023612676,0.00024621934,0.00021708122,0.00089390366,0.00008794964,0.00119772,3.4563445e-7,0.0000015191889,0.0000498382,0.9828733,0.0003275742],"about_ca_topic_score_codex":0.0049481364,"about_ca_topic_score_gemma":0.002800292,"teacher_disagreement_score":0.92497593,"about_ca_system_score_codex":0.00007958638,"about_ca_system_score_gemma":0.00010659419,"threshold_uncertainty_score":0.99991846},"labels":[],"label_agreement":null},{"id":"W2093963332","doi":"10.1002/hup.1143","title":"Relative association of treatment‐emergent adverse events with quality of life of patients with schizophrenia: <i>post hoc</i> analysis from a 3‐year observational study","year":2010,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Memorial University of Newfoundland","funders":"","keywords":"Tardive dyskinesia; Adverse effect; Medicine; Observational study; Post-hoc analysis; Dyskinesia; Sexual dysfunction; Extrapyramidal symptoms; Schizophrenia (object-oriented programming); Quality of life (healthcare); Internal medicine; Antipsychotic; Association (psychology); Psychiatry; Psychology; Parkinson's disease; Disease","score_opus":0.07694083267069264,"score_gpt":0.4372907074699322,"score_spread":0.3603498747992396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093963332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99845976,0.00005672848,0.0000019094032,0.00009558208,0.0001102904,0.00091617473,0.0003063004,0.000009730265,0.00004355564],"genre_scores_gemma":[0.99812347,0.000017296486,0.0012679297,0.00004931222,0.00006663193,0.00007621745,0.0003319196,0.000012777936,0.000054429704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774235,0.0002988682,0.0009098399,0.00040396323,0.00048031728,0.00016467707],"domain_scores_gemma":[0.99813396,0.0003546183,0.00068622816,0.00023606633,0.00033920334,0.0002499235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031201087,0.00019773928,0.0008803675,0.00013856194,0.000074210286,0.0000016220615,0.00007903971,0.00012292337,0.00074916583],"category_scores_gemma":[0.00006287172,0.00013183462,0.00023209419,0.0002735863,0.00028109495,0.000087451874,0.000039656927,0.00023917248,0.0000029420628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.140354,0.012405093,0.83430034,0.000008037133,0.008321596,0.000002468468,0.00041609403,0.0000019946947,0.0040111328,0.000056251753,0.000026846294,0.000096131065],"study_design_scores_gemma":[0.08880747,0.014188953,0.8935783,0.000009658979,0.0015364588,9.492528e-8,0.0005743372,0.000008584475,0.0011655668,0.00003141044,0.0000044562744,0.00009470843],"about_ca_topic_score_codex":0.00035044827,"about_ca_topic_score_gemma":0.00060001237,"teacher_disagreement_score":0.059277937,"about_ca_system_score_codex":0.00006634826,"about_ca_system_score_gemma":0.0001839386,"threshold_uncertainty_score":0.82028407},"labels":[],"label_agreement":null},{"id":"W2095301214","doi":"10.1002/hup.1086","title":"Effect of metabolic blockade on the psychoactive effects of dextromethorphan","year":2009,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Dextromethorphan; Dextrorphan; Quinidine; Pharmacology; Euphoriant; Active metabolite; Pharmacokinetics; CYP2D6; Metabolite; Levorphanol; Pharmacodynamics; Drug; Medicine; Internal medicine; Cytochrome P450; Antagonist; Metabolism; Receptor; (+)-Naloxone","score_opus":0.0356026045328353,"score_gpt":0.47899230181106217,"score_spread":0.44338969727822686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095301214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990601,0.0039679618,0.0000018876534,0.0004562752,0.0003620105,0.00084065564,0.0000016649332,0.000016245393,0.0037522835],"genre_scores_gemma":[0.997876,0.00021399667,0.00001887816,0.0013979365,0.00024104494,0.000051800092,0.000001503341,0.000011135835,0.00018769882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761134,0.0010254071,0.00054157415,0.00034342604,0.00024605426,0.00023218486],"domain_scores_gemma":[0.99796957,0.0013930034,0.00015919926,0.00025449353,0.000037788526,0.00018597001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010347955,0.00019174286,0.0006621943,0.00011042386,0.000117620024,0.00000450791,0.00015582822,0.00020222142,0.00042499424],"category_scores_gemma":[0.00009958965,0.00011221144,0.00026991524,0.00017135488,0.00071753334,0.000030628893,0.000028686278,0.0006445411,0.000019903624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015698923,0.0022140297,0.0030939998,0.000062861815,0.00050115725,0.000043505912,0.00024332866,4.213113e-7,0.9561403,0.0011933307,0.001652367,0.019155791],"study_design_scores_gemma":[0.015087566,0.023287913,0.029222019,0.000081781574,0.00024879814,0.000014957757,0.000053136333,0.000011576045,0.9308466,0.00018721858,0.000856318,0.00010212118],"about_ca_topic_score_codex":0.0000019223928,"about_ca_topic_score_gemma":5.054187e-8,"teacher_disagreement_score":0.026128018,"about_ca_system_score_codex":0.0000064264877,"about_ca_system_score_gemma":0.000020058058,"threshold_uncertainty_score":0.46533892},"labels":[],"label_agreement":null},{"id":"W2098344591","doi":"10.1002/hup.949","title":"Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double‐blind, placebo‐controlled studies","year":2008,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Duloxetine; Tolerability; Placebo; Internal medicine; Anxiety; Psychology; Nausea; Adverse effect; Medicine; Somatic anxiety; Generalized anxiety disorder; Randomized controlled trial; Anesthesia; Psychiatry","score_opus":0.07486002951016098,"score_gpt":0.43663988467652665,"score_spread":0.3617798551663657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098344591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809667,0.015252403,0.000020230198,0.000096044256,0.00049560406,0.0026598684,0.000030483245,0.00003210731,0.0004465552],"genre_scores_gemma":[0.9898772,0.008562777,0.0002210967,0.00021414833,0.00008976943,0.00082727487,0.000042199827,0.000029458368,0.00013605536],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951526,0.0010915542,0.0019929695,0.0010667294,0.00030933556,0.00038683068],"domain_scores_gemma":[0.9964222,0.0018238333,0.0009140397,0.00033049617,0.00030738738,0.00020209306],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011953672,0.00046619467,0.003134603,0.0006894013,0.0001955778,0.0000100368625,0.00021643813,0.00025784885,0.00067565433],"category_scores_gemma":[0.00021310648,0.00033360685,0.00043891682,0.0009060721,0.0023833113,0.00010954039,0.00012981944,0.00033776424,0.0000031495886],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.528456,0.0061844,0.45281166,0.000021767626,0.0081966845,0.000006370027,0.002103853,0.000006749853,0.00020367673,0.00003510115,0.00021349062,0.0017602633],"study_design_scores_gemma":[0.8044338,0.0016845283,0.1895615,0.000024074607,0.0028715485,0.000003828259,0.0007323694,0.00003800111,0.00020366405,0.00007527538,0.00008147577,0.00028992852],"about_ca_topic_score_codex":0.00012883669,"about_ca_topic_score_gemma":0.000053634976,"teacher_disagreement_score":0.2759778,"about_ca_system_score_codex":0.0000258858,"about_ca_system_score_gemma":0.000029626517,"threshold_uncertainty_score":0.9999116},"labels":[],"label_agreement":null},{"id":"W2099385540","doi":"10.1002/hup.596","title":"Effects of modafinil on cognitive and meta‐cognitive performance","year":2004,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Defence Research and Development Canada","funders":"","keywords":"Modafinil; Psychology; Cognition; Vigilance (psychology); Effects of sleep deprivation on cognitive performance; Placebo; Mood; Sleep deprivation; Audiology; Clinical psychology; Psychiatry; Medicine; Cognitive psychology","score_opus":0.1110857118431437,"score_gpt":0.461557397347303,"score_spread":0.3504716855041593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099385540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996266,0.0007573842,0.0000058858527,0.00009714999,0.0002775096,0.00052383565,0.0000131044035,0.00002872517,0.0020304157],"genre_scores_gemma":[0.99666077,0.00043963848,0.000009886588,0.00249299,0.00010308522,0.00017979766,0.0000015352052,0.0000163695,0.0000959508],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982847,0.00026488776,0.00035892925,0.0005987982,0.0002074814,0.00028520674],"domain_scores_gemma":[0.99837524,0.0012287779,0.00009451249,0.000068542504,0.000030414738,0.00020248657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020601561,0.00020153858,0.00043723293,0.00009215327,0.00024927402,0.000016684546,0.00011921524,0.000121805904,0.00021475877],"category_scores_gemma":[0.0001328798,0.00015991495,0.000111209476,0.00010173555,0.0015906047,0.000117194046,0.000113881004,0.00038623926,0.00004197221],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0141480435,0.008402421,0.0032846027,0.00030740685,0.0011708863,0.00028152418,0.0021287247,0.0000044502954,0.9542435,0.0036359667,0.00019244885,0.012200019],"study_design_scores_gemma":[0.017819772,0.003150345,0.005054423,0.00004149758,0.00038600533,0.00001574287,0.00014786635,0.000018243465,0.9727092,0.00045115993,0.000021407986,0.0001843463],"about_ca_topic_score_codex":0.0000054710285,"about_ca_topic_score_gemma":3.600881e-7,"teacher_disagreement_score":0.018465685,"about_ca_system_score_codex":0.000008853885,"about_ca_system_score_gemma":0.000018935243,"threshold_uncertainty_score":0.6521143},"labels":[],"label_agreement":null},{"id":"W2102232838","doi":"10.1002/hup.959","title":"Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open‐label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidone","year":2008,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Olanzapine; Risperidone; Quetiapine; Polypharmacy; Antipsychotic; Clozapine; Medicine; Schizophrenia (object-oriented programming); Refractory (planetary science); Internal medicine; Atypical antipsychotic; Adverse effect; Psychiatry; Psychology; Pharmacology","score_opus":0.10420626554927495,"score_gpt":0.4711181981429769,"score_spread":0.3669119325937019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102232838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98404324,0.00086099666,0.000112595415,0.00022931286,0.00025225186,0.014109682,0.00033829632,0.000034586403,0.000019023726],"genre_scores_gemma":[0.9879484,0.0004609952,0.007283015,0.00017033386,0.00032527826,0.0032947327,0.00025196912,0.000085469444,0.00017977075],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966011,0.00041353912,0.00093016034,0.001176655,0.0003320993,0.0005464421],"domain_scores_gemma":[0.9973993,0.0005888186,0.00028126588,0.00047588637,0.0002667435,0.0009880064],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042878438,0.0005898285,0.0017708886,0.00031182315,0.00031668952,0.000028707473,0.00021410135,0.00016754918,0.00007657313],"category_scores_gemma":[0.000040909046,0.0003909812,0.00015613367,0.00022973177,0.00062220165,0.00018235632,0.00010124181,0.00015855899,0.0000027050723],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9043483,0.022593267,0.006499641,0.00013242397,0.0017135608,0.000058946553,0.00059973256,0.0000028703096,0.05917321,0.00004954152,0.00017042301,0.0046580974],"study_design_scores_gemma":[0.66056186,0.2796881,0.023267424,0.00023424884,0.00056173734,0.000021977048,0.00007138016,0.000067162044,0.034827076,0.000020692316,0.00033527773,0.0003430928],"about_ca_topic_score_codex":0.00022220831,"about_ca_topic_score_gemma":0.000064054046,"teacher_disagreement_score":0.2570948,"about_ca_system_score_codex":0.00022905083,"about_ca_system_score_gemma":0.00037219367,"threshold_uncertainty_score":0.9998542},"labels":[],"label_agreement":null},{"id":"W2104759830","doi":"10.1002/hup.1227","title":"Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent‐onset bipolar disorder","year":2011,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Bipolar disorder; Psychiatry; Psychotropic medication; Pediatrics; Comorbidity; Medical prescription; Medicaid; Lithium (medication); Mental health; Pharmacology","score_opus":0.058856367615107076,"score_gpt":0.4062285793716007,"score_spread":0.3473722117564936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104759830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900657,0.008620725,0.000014705933,0.0002647033,0.00012504657,0.000536081,0.000011890066,0.000024369734,0.00033680923],"genre_scores_gemma":[0.997266,0.0013728472,0.00066365063,0.0003841637,0.00004398367,0.00013914425,0.00008809154,0.000016755776,0.000025360301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985245,0.00010051227,0.00059944956,0.00039090627,0.00018106417,0.00020356977],"domain_scores_gemma":[0.99937373,0.000039504364,0.0001036345,0.00014191626,0.00001863314,0.0003225989],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013845466,0.0002037642,0.00042879937,0.00011288446,0.00011556312,0.000003037409,0.000061518775,0.00016280626,0.0013358674],"category_scores_gemma":[0.000003904614,0.00014711582,0.000050117058,0.00006808377,0.0006951534,0.000039159593,0.000031397954,0.00021338755,0.000010427674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011093643,0.012364236,0.96778643,0.00002614573,0.00033904807,0.000024218203,0.0028418147,7.74896e-9,0.0008242155,0.00007341223,0.000093180795,0.014517913],"study_design_scores_gemma":[0.028086035,0.0026649884,0.9636043,0.00008500456,0.00011443152,0.00010263596,0.0005579941,0.0000053717945,0.0017981626,0.000039091257,0.0028005524,0.00014147289],"about_ca_topic_score_codex":0.000053494947,"about_ca_topic_score_gemma":0.0002132668,"teacher_disagreement_score":0.02697667,"about_ca_system_score_codex":0.000030240839,"about_ca_system_score_gemma":0.00011550985,"threshold_uncertainty_score":0.99957705},"labels":[],"label_agreement":null},{"id":"W2115657575","doi":"10.1002/hup.933","title":"Orally disintegrating olanzapine and potential differences in treatment‐emergent weight gain","year":2008,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Memorial University of Newfoundland","funders":"","keywords":"Olanzapine; Weight gain; Medicine; Action (physics); Psychology; Randomized controlled trial; Pharmacology; Body weight; Psychiatry; Internal medicine; Schizophrenia (object-oriented programming)","score_opus":0.14258962182082963,"score_gpt":0.49568079603468274,"score_spread":0.3530911742138531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115657575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25574586,0.74242806,5.363157e-7,0.00011736024,0.00043089106,0.0010562348,0.000026814198,0.000032419564,0.00016179148],"genre_scores_gemma":[0.053512245,0.9442414,0.00023600826,0.00011731288,0.00074584724,0.00038864106,0.00019178037,0.00004671566,0.00052005873],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965425,0.00048293418,0.001242077,0.0009988229,0.00022776578,0.00050590554],"domain_scores_gemma":[0.9987161,0.0002035793,0.00022467274,0.00023286979,0.00002262778,0.00060013286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015464128,0.0006618978,0.0024739269,0.00027138882,0.00022980045,0.000030021158,0.0001278799,0.00042313646,0.00080720615],"category_scores_gemma":[0.000017973221,0.00042093598,0.0005269595,0.00014203528,0.00072970206,0.000053174357,0.00012366827,0.00069553684,0.00003792955],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077314973,0.0058810757,0.0060009058,0.00080256944,0.0018184329,0.002995823,0.00022120395,1.7834044e-8,0.00009600727,0.000109710585,0.0023105165,0.97203225],"study_design_scores_gemma":[0.30299452,0.04797403,0.021500045,0.0144606,0.0069692293,0.008273402,0.0011607837,0.0002246587,0.00021781585,0.0005280572,0.5911998,0.004497048],"about_ca_topic_score_codex":0.000058258607,"about_ca_topic_score_gemma":0.000029945093,"teacher_disagreement_score":0.9675352,"about_ca_system_score_codex":0.00013297891,"about_ca_system_score_gemma":0.00019744555,"threshold_uncertainty_score":0.9998242},"labels":[],"label_agreement":null},{"id":"W2119461820","doi":"10.1002/hup.766","title":"Patterns of simultaneous polysubstance use in drug using university students","year":2006,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":275,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Dalhousie University","funders":"","keywords":"Polysubstance dependence; Cannabis; Psilocybin; MDMA; Context (archaeology); Amphetamine; Drug; Methylphenidate; Pharmacology; Alcohol; Psychiatry; Psychology; Hallucinogen; Medicine; Substance abuse; Chemistry; Internal medicine; Attention deficit hyperactivity disorder; Dopamine","score_opus":0.07716607449409428,"score_gpt":0.420089419819193,"score_spread":0.3429233453250987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119461820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991342,0.000036441397,0.0000044500684,0.000014489908,0.00042300136,0.00029133246,0.000025612497,0.00003058241,0.00003993511],"genre_scores_gemma":[0.9991965,0.000025179595,0.000057887504,0.00038262355,0.00005172981,0.0000026449366,0.0000010301763,0.000015103227,0.00026724878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981625,0.0003324702,0.0005147134,0.0005415619,0.00019651827,0.00025225175],"domain_scores_gemma":[0.99932694,0.0002782568,0.00014606166,0.00014260225,0.000012612108,0.00009351822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011863583,0.00016177363,0.00028100857,0.00010557934,0.00010260008,0.000019737454,0.0003190544,0.00007936026,0.00021833014],"category_scores_gemma":[0.000008626119,0.00017463355,0.00008463872,0.00012608156,0.00040508527,0.00020091257,0.000089094814,0.00027058573,0.000008137894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004252039,0.0009811397,0.3721831,0.000003560361,0.0000021558321,0.00023887862,0.000092863986,0.000020609079,0.6259243,0.00004503633,0.00002759339,0.00005555874],"study_design_scores_gemma":[0.015444064,0.00029777113,0.10277466,0.0000436684,0.000034274526,0.00003283527,0.00024192395,0.00015714603,0.8801201,0.000038966133,0.0004215126,0.0003931019],"about_ca_topic_score_codex":0.00030110832,"about_ca_topic_score_gemma":0.00005681553,"teacher_disagreement_score":0.26940846,"about_ca_system_score_codex":0.000034815115,"about_ca_system_score_gemma":0.000009839423,"threshold_uncertainty_score":0.71213496},"labels":[],"label_agreement":null},{"id":"W2121605598","doi":"10.1002/1099-1077(200010)15:7<479::aid-hup206>3.0.co;2-5","title":"Quantitative EEG methods and measures in human psychopharmacological research","year":2000,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"EEG and Brain-Computer Interfaces","field":"Neuroscience","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Royal Ottawa Mental Health Centre","funders":"","keywords":"Electroencephalography; Profiling (computer programming); Statistical analysis; Computer science; Psychology; Neuroscience; Statistics; Mathematics","score_opus":0.33804569854435645,"score_gpt":0.6142408501454625,"score_spread":0.276195151601106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121605598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872683,0.0013149594,0.000009583656,0.0007598003,0.0006161098,0.00050494506,0.0000054946727,0.000081644466,0.009439106],"genre_scores_gemma":[0.9936537,0.00046890424,0.0013334741,0.0033378978,0.00022078434,0.000115751216,0.0000014910999,0.000024052895,0.0008439317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99321836,0.003743014,0.0008637818,0.0012616335,0.0002870773,0.00062615616],"domain_scores_gemma":[0.9976063,0.0017517856,0.0000825159,0.0001919095,0.000032247135,0.00033524237],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002733675,0.00029152847,0.0005288437,0.00022339272,0.0006198897,0.000100515965,0.00043947095,0.0002575179,0.0030532451],"category_scores_gemma":[0.00009171894,0.0002466499,0.000103537364,0.00028600605,0.0027156523,0.0001974363,0.0001968013,0.001241129,0.00007255534],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018287519,0.0013881796,0.0013622254,0.000008771133,0.00002328918,0.00009408624,0.001120258,0.0000031348548,0.9706119,0.0019998685,0.0059007374,0.015658848],"study_design_scores_gemma":[0.03981491,0.012090035,0.029381225,0.00011873689,0.000053660235,0.00021873607,0.0018319315,0.0016829749,0.84027845,0.020768085,0.05221166,0.0015496117],"about_ca_topic_score_codex":0.000024128745,"about_ca_topic_score_gemma":0.0000060629063,"teacher_disagreement_score":0.13033342,"about_ca_system_score_codex":0.00002786178,"about_ca_system_score_gemma":0.000016811313,"threshold_uncertainty_score":0.99999857},"labels":[],"label_agreement":null},{"id":"W2130846979","doi":"10.1002/hup.595","title":"Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross‐over study","year":2004,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Donepezil; Clinical Global Impression; Placebo; Clozapine; Schizophrenia (object-oriented programming); Internal medicine; Psychosis; Antipsychotic; Psychology; Medicine; Anesthesia; Psychiatry; Dementia","score_opus":0.07556202214836083,"score_gpt":0.49482608847920817,"score_spread":0.41926406633084734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130846979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694,0.00075560855,0.0000011690807,0.00014792998,0.0003111816,0.0016828643,0.000007528757,0.000026301012,0.00012741893],"genre_scores_gemma":[0.9986531,0.0001432591,0.0003298608,0.0003502605,0.00017387932,0.00023007882,0.000038719212,0.00002284023,0.00005796945],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99803704,0.000105238534,0.00082672323,0.0005083518,0.00027693098,0.0002456928],"domain_scores_gemma":[0.99930114,0.000051070285,0.00014057326,0.0001965499,0.000058774804,0.00025188253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028917732,0.00021457669,0.0004937675,0.00019152705,0.00010347135,0.000018593239,0.000098210716,0.00012805438,0.00066319434],"category_scores_gemma":[0.000008189188,0.00017778977,0.00012830166,0.00017135426,0.00041328292,0.000117659365,0.000059614795,0.00031530342,0.000023974695],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6134722,0.018619888,0.3578177,0.000013970188,0.00030393832,0.000067614055,0.00072591467,0.0000051606244,0.006698929,0.00014599085,0.000099220364,0.0020294434],"study_design_scores_gemma":[0.5973533,0.0067559015,0.39023784,0.000022793698,0.000047039503,0.0000054674215,0.00020203694,0.0000053199683,0.0049834563,0.000246377,0.00002450018,0.000115985975],"about_ca_topic_score_codex":0.00018962688,"about_ca_topic_score_gemma":0.00007932001,"teacher_disagreement_score":0.032420125,"about_ca_system_score_codex":0.00009212924,"about_ca_system_score_gemma":0.00007906829,"threshold_uncertainty_score":0.7261513},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2134860896","doi":"10.1002/hup.1158","title":"Efficacy of reboxetine in adults with attention‐deficit/hyperactivity disorder: A randomized, placebo‐controlled clinical trial","year":2010,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Reboxetine; Placebo; Clinical Global Impression; Rating scale; Psychology; Global Assessment of Functioning; Irritability; Anxiety; Attention deficit hyperactivity disorder; Randomized controlled trial; Clinical trial; Hamilton Anxiety Rating Scale; Psychiatry; Clinical psychology; Medicine; Internal medicine; Reuptake inhibitor; Developmental psychology; Schizophrenia (object-oriented programming)","score_opus":0.043170996251071146,"score_gpt":0.4453527279245991,"score_spread":0.402181731673528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134860896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088144,0.0003208013,0.000014535928,0.00095055747,0.0014734457,0.005072559,0.0000062037016,0.00006433266,0.0012161053],"genre_scores_gemma":[0.99762994,0.00014681394,0.00034775777,0.00030802956,0.00060901314,0.00050329225,0.00003284895,0.000046662513,0.00037566837],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947468,0.0012021903,0.0023933412,0.0009193547,0.00034749598,0.00039082175],"domain_scores_gemma":[0.99582416,0.002591854,0.0007354968,0.00040686468,0.000114599636,0.0003270301],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028360412,0.00039658573,0.0026447005,0.00021153809,0.00014509588,0.000017865133,0.00015599372,0.00046570878,0.0013174127],"category_scores_gemma":[0.0008762949,0.00029465402,0.00079239235,0.00018090325,0.0023513257,0.00015413015,0.00009870104,0.0016668312,0.000035311474],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81140965,0.014724111,0.16549173,0.000031283485,0.00045086123,0.000043231863,0.00007326051,0.0000011699609,0.006379508,0.00013626042,0.00006548796,0.0011934352],"study_design_scores_gemma":[0.92002195,0.0034603002,0.0747179,0.0000853633,0.00043736302,0.000055983037,0.000502038,0.00029938313,0.000036003672,0.00001741592,0.000092592265,0.0002737355],"about_ca_topic_score_codex":0.00005716443,"about_ca_topic_score_gemma":0.00006666293,"teacher_disagreement_score":0.10861227,"about_ca_system_score_codex":0.0000147625415,"about_ca_system_score_gemma":0.000097434284,"threshold_uncertainty_score":0.9999506},"labels":[],"label_agreement":null},{"id":"W2134906904","doi":"10.1002/hup.1159","title":"The role of nicotine content information in smokers' subjective responses to nicotine and placebo inhalers","year":2010,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Nicotine; Placebo; Craving; Inhaler; Medicine; Abstinence; Smoking cessation; Nicotine withdrawal; Psychology; Addiction; Psychiatry; Internal medicine; Asthma; Alternative medicine","score_opus":0.04181029149686435,"score_gpt":0.40989604821622433,"score_spread":0.36808575671936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134906904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771774,0.00012618954,5.6146234e-7,0.0005425345,0.00051940436,0.00049391104,0.0000058554656,0.000015574537,0.0005782604],"genre_scores_gemma":[0.99902076,0.00004111851,0.00002908487,0.00067889434,0.000087562184,0.00006437882,0.000008662139,0.000006341648,0.000063197556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989651,0.00009525164,0.00051042694,0.00016943681,0.00011429793,0.00014550805],"domain_scores_gemma":[0.99934137,0.0002574864,0.00011027941,0.00010944758,0.000051304338,0.00013011874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005907693,0.000104764746,0.00022341908,0.00009435703,0.0001111505,0.000013845465,0.000059359867,0.00012543124,0.000115333656],"category_scores_gemma":[0.0000839122,0.00007719985,0.000044498276,0.00006370293,0.0004073733,0.00009306293,0.00005118108,0.00036870706,0.000006527115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008963504,0.00030318406,0.685365,0.0000047993735,0.00002822156,0.0000012709723,0.0011847817,1.278159e-7,0.2996882,0.00017813701,0.00028883852,0.003993896],"study_design_scores_gemma":[0.012874198,0.0011520468,0.8636965,0.000018280092,0.000042755157,0.00002331421,0.0039004697,0.000023093024,0.11607504,0.00005830028,0.0020379638,0.00009803232],"about_ca_topic_score_codex":0.00004397865,"about_ca_topic_score_gemma":0.000021385014,"teacher_disagreement_score":0.18361315,"about_ca_system_score_codex":0.0000150748865,"about_ca_system_score_gemma":0.000024114057,"threshold_uncertainty_score":0.31481186},"labels":[],"label_agreement":null},{"id":"W2135042408","doi":"10.1002/hup.2431","title":"Olanzapine as the ideal “trip terminator”? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance‐related psychotic symptoms","year":2015,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada; Public Health Agency of Canada; World Health Organization","keywords":"Olanzapine; Psychiatry; Medicine; Psychology; Schizophrenia (object-oriented programming)","score_opus":0.11187454134655671,"score_gpt":0.47933637828394826,"score_spread":0.36746183693739154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135042408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959778,0.0017622906,0.000009048133,0.0005207397,0.00075984263,0.00078701373,0.000053560674,0.000027933751,0.0001017588],"genre_scores_gemma":[0.9981234,0.00012435322,0.00092974474,0.00052964716,0.00008054613,0.000033797718,0.00007420355,0.000019431458,0.00008485546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969617,0.0001876603,0.0013354374,0.00072745606,0.00043731497,0.00035042694],"domain_scores_gemma":[0.9978033,0.00046857193,0.0004469417,0.0004491205,0.00017091804,0.00066118245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008053887,0.00028992945,0.00096450344,0.0003487497,0.00013047986,0.00002103817,0.00013843742,0.00018815033,0.0000841157],"category_scores_gemma":[0.0002182824,0.00020928275,0.0003451382,0.0007359243,0.00060768006,0.00013035178,0.000067630855,0.00047812,0.000002892029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05073243,0.009175542,0.8728912,0.00004634707,0.00977656,0.00058145716,0.0046620523,0.000024420662,0.046940435,0.00023465633,0.0026837587,0.0022511561],"study_design_scores_gemma":[0.06690817,0.007955275,0.91058874,0.00034069442,0.004873964,0.0003884521,0.0021580046,0.0012084726,0.004325291,0.00044427317,0.00025977136,0.00054887275],"about_ca_topic_score_codex":0.00007496292,"about_ca_topic_score_gemma":0.000031851872,"teacher_disagreement_score":0.04261514,"about_ca_system_score_codex":0.000043252872,"about_ca_system_score_gemma":0.00009524199,"threshold_uncertainty_score":0.8534303},"labels":[],"label_agreement":null},{"id":"W2140543061","doi":"10.1002/hup.452","title":"Are there gender differences in the prescribing of hypnotic medications for insomnia?","year":2002,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sleep and related disorders","field":"Psychology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; University of Calgary; Saint John Regional Hospital; University of British Columbia Hospital; University Health Network; University of Toronto; Centre for Addiction and Mental Health; Toronto Western Hospital; Lakehead University","funders":"","keywords":"Zopiclone; Insomnia; Pharmacy; Medicine; Medical prescription; Psychiatry; Hypnotic; Marital status; Family medicine; Population; Pharmacology","score_opus":0.17472325250014586,"score_gpt":0.44678380161715897,"score_spread":0.2720605491170131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140543061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796719,0.009642604,0.000009250513,0.0008073221,0.0009994913,0.0005070763,0.0000076347715,0.000018952886,0.008335782],"genre_scores_gemma":[0.99735546,0.0001684852,0.000024016115,0.001777829,0.00016596235,0.00024523854,0.0000034108198,0.000011484288,0.0002481004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853015,0.00030363447,0.00053227745,0.0003214539,0.00009127977,0.00022117804],"domain_scores_gemma":[0.9990474,0.00049795845,0.00019983055,0.00017419676,0.000015627698,0.000065014545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029730258,0.00012973842,0.0002605715,0.00006772565,0.00015163793,0.000008164619,0.00026138718,0.00020880625,0.0029972747],"category_scores_gemma":[0.000014655073,0.00008686701,0.000109277265,0.0000904715,0.0006463851,0.0000331501,0.000026868418,0.00029810975,0.000028850958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016023157,0.020473452,0.765495,0.00006208749,0.0027299207,0.000065040724,0.045759887,0.0000031446657,0.0050121183,0.014638782,0.13562584,0.00853243],"study_design_scores_gemma":[0.050430432,0.0015850352,0.87840545,0.000074662574,0.00066932663,0.00003630295,0.058334704,0.00046833602,0.0002696592,0.004548104,0.0045629777,0.0006150022],"about_ca_topic_score_codex":0.000011514391,"about_ca_topic_score_gemma":0.00000473742,"teacher_disagreement_score":0.13106287,"about_ca_system_score_codex":0.000004896485,"about_ca_system_score_gemma":0.00000315229,"threshold_uncertainty_score":0.99791414},"labels":[],"label_agreement":null},{"id":"W2140710408","doi":"10.1002/hup.1069","title":"Is moderate substance use associated with altered executive functioning in a population‐based sample of young adults?","year":2009,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft","keywords":"Impulsivity; Ecstasy; Psychology; Stroop effect; Cannabis; Cognition; Neuropsychology; Executive functions; Population; Clinical psychology; Cognitive skill; Young adult; Prospective memory; Developmental psychology; Psychiatry; Medicine","score_opus":0.07747693258983618,"score_gpt":0.4045433607698549,"score_spread":0.32706642818001874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140710408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99868405,0.00040535635,0.000016301026,0.00014676068,0.0001833142,0.00038387123,0.0000080661475,0.000040534745,0.0001317716],"genre_scores_gemma":[0.99735355,0.00003004057,0.00036368257,0.0018750236,0.0000649692,0.000027309341,0.00009219342,0.000013367823,0.0001798549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986499,0.00009131439,0.00052953116,0.00036969525,0.00014182916,0.00021775096],"domain_scores_gemma":[0.99929374,0.00024159791,0.0001794322,0.00012358723,0.000054000877,0.00010764702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012903489,0.00018224743,0.0004937717,0.00010293732,0.000105652616,0.0000101937,0.000041609477,0.00011822657,0.00029003975],"category_scores_gemma":[0.000025850053,0.00014798575,0.00009692233,0.00017644404,0.0001372501,0.0001422227,0.000005372331,0.00019767792,0.000001713904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013229524,0.0013739095,0.9809045,0.0000032981086,0.00013175541,0.00002795485,0.0016920812,0.000006385207,0.0020371315,0.000033260145,0.00035043593,0.00020975026],"study_design_scores_gemma":[0.03900026,0.0016015329,0.953306,0.00016605764,0.00009581608,0.000004109669,0.00043376486,0.0006463152,0.0044984603,0.00008440485,0.000005755563,0.00015752987],"about_ca_topic_score_codex":0.00007005465,"about_ca_topic_score_gemma":0.0001800423,"teacher_disagreement_score":0.027598523,"about_ca_system_score_codex":0.00006179337,"about_ca_system_score_gemma":0.000019623114,"threshold_uncertainty_score":0.60346836},"labels":[],"label_agreement":null},{"id":"W2141432085","doi":"10.1002/hup.693","title":"A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI‐cycle) to psychiatric disorders—focus on magnetic resonance spectroscopy (MRS) studies","year":2005,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Bipolar disorder; Inositol; Panic disorder; Schizophrenia (object-oriented programming); Psychiatry; Lithium (medication); Phosphatidylinositol; Psychology; Second messenger system; Neuroscience; Medicine; Internal medicine; Signal transduction; Biology; Biochemistry; Anxiety; Receptor","score_opus":0.03522219291729117,"score_gpt":0.43569766055542647,"score_spread":0.4004754676381353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141432085","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006125536,0.98647696,1.3096141e-7,0.00123834,0.0009890351,0.004055258,0.00004403239,0.000021552616,0.0010491828],"genre_scores_gemma":[0.015834657,0.9816538,0.00012508586,0.001154074,0.0003292402,0.00055844884,0.000005300877,0.000046025045,0.00029335223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99619925,0.0006901203,0.0017615764,0.00076689926,0.00027106603,0.00031106186],"domain_scores_gemma":[0.99786705,0.00061289856,0.0006834481,0.00061137613,0.000057789486,0.00016744685],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053932494,0.0005571613,0.002951729,0.000094675685,0.00023281718,0.000009067836,0.00031575526,0.00024515885,0.00017057465],"category_scores_gemma":[0.000038578826,0.00028973713,0.00070383435,0.00032032316,0.0011260549,0.000029770994,0.00019722448,0.000663776,0.000014613309],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055302917,0.0060584433,0.0023831776,0.14095055,0.003022916,0.000014509394,0.001262144,1.0201321e-7,0.00009568967,0.0027722572,0.03708803,0.8008219],"study_design_scores_gemma":[0.022165962,0.004165099,0.0019631952,0.06917471,0.0060821986,0.00012524275,0.0002766232,0.0000029607802,0.00023327323,0.000121110745,0.89510924,0.00058038096],"about_ca_topic_score_codex":0.00001305224,"about_ca_topic_score_gemma":0.000021830258,"teacher_disagreement_score":0.8580212,"about_ca_system_score_codex":0.000067667475,"about_ca_system_score_gemma":0.00009013051,"threshold_uncertainty_score":0.9999555},"labels":[],"label_agreement":null},{"id":"W2146640192","doi":"10.1002/hup.2351","title":"Abnormal maximal finger tapping in abstinent cannabis users","year":2013,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cannabis; Finger tapping; Tapping; Effects of cannabis; Audiology; Index finger; Psychology; Medicine; Psychiatry","score_opus":0.05107438364688988,"score_gpt":0.40660332734212573,"score_spread":0.35552894369523586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146640192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940406,0.00095990323,5.660089e-7,0.001585829,0.000646346,0.00054579467,7.3572545e-7,0.00006060685,0.0021596388],"genre_scores_gemma":[0.99340546,0.00009294673,0.00020791477,0.0041623046,0.00032441854,0.00018202195,0.000015629988,0.000021051583,0.001588263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984437,0.000060414146,0.0005895011,0.00041231327,0.00011996166,0.0003740788],"domain_scores_gemma":[0.99944156,0.000063362226,0.000077320154,0.00013842006,0.000024497294,0.00025484918],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015822396,0.00021394974,0.00044026354,0.00010940372,0.00010296339,0.000017091957,0.00007752205,0.00014957674,0.0044327434],"category_scores_gemma":[0.000010552607,0.00017575988,0.00013376183,0.000087409986,0.0003267834,0.0001374792,0.000047728277,0.00031796892,0.0002175868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001119981,0.0012562327,0.9394128,0.000011570218,0.00015248357,0.00019008726,0.0012281344,8.1947064e-7,0.023060612,0.000058583202,0.031449284,0.002059422],"study_design_scores_gemma":[0.030946413,0.0008337037,0.9595984,0.000050424158,0.000073757954,0.000055135646,0.0014656959,0.00008770675,0.0042186873,0.00008836739,0.0022817054,0.00029995348],"about_ca_topic_score_codex":0.0000702599,"about_ca_topic_score_gemma":0.000020199634,"teacher_disagreement_score":0.029826432,"about_ca_system_score_codex":0.000050528313,"about_ca_system_score_gemma":0.000020630168,"threshold_uncertainty_score":0.99647737},"labels":[],"label_agreement":null},{"id":"W2147012135","doi":"10.1002/hup.1021","title":"The SNRI venlafaxine improves emotional unawareness in patients with post‐stroke depression","year":2009,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venlafaxine; Alexithymia; Fluoxetine; Psychology; Depression (economics); Toronto Alexithymia Scale; Stroke (engine); Reuptake inhibitor; Psychiatry; Post-stroke depression; Internal medicine; Medicine; Anesthesia; Serotonin; Antidepressant; Anxiety; Activities of daily living","score_opus":0.016311950886870746,"score_gpt":0.3726536744238983,"score_spread":0.35634172353702753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147012135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963751,0.0006755722,0.0000015518061,0.00071651593,0.00040671538,0.00048602888,0.000007638901,0.000025244726,0.0013056591],"genre_scores_gemma":[0.9974619,0.000053517033,0.00006807604,0.0018921738,0.00011261171,0.0000347522,0.0000440284,0.000011745155,0.00032117064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987508,0.000075944336,0.0004144968,0.00034544544,0.00016834115,0.00024496825],"domain_scores_gemma":[0.99946266,0.000078894234,0.00009696856,0.00016608828,0.00003758682,0.00015781481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001289147,0.00017930563,0.00028363132,0.000049898128,0.00022728862,0.00001794375,0.0000940162,0.00010019642,0.00012189173],"category_scores_gemma":[0.000008969485,0.00010292166,0.0000778778,0.000056002737,0.00027398716,0.00006506608,0.000025927748,0.00021490493,0.000011836023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011428739,0.0075075985,0.95709383,0.000009214812,0.00017590214,0.00002475588,0.00019841768,3.4426677e-7,0.0079488335,0.00012036265,0.00095317984,0.014538831],"study_design_scores_gemma":[0.033239175,0.0034158619,0.96175957,0.00008519449,0.000034572196,0.000006487763,0.00012091467,0.000013912758,0.000499937,0.00026271696,0.000442135,0.00011951725],"about_ca_topic_score_codex":0.0000053905555,"about_ca_topic_score_gemma":0.000002568461,"teacher_disagreement_score":0.021810437,"about_ca_system_score_codex":0.000020601248,"about_ca_system_score_gemma":0.000021315213,"threshold_uncertainty_score":0.41970235},"labels":[],"label_agreement":null},{"id":"W2147643260","doi":"10.1002/hup.420","title":"Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients","year":2002,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bipolar disorder; Lithium (medication); Mood stabilizer; Internal medicine; Endocrinology; Treatment of bipolar disorder; Mood; Psychology; Sodium; Inositol; Chemistry; Medicine; Psychiatry; Mania; Receptor","score_opus":0.03286246463283928,"score_gpt":0.3658692815645677,"score_spread":0.33300681693172846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147643260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769046,0.019932823,8.484112e-7,0.00045151458,0.00023474453,0.0008120947,0.000012304278,0.000045948946,0.0016051545],"genre_scores_gemma":[0.9964779,0.002132747,0.00006210627,0.0003161443,0.00017899387,0.00015554292,0.000015904656,0.000029517574,0.00063111976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837863,0.00012527993,0.00037538825,0.0006047756,0.00013712488,0.00037880728],"domain_scores_gemma":[0.9993475,0.000050822204,0.00009193621,0.00018429305,0.00001604012,0.00030941382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008707513,0.00031358766,0.0005193072,0.00007828959,0.00018181659,0.000019504003,0.000053568627,0.00017060828,0.0005329188],"category_scores_gemma":[0.0000015956899,0.00023005262,0.00009523728,0.000082003666,0.00044930444,0.00010869764,0.00005121149,0.00027616383,0.00003301959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002452397,0.008266779,0.9585962,0.00003346811,0.00032210923,0.000060100734,0.0007197735,2.7089698e-7,0.004929657,0.00002307347,0.00023390619,0.024362227],"study_design_scores_gemma":[0.090797625,0.019169843,0.8580282,0.00005477083,0.00033925506,0.000071237926,0.000100911864,0.0002550139,0.016967736,0.000026734404,0.013745326,0.00044334092],"about_ca_topic_score_codex":0.00017871615,"about_ca_topic_score_gemma":0.00009164528,"teacher_disagreement_score":0.100568034,"about_ca_system_score_codex":0.00013035917,"about_ca_system_score_gemma":0.000022404845,"threshold_uncertainty_score":0.93812734},"labels":[],"label_agreement":null},{"id":"W2149936913","doi":"10.1002/hup.966","title":"Targeted scoring criteria reduce variance in global impressions","year":2008,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Variance (accounting); Psychology; Reliability (semiconductor); Anxiety; Clinical trial; Clinical psychology; Medicine; Psychiatry","score_opus":0.09156338908345499,"score_gpt":0.47542234471080275,"score_spread":0.38385895562734773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149936913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386716,0.0009396616,0.000010953206,0.00072842796,0.00069775,0.0002724178,0.0000058179094,0.000056987734,0.0034208063],"genre_scores_gemma":[0.99667704,0.000068374786,0.00091980275,0.0018323723,0.0002524048,0.000034683133,0.000010168825,0.000009852856,0.0001953201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848133,0.00012619626,0.0005320725,0.00046194263,0.00009985792,0.00029862314],"domain_scores_gemma":[0.99941075,0.000060327733,0.000063240615,0.00014687852,0.00002374031,0.0002950902],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017783936,0.00016288774,0.00036090196,0.00004226262,0.000180465,0.0000066073085,0.00008767502,0.00011989837,0.00092738244],"category_scores_gemma":[0.000061142295,0.00015288444,0.00009772368,0.00011569224,0.00064231793,0.000080512094,0.00007505184,0.0003556351,0.000030040821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006308863,0.004097549,0.7046492,0.000034066146,0.00006372369,0.0006701157,0.0004657826,0.0000024783646,0.2690669,0.00020891175,0.013626215,0.0008061793],"study_design_scores_gemma":[0.021388156,0.0014187475,0.9720545,0.000099420184,0.000035126348,0.0006936836,0.00036232636,0.00017942704,0.002400863,0.0004522931,0.0007121681,0.00020328478],"about_ca_topic_score_codex":0.00004839718,"about_ca_topic_score_gemma":0.000004304329,"teacher_disagreement_score":0.26740527,"about_ca_system_score_codex":0.00003203198,"about_ca_system_score_gemma":0.00004632755,"threshold_uncertainty_score":0.99998593},"labels":[],"label_agreement":null},{"id":"W2150086017","doi":"10.1002/hup.2288","title":"Exploratory study on association of genetic variation in <i>TBC1D1</i> with antipsychotic‐induced weight gain","year":2013,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Case Western Reserve University; Canadian Institutes of Health Research; Bristol-Myers Squibb","keywords":"Clozapine; Antipsychotic; Allele; Internal medicine; Olanzapine; Weight gain; Genetic association; Endocrinology; Single-nucleotide polymorphism; Biology; Medicine; Schizophrenia (object-oriented programming); Genetics; Genotype; Gene; Body weight; Psychiatry","score_opus":0.027168791714442204,"score_gpt":0.36202328297702846,"score_spread":0.33485449126258626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150086017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946151,0.0039206897,0.000006275892,0.00002864425,0.0005720022,0.00058822514,0.0000035610763,0.000008090515,0.00025744858],"genre_scores_gemma":[0.9973615,0.00088705344,0.00005413557,0.0010211546,0.00038226886,0.00020683714,0.000009456181,0.000019892372,0.000057728383],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982822,0.0003643471,0.0005229275,0.00046489478,0.00014841396,0.00021721685],"domain_scores_gemma":[0.9993981,0.00003800292,0.0002202124,0.00018983167,0.000055916935,0.00009791603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036102312,0.000172089,0.000303386,0.000059186714,0.00005788962,0.000013114597,0.00011878825,0.00018268253,0.00020066153],"category_scores_gemma":[0.000013451136,0.00014835583,0.000057453213,0.00007521427,0.00008721938,0.000010634845,0.000034858087,0.00017172222,0.000017349668],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012605307,0.0037136206,0.20500305,0.00000958849,0.00020553241,0.000003897632,0.0009977528,0.0000069144203,0.7806133,0.000016081005,0.004346447,0.0038232477],"study_design_scores_gemma":[0.039562758,0.009897115,0.77927154,0.0000329687,0.00012354543,0.0000022578736,0.0022952412,0.00004460923,0.16420817,0.00015696847,0.0037546507,0.00065017055],"about_ca_topic_score_codex":0.00001631567,"about_ca_topic_score_gemma":0.000023106944,"teacher_disagreement_score":0.6164051,"about_ca_system_score_codex":0.000017692344,"about_ca_system_score_gemma":0.000026480362,"threshold_uncertainty_score":0.6049775},"labels":[],"label_agreement":null},{"id":"W2153999053","doi":"10.1002/hup.434","title":"Dextro‐amphetamine increases phosphoinositol cycle activity in volunteers: an MRS study","year":2002,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Amphetamine; Phosphomonoesters; Dopamine; Endocrinology; Internal medicine; Medicine; Energy metabolism","score_opus":0.10172467838576102,"score_gpt":0.4365998499269413,"score_spread":0.3348751715411803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153999053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99757445,0.00011079516,7.2499375e-7,0.000096967284,0.000725094,0.0009641882,0.000011058243,0.00013461347,0.00038212707],"genre_scores_gemma":[0.9972965,0.0000414567,0.000022799282,0.002031885,0.00018307708,0.00024557923,0.0000010051654,0.000037970312,0.00013969315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964819,0.0009005191,0.0006789244,0.0011852635,0.0002686695,0.00048472374],"domain_scores_gemma":[0.99893665,0.00021738843,0.00011695555,0.00034114925,0.000013180378,0.0003746936],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026747986,0.0003367548,0.00048394396,0.00013577486,0.00026829194,0.00006575438,0.00044151724,0.00014168667,0.003161602],"category_scores_gemma":[0.00003417908,0.00033055103,0.00011665245,0.00021214096,0.0007794623,0.0005274667,0.0001228906,0.0006012281,0.0001917293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008078931,0.016907105,0.1866663,0.000003677851,0.000009058378,0.00028681528,0.00079984893,0.0000023600558,0.7915634,0.00001202631,0.00035138716,0.0025901692],"study_design_scores_gemma":[0.041213498,0.0081797745,0.28478244,0.000025385343,0.000093039576,0.00013604747,0.0009725457,0.0011027157,0.6617651,0.000058525857,0.0005348303,0.0011360669],"about_ca_topic_score_codex":0.00018576856,"about_ca_topic_score_gemma":0.00004157386,"teacher_disagreement_score":0.12979825,"about_ca_system_score_codex":0.00003967432,"about_ca_system_score_gemma":0.0000079935535,"threshold_uncertainty_score":0.99991465},"labels":[],"label_agreement":null},{"id":"W2161905994","doi":"10.1002/hup.612","title":"Comorbidity in bipolar disorder: a framework for rational treatment selection","year":2004,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University of British Columbia; University Health Network","funders":"","keywords":"Bipolar disorder; Schema (genetic algorithms); Bipolar illness; Psychology; Comorbidity; Interim; Psychotherapist; Psychiatry; Mood; Treatment of bipolar disorder; Mood disorders; Clinical psychology; Computer science; Mania; Political science; Information retrieval","score_opus":0.12455225914556964,"score_gpt":0.5153120266579259,"score_spread":0.3907597675123562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161905994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031285053,0.9929074,0.000059402682,0.00014045864,0.0007082591,0.0028563528,0.00007459065,0.000053707103,0.000071340015],"genre_scores_gemma":[0.004508025,0.9910803,0.0011246987,0.00015339056,0.00063786126,0.0017455552,0.00052349793,0.000060265822,0.00016643958],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975591,0.00020110517,0.0009977417,0.0007859304,0.000116616575,0.0003395067],"domain_scores_gemma":[0.99909556,0.00026048656,0.00021675073,0.0001693431,0.000023712282,0.00023416305],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019006719,0.00050472957,0.0017537302,0.00018178132,0.00021427032,0.000018524921,0.00008037656,0.0007058031,0.000467803],"category_scores_gemma":[0.00001566881,0.00039200878,0.00072222174,0.00014671849,0.00028797073,0.000041341416,0.000034770066,0.00055897736,0.000035910296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00161137,0.01741393,0.010827899,0.003158719,0.0018540298,0.00003101832,0.00026386886,5.320491e-7,0.00001661024,0.0038432048,0.00044150013,0.9605373],"study_design_scores_gemma":[0.018524759,0.004314013,0.0007318907,0.0014011703,0.0014315732,0.00010831143,0.000032364744,0.0000066704793,0.000012103758,0.0011332463,0.9719442,0.00035967873],"about_ca_topic_score_codex":0.000057616813,"about_ca_topic_score_gemma":0.000080200065,"teacher_disagreement_score":0.9715027,"about_ca_system_score_codex":0.00034745515,"about_ca_system_score_gemma":0.00028454553,"threshold_uncertainty_score":0.9998532},"labels":[],"label_agreement":null},{"id":"W2164852716","doi":"10.1002/hup.1077","title":"The association between concurrent psychotropic medications and self‐reported adherence with taking a mood stabilizer in bipolar disorder","year":2009,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto","funders":"","keywords":"Pill; Mood; Mood stabilizer; Dose; Medicine; Bipolar disorder; Psychiatry; Internal medicine; Pharmacology","score_opus":0.041736593923146104,"score_gpt":0.42737531153427755,"score_spread":0.38563871761113144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164852716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98139584,0.015261665,0.000009177405,0.001974724,0.00017175706,0.0006008023,0.0000046253667,0.000045071993,0.0005363169],"genre_scores_gemma":[0.9974884,0.0018064097,0.00007504425,0.00033857927,0.00012327578,0.00008601498,0.000021041824,0.000009983951,0.000051278454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985119,0.00014861193,0.00052630826,0.00038385132,0.0001786785,0.00025063526],"domain_scores_gemma":[0.9992301,0.0001990347,0.0002254502,0.00014291932,0.000028247445,0.00017425753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002757564,0.00016602164,0.00031547982,0.00004719067,0.0002665132,0.000022530228,0.00006273637,0.00013478051,0.0000852477],"category_scores_gemma":[0.000018863546,0.00010836644,0.000052207582,0.00011342567,0.00023637855,0.00005427495,0.000020378597,0.00037015943,0.000003994424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002269736,0.0016956425,0.978659,0.0000054703787,0.00040107564,0.000004011131,0.00060037186,5.246836e-8,0.0009925923,0.00014558056,0.00008587313,0.01718336],"study_design_scores_gemma":[0.015165511,0.0020855898,0.977111,0.00002514259,0.00032845078,0.000014650177,0.00022438286,0.00002292287,0.0001528892,0.00013533779,0.004612535,0.00012160201],"about_ca_topic_score_codex":0.00002700249,"about_ca_topic_score_gemma":0.00009510995,"teacher_disagreement_score":0.017061757,"about_ca_system_score_codex":0.00004444249,"about_ca_system_score_gemma":0.000036090256,"threshold_uncertainty_score":0.4419055},"labels":[],"label_agreement":null},{"id":"W2168982155","doi":"10.1002/hup.858","title":"Cerebro‐ and cardiovascular conditions in adults with schizophrenia treated with antipsychotic medications","year":2007,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Antipsychotic; Ziprasidone; Aripiprazole; Schizophrenia (object-oriented programming); Internal medicine; Odds ratio; Incidence (geometry); Stroke (engine); Myocardial infarction; Antipsychotic Agent; Cardiology; Retrospective cohort study; Cardiomyopathy; Psychiatry; Pediatrics; Heart failure","score_opus":0.02795511633994579,"score_gpt":0.39755387301401124,"score_spread":0.36959875667406544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168982155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496824,0.0027458016,0.00001258643,0.00035160195,0.000063484884,0.0008393268,0.000010286578,0.000051833955,0.0009568488],"genre_scores_gemma":[0.9978713,0.0003275817,0.0010395625,0.000314081,0.00016279852,0.00012496975,0.000064502085,0.000023861088,0.00007137649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829084,0.00009785408,0.00041644202,0.0005911823,0.0002456786,0.00035799798],"domain_scores_gemma":[0.9989666,0.00013920706,0.000054540575,0.0002457306,0.000047276757,0.00054666906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035311136,0.00021930296,0.00048243048,0.00020156789,0.00019096553,0.000012134204,0.000057438487,0.00013249948,0.00034327703],"category_scores_gemma":[0.000007759713,0.00015032498,0.00009037753,0.00021785601,0.0010605847,0.00006947687,0.000026515148,0.00039876442,0.0000167686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18252198,0.005165188,0.7938192,0.00007720089,0.0031497153,0.0020694844,0.00052149687,0.0000012621521,0.003384889,0.0012037618,0.0009011784,0.007184675],"study_design_scores_gemma":[0.12704432,0.0059920824,0.862745,0.00021036352,0.00039966745,0.0006551962,0.0007371763,0.000027153794,0.0016373324,0.000084789346,0.00021864464,0.00024830244],"about_ca_topic_score_codex":0.00006258442,"about_ca_topic_score_gemma":0.0001505815,"teacher_disagreement_score":0.06892581,"about_ca_system_score_codex":0.000029680108,"about_ca_system_score_gemma":0.0000630399,"threshold_uncertainty_score":0.6130074},"labels":[],"label_agreement":null},{"id":"W2275368612","doi":"10.1002/hup.2521","title":"Amygdala responses to quetiapine XR and citalopram treatment in major depression: the role of 5‐HTTLPR‐S/Lg polymorphisms","year":2016,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"Quetiapine; Citalopram; Amygdala; Major depressive disorder; Antidepressant; Quetiapine Fumarate; Psychology; 5-HTTLPR; Serotonin transporter; Internal medicine; Oncology; Neuroimaging; Medicine; Psychiatry; Serotonin; Schizophrenia (object-oriented programming); Hippocampus; Antipsychotic; Atypical antipsychotic; Receptor","score_opus":0.05734310990205295,"score_gpt":0.4195964379191912,"score_spread":0.3622533280171383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275368612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961943,0.0007071289,8.603835e-7,0.0018217482,0.00033964842,0.000697765,0.00002351594,0.00003413631,0.0001809154],"genre_scores_gemma":[0.9969291,0.00015519279,0.00004818466,0.0020394896,0.00010219904,0.00027118047,3.8046537e-7,0.000021582835,0.00043270126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977075,0.00050755916,0.00061000226,0.000700867,0.00016208825,0.00031197403],"domain_scores_gemma":[0.9988161,0.00056408596,0.000112434085,0.00026285087,0.000011417197,0.00023312129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021736053,0.00023426476,0.00034451042,0.00011234138,0.00015059148,0.000020505906,0.00027404612,0.00010829141,0.0005715],"category_scores_gemma":[0.000045661483,0.00013356919,0.0000883438,0.000118464675,0.0010607641,0.0001181658,0.00012689224,0.00015400889,0.00004079865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022179673,0.00070822827,0.082586646,0.000001469748,0.000007117514,0.000035545607,0.0004552414,5.396712e-8,0.90077424,0.00012188433,0.00016237063,0.012929261],"study_design_scores_gemma":[0.0072960723,0.0013922841,0.07085194,0.000028511566,0.000019643065,0.000048962167,0.00009610933,0.000001504793,0.9159847,0.00020055012,0.0039022395,0.00017746925],"about_ca_topic_score_codex":0.000033465207,"about_ca_topic_score_gemma":0.000007337825,"teacher_disagreement_score":0.015210503,"about_ca_system_score_codex":0.000025430803,"about_ca_system_score_gemma":0.000020025693,"threshold_uncertainty_score":0.62575245},"labels":[],"label_agreement":null},{"id":"W2277091616","doi":"10.1002/hup.2519","title":"Genetic association analysis of N‐methyl‐<scp>d</scp>‐aspartate receptor subunit gene<i>GRIN2B</i>and clinical response to clozapine","year":2016,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Genentech; Sunovion; Eisai; Sanofi; National Alliance for Research on Schizophrenia and Depression; GlaxoSmithKline; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Clozapine; Schizophrenia (object-oriented programming); Glutamate receptor; Atypical antipsychotic; Medicine; Internal medicine; Antipsychotic; Pharmacology; Receptor; Psychiatry","score_opus":0.09698878444911962,"score_gpt":0.47350505035859003,"score_spread":0.3765162659094704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277091616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960378,0.0001761224,0.000009240496,0.0014438445,0.0015508197,0.0005339106,0.00009412588,0.00006460948,0.00008953399],"genre_scores_gemma":[0.98929244,0.0020146982,0.00007973053,0.005905781,0.0002915333,0.00007486103,0.0000012638517,0.000031414707,0.002308248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9925931,0.0033947823,0.00140468,0.0014302811,0.00047316393,0.00070400134],"domain_scores_gemma":[0.990044,0.008327481,0.00043385374,0.00034106028,0.000093020775,0.00076061377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026849073,0.00030884353,0.0008559588,0.0005325551,0.00036352634,0.000042604734,0.0005381863,0.00028209857,0.00047877582],"category_scores_gemma":[0.002507459,0.00024033441,0.00033096885,0.00093081925,0.0015351267,0.00016908438,0.00043120657,0.0004989952,0.00017370716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023970304,0.00081187807,0.09038764,0.000003453889,0.00018764021,0.0000484592,0.00015036529,0.0000015838868,0.89888614,0.000016920832,0.005908043,0.0012008675],"study_design_scores_gemma":[0.008898113,0.0034360406,0.18269227,0.000009167892,0.0003962616,0.000011539341,0.00004525796,0.00008573625,0.78557366,0.0000400861,0.018617654,0.00019421481],"about_ca_topic_score_codex":0.0000061551395,"about_ca_topic_score_gemma":0.0000035975931,"teacher_disagreement_score":0.11331247,"about_ca_system_score_codex":0.00005061395,"about_ca_system_score_gemma":0.00006726027,"threshold_uncertainty_score":0.9800553},"labels":[],"label_agreement":null},{"id":"W2340065564","doi":"10.1002/hup.2532","title":"SSRI‐antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP‐PD study","year":2016,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Centre for Addiction and Mental Health","funders":"National Center for Research Resources; National Institute of Mental Health","keywords":"Sertraline; Olanzapine; Pharmacokinetics; Psychology; Depression (economics); Population; NONMEM; Antipsychotic; Psychiatry; Medicine; Risperidone; Pharmacology; Internal medicine; Schizophrenia (object-oriented programming); Antidepressant","score_opus":0.073962093520956,"score_gpt":0.4661101876067339,"score_spread":0.3921480940857779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340065564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99208343,0.0016902336,0.000004608184,0.003841657,0.00050993654,0.0016679461,0.000010399708,0.000016574926,0.0001752317],"genre_scores_gemma":[0.99818754,0.0002677878,0.000072503804,0.0008535479,0.00023766443,0.00022553261,0.000016424166,0.000015791617,0.00012321104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699193,0.0007478454,0.0009809885,0.0005794777,0.0004001569,0.00029962824],"domain_scores_gemma":[0.9981173,0.0010387948,0.000188616,0.00046074903,0.00004914122,0.00014534392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010825645,0.0002116306,0.0004483409,0.000092456175,0.000094587966,0.000015063482,0.000303166,0.00010318919,0.00046279817],"category_scores_gemma":[0.00009571302,0.000101865735,0.00010794551,0.00022191922,0.0005259743,0.000074985845,0.00007599833,0.00044046994,0.00001060197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03130073,0.01291215,0.9221658,0.000011051157,0.00021380735,0.0009642693,0.0012954485,5.6918657e-7,0.021448333,0.000063132895,0.004207777,0.0054169125],"study_design_scores_gemma":[0.073755205,0.0020659114,0.9202092,0.00011240073,0.00009846869,0.00011137038,0.0008708329,0.000052218853,0.0018231141,0.0005674326,0.000215781,0.00011805275],"about_ca_topic_score_codex":0.00017277952,"about_ca_topic_score_gemma":0.0001280654,"teacher_disagreement_score":0.04245447,"about_ca_system_score_codex":0.000028488255,"about_ca_system_score_gemma":0.00005134531,"threshold_uncertainty_score":0.50673157},"labels":[],"label_agreement":null},{"id":"W2441656824","doi":"10.1002/hup.2537","title":"Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute; University of Saskatchewan","funders":"","keywords":"Randomized controlled trial; Meta-analysis; Cochrane Library; Medicine; Internal medicine; Placebo; Wechsler Adult Intelligence Scale; Psychiatry; Discontinuation; Strictly standardized mean difference; Antipsychotic; Positive and Negative Syndrome Scale; Schizophrenia (object-oriented programming); Psychology; Pediatrics; Psychosis; Cognition","score_opus":0.223928782359479,"score_gpt":0.5341257611764547,"score_spread":0.3101969788169757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2441656824","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023855288,0.98980874,0.0000032681335,0.00013473102,0.00009629606,0.00691056,0.0005860568,0.000024511977,0.00005033383],"genre_scores_gemma":[0.0028422298,0.9862232,0.000022374918,0.00465537,0.00018717223,0.0053637545,0.00026889797,0.00005253264,0.00038442234],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955542,0.0008924124,0.001961674,0.0011529748,0.00014220807,0.00029651786],"domain_scores_gemma":[0.9973956,0.0013643872,0.0005350745,0.0002564591,0.000112146394,0.0003363788],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054389855,0.00066725054,0.010184955,0.000353206,0.00011076004,0.000019543539,0.00010659994,0.00029394904,0.00058383314],"category_scores_gemma":[0.00019183676,0.000384547,0.0028696375,0.0003043568,0.0004065086,0.00006683006,0.00009513226,0.00039435283,0.000019130754],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023220908,0.0027066052,0.000023969078,0.6991907,0.2910568,0.00021998353,0.00008861754,6.7261117e-9,0.000032331493,0.00006891195,0.0020844813,0.002205509],"study_design_scores_gemma":[0.009688872,0.00083504256,0.000012316385,0.028633947,0.95777893,0.00009129001,0.000025548225,9.183882e-7,0.000009235987,0.000012426218,0.002473267,0.00043821338],"about_ca_topic_score_codex":0.0000016162556,"about_ca_topic_score_gemma":0.0000038061291,"teacher_disagreement_score":0.6705567,"about_ca_system_score_codex":0.000028365175,"about_ca_system_score_gemma":0.00007873139,"threshold_uncertainty_score":0.99986064},"labels":[],"label_agreement":null},{"id":"W2536887084","doi":"10.1002/hup.2548","title":"Captagon: use and trade in the Middle East","year":2016,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency; Public Health Agency of Canada; World Health Organization","keywords":"Middle East; Geography; Archaeology","score_opus":0.519538922703045,"score_gpt":0.5583681680123407,"score_spread":0.03882924530929566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536887084","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06381879,0.9330642,4.3337985e-7,0.001014331,0.0004888503,0.00086232764,0.000028796305,0.000028017375,0.0006942346],"genre_scores_gemma":[0.04587246,0.9455553,0.000013125609,0.0072262175,0.0009545004,0.00015900706,0.000021035392,0.000032715692,0.0001656152],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968122,0.0008622501,0.0011313907,0.000649806,0.00017010314,0.00037421065],"domain_scores_gemma":[0.99842465,0.0008755232,0.00018860066,0.00022310301,0.000009019478,0.00027912462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093085034,0.0003857912,0.0014337884,0.00008925032,0.00015536683,0.0000490394,0.00018521836,0.00042684452,0.00041733874],"category_scores_gemma":[0.000042724194,0.00021907686,0.00033781814,0.00008989005,0.0009993527,0.00010052933,0.00010179654,0.0011057036,0.000043435248],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017729589,0.0037693535,0.0007469871,0.006267889,0.00087315554,0.0009229554,0.0027888648,4.198121e-9,0.00046139196,0.001723771,0.01073255,0.9699401],"study_design_scores_gemma":[0.00709579,0.00047596992,0.00015102839,0.003459775,0.00054494216,0.00051572867,0.00042063833,0.0000020093942,0.000007557624,0.00007399194,0.98695403,0.0002985524],"about_ca_topic_score_codex":0.0000052693786,"about_ca_topic_score_gemma":0.0000014216394,"teacher_disagreement_score":0.97622144,"about_ca_system_score_codex":0.00003166227,"about_ca_system_score_gemma":0.00004896086,"threshold_uncertainty_score":0.8933695},"labels":[],"label_agreement":null},{"id":"W2560733466","doi":"10.1002/hup.2565","title":"Association between overall rate of change in rising breath alcohol concentration and the magnitude of acute tolerance of subjective intoxication via the Mellanby method","year":2016,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"National Institute on Alcohol Abuse and Alcoholism","keywords":"Association (psychology); Alcohol; Alcohol intoxication; Psychology; Medicine; Chemistry; Environmental health; Poison control; Injury prevention; Psychotherapist; Biochemistry","score_opus":0.07614439659618503,"score_gpt":0.457343282927691,"score_spread":0.38119888633150595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560733466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972483,0.00080409995,0.000030695388,0.0011410156,0.000111869864,0.0005763399,0.000008838568,0.000004983545,0.000073879695],"genre_scores_gemma":[0.99856454,0.00068794255,0.00012283475,0.00040624657,0.0001192152,0.00004173984,0.000005883727,0.000005571302,0.000046019555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987728,0.00038142005,0.00049061497,0.00016792415,0.00008735342,0.0000998734],"domain_scores_gemma":[0.9985684,0.0008887759,0.00036886273,0.00008991525,0.000053954267,0.000030097677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007857431,0.00009287087,0.00040921703,0.00002301687,0.000040910218,0.0000019069573,0.000051074967,0.00008706266,0.000058847192],"category_scores_gemma":[0.00002198238,0.000046441342,0.00007481918,0.00005055478,0.00034512876,0.00007023205,0.00001946222,0.00009155443,7.008913e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031430507,0.00018930704,0.7603833,0.000008142162,0.0004714427,0.0000010515834,0.0037038638,4.4101885e-8,0.22815749,0.00012546465,0.000042901454,0.003773953],"study_design_scores_gemma":[0.027208576,0.00034931808,0.7645068,0.000055932738,0.00038773593,0.0000013965441,0.00015765388,0.000039746803,0.2067801,0.0004561958,0.000006357705,0.00005018772],"about_ca_topic_score_codex":0.000056648838,"about_ca_topic_score_gemma":0.000011030847,"teacher_disagreement_score":0.024065526,"about_ca_system_score_codex":0.000033094533,"about_ca_system_score_gemma":0.000009391958,"threshold_uncertainty_score":0.18938228},"labels":[],"label_agreement":null},{"id":"W2582330345","doi":"10.1002/hup.2568","title":"Association study between the neurexin‐1 gene and tardive dyskinesia","year":2017,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"Tardive dyskinesia; Neurexin; Association (psychology); Dyskinesia; Medicine; Gene; Psychiatry; Genetics; Psychology; Schizophrenia (object-oriented programming); Internal medicine; Biology; Psychotherapist; Parkinson's disease; Receptor; Postsynaptic potential","score_opus":0.1729668456250712,"score_gpt":0.5169184704713332,"score_spread":0.343951624846262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582330345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373,0.00007173074,3.9893845e-7,0.0033693088,0.0014409854,0.0007647526,0.00001131174,0.000044134224,0.00056739675],"genre_scores_gemma":[0.99398917,0.00016943587,0.000002361373,0.0040650615,0.00074279925,0.000091504866,3.796153e-7,0.00001832531,0.00092097395],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968211,0.0010356704,0.00045266366,0.0009102554,0.00033545078,0.000444842],"domain_scores_gemma":[0.9981642,0.0008839995,0.00029984216,0.000379387,0.000027034488,0.00024555597],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0010587245,0.00021281703,0.0003450312,0.000057711262,0.0030411913,0.00025612858,0.00079354446,0.00011995104,0.0001740494],"category_scores_gemma":[0.00032278904,0.00015279592,0.00008169035,0.000067865556,0.0017338167,0.00027470564,0.00067747117,0.00073947455,0.00005692783],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025182226,0.0005152507,0.46383348,0.00000164583,0.000027308242,0.00010982163,0.00020560651,9.938558e-8,0.5312073,0.000024365085,0.0034186114,0.00040464094],"study_design_scores_gemma":[0.01028917,0.0020750882,0.7573361,0.0000023834912,0.0001095146,0.00002978731,0.00014576629,0.000035533663,0.22698428,0.0002399081,0.0024765977,0.00027589634],"about_ca_topic_score_codex":0.000012686886,"about_ca_topic_score_gemma":0.0000017713631,"teacher_disagreement_score":0.30422306,"about_ca_system_score_codex":0.000017549732,"about_ca_system_score_gemma":0.000019700816,"threshold_uncertainty_score":0.99825674},"labels":[],"label_agreement":null},{"id":"W2757123312","doi":"10.1002/hup.2633","title":"Does early antipsychotic response predict long‐term treatment outcome?","year":2017,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Health Sciences Centre; McMaster University Medical Centre; McMaster University","funders":"Ontario Mental Health Foundation; McMaster University; Stanley Medical Research Institute","keywords":"Term (time); Antipsychotic; Psychology; Outcome (game theory); Psychiatry; Schizophrenia (object-oriented programming); Medicine; Clinical psychology; Economics","score_opus":0.11239248763713088,"score_gpt":0.5126923681999532,"score_spread":0.40029988056282234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757123312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993518,0.00050758757,0.0000011549097,0.0027245276,0.0015751714,0.00093545415,0.00002233106,0.00008566645,0.0006301264],"genre_scores_gemma":[0.9936329,0.00022195851,0.00017071812,0.00050583336,0.00076004915,0.00017872045,0.000016729036,0.00003437474,0.004478713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760246,0.00026417224,0.0006607347,0.000747883,0.00024243737,0.0004823052],"domain_scores_gemma":[0.9980675,0.00018527228,0.00018770923,0.0007444651,0.000038193102,0.0007768329],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043909365,0.00033356948,0.00067281624,0.00010346638,0.0008191992,0.00011193208,0.00024199665,0.00020536219,0.0012558826],"category_scores_gemma":[0.000057591955,0.00018815958,0.00032198604,0.000026293761,0.0012235154,0.0001352716,0.00012198014,0.0003346439,0.0002019167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12839592,0.0031311978,0.8492818,0.00001216334,0.00055678096,0.0007926701,0.00011888391,1.2256585e-8,0.011869174,0.000032477827,0.0006352292,0.0051737246],"study_design_scores_gemma":[0.06121754,0.0073018703,0.92475355,0.000031620217,0.0002000015,0.00007099418,0.000032046064,0.000006477744,0.0056303064,0.00009761564,0.0004690321,0.00018892791],"about_ca_topic_score_codex":0.000033749377,"about_ca_topic_score_gemma":0.0000195736,"teacher_disagreement_score":0.075471796,"about_ca_system_score_codex":0.00008603167,"about_ca_system_score_gemma":0.000073050884,"threshold_uncertainty_score":0.9996571},"labels":[],"label_agreement":null},{"id":"W2761909751","doi":"10.1002/hup.2631","title":"Association between antipsychotic treatment and leptin levels across multiple psychiatric populations: An updated meta‐analysis","year":2017,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Regulation of Appetite and Obesity","field":"Neuroscience","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Leptin; Meta-analysis; Schizophrenia (object-oriented programming); Antipsychotic; Medicine; Psychiatry; Medical diagnosis; Internal medicine; Anorexia nervosa; Association (psychology); Psychology; Bipolar disorder; Clinical psychology; Obesity; Cognition; Eating disorders; Psychotherapist","score_opus":0.5028972578192248,"score_gpt":0.5739493626426665,"score_spread":0.07105210482344171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761909751","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3096671,0.6872708,0.000007546877,0.00013225796,0.0008963673,0.0012317105,0.00053130934,0.00010917637,0.0001537424],"genre_scores_gemma":[0.20871769,0.7872887,0.0001926418,0.0002841479,0.00087987434,0.0001829498,0.00049202144,0.0000636045,0.0018983332],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946849,0.0014154122,0.0015701867,0.0015785572,0.00025098858,0.0005000093],"domain_scores_gemma":[0.99690455,0.00055221823,0.0014932103,0.0006113557,0.000036767917,0.00040188493],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0008185711,0.00066510617,0.0033659476,0.00028979642,0.0014305133,0.0002779131,0.00043979823,0.00073290634,0.0007309802],"category_scores_gemma":[0.00004874642,0.0005278072,0.0015875739,0.0003203751,0.00046270373,0.00034681644,0.00013607276,0.00048216167,0.000071097835],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001263079,0.0145217655,0.15669057,0.0014841578,0.27038872,0.0001258089,0.0017632785,0.000014994329,0.0015698018,0.0006361812,0.006943653,0.544598],"study_design_scores_gemma":[0.010705694,0.0015668081,0.025957895,0.00006775592,0.23838426,0.000022322385,0.000047694848,0.0000827511,0.0003292133,0.00030228202,0.72093135,0.0016020001],"about_ca_topic_score_codex":0.00004433747,"about_ca_topic_score_gemma":0.00005345217,"teacher_disagreement_score":0.71398765,"about_ca_system_score_codex":0.00009313876,"about_ca_system_score_gemma":0.000041140232,"threshold_uncertainty_score":0.99986947},"labels":[],"label_agreement":null},{"id":"W2783639535","doi":"10.1002/hup.2646","title":"Relative short‐term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder","year":2018,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Treatment of Major Depression","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Servier","keywords":"Vortioxetine; Agomelatine; Tolerability; Major depressive disorder; Placebo; Rating scale; Depression (economics); Medicine; Antidepressant; Psychiatry; Clinical efficacy; Internal medicine; Adverse effect; Psychology; Anxiety; Alternative medicine; Mood","score_opus":0.07839844261861603,"score_gpt":0.47691245931013204,"score_spread":0.398514016691516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783639535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5820181,0.41602603,5.1661465e-7,0.000010781037,0.0005560085,0.0011149992,0.00006185517,0.000021736323,0.00018999321],"genre_scores_gemma":[0.5377207,0.46103144,0.00019827919,0.000035420955,0.00033095517,0.0001902031,0.00039577167,0.000057209065,0.000040016075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961195,0.00046200995,0.0017386276,0.0011318835,0.00023330837,0.0003146495],"domain_scores_gemma":[0.9977897,0.0009412619,0.0005219974,0.00037848408,0.00007027426,0.00029830344],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019338648,0.0005688259,0.0022805806,0.00016168166,0.0001113514,0.000011411155,0.00016284396,0.00063109555,0.0012438197],"category_scores_gemma":[0.00016037712,0.00043855424,0.00033860162,0.000110033,0.0009856807,0.00011719126,0.0003515565,0.0007713542,0.00001518204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015755437,0.010521642,0.51512426,0.0020590879,0.0020341112,0.000082410894,0.00070892123,3.7699266e-8,0.00018735028,0.000011040073,0.00032217338,0.45319355],"study_design_scores_gemma":[0.16711113,0.008514575,0.7928075,0.0060169077,0.005503926,0.000012779375,0.00013437825,0.000011308505,0.00025172436,0.000043799824,0.018474672,0.0011172805],"about_ca_topic_score_codex":0.000047240897,"about_ca_topic_score_gemma":0.000017765336,"teacher_disagreement_score":0.45207626,"about_ca_system_score_codex":0.00007817908,"about_ca_system_score_gemma":0.000040186602,"threshold_uncertainty_score":0.99980664},"labels":[],"label_agreement":null},{"id":"W2788553801","doi":"10.1002/hup.2650","title":"Alcohol mixed with energy drink (AMED): A critical review and meta‐analysis","year":2018,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Coffee research and impacts","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Affect (linguistics); Consumption (sociology); Environmental health; Alcohol consumption; Alcohol; Meta-analysis; Alcohol intoxication; Population; Psychology; Medicine; Injury prevention; Poison control","score_opus":0.3011140529374183,"score_gpt":0.5766542435589871,"score_spread":0.2755401906215688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788553801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023572473,0.99628276,0.000004522919,0.0012683391,0.00015500322,0.0009915497,0.000047437643,0.000051273786,0.0009633973],"genre_scores_gemma":[0.0016439891,0.99019945,0.00014615525,0.0054986454,0.0005177181,0.0005249351,0.00012069791,0.00006443632,0.0012839731],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955418,0.0009097797,0.0012949512,0.001245544,0.00034793027,0.0006599755],"domain_scores_gemma":[0.9969428,0.00075845513,0.00024865603,0.00051130325,0.00011399326,0.0014247533],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080680166,0.00069576665,0.0065965904,0.00033286907,0.00022078244,0.00004815665,0.0002160847,0.00046519953,0.005864305],"category_scores_gemma":[0.00010954302,0.00042491755,0.0018063909,0.00047090414,0.002290044,0.00008370512,0.00024305827,0.0008931695,0.000047613175],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022048468,0.004969184,0.00009138361,0.04824923,0.6445785,0.001288914,0.000071239454,5.642079e-9,0.00003786065,0.0006303072,0.20201701,0.095861495],"study_design_scores_gemma":[0.0024854017,0.0021658288,0.000018856514,0.0007219438,0.41555256,0.00033911585,0.0000076076635,0.000001062599,0.0000072384128,0.00001330273,0.57835674,0.00033032082],"about_ca_topic_score_codex":0.000019471923,"about_ca_topic_score_gemma":0.000013838582,"teacher_disagreement_score":0.37633976,"about_ca_system_score_codex":0.000036814872,"about_ca_system_score_gemma":0.00018788493,"threshold_uncertainty_score":0.9998203},"labels":[],"label_agreement":null},{"id":"W2789944740","doi":"10.1002/hup.2652","title":"Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the <scp>PULSAR</scp> study)","year":2018,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcosine; Positive and Negative Syndrome Scale; Placebo; Internal medicine; Schizophrenia (object-oriented programming); Medicine; Tolerability; Psychology; Gastroenterology; Psychosis; Psychiatry; Adverse effect; Glycine; Chemistry","score_opus":0.056462792834141795,"score_gpt":0.3922525650532731,"score_spread":0.3357897722191313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789944740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982227,0.00003935984,3.0917175e-7,0.00003998819,0.00043318188,0.00073937216,0.0000541471,0.000013685541,0.00045727604],"genre_scores_gemma":[0.99946445,0.000011095499,0.000019595102,0.0002240186,0.000060720926,0.00003596489,0.0000015413178,0.00001398988,0.00016864398],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980967,0.00032997006,0.00070119574,0.0004775302,0.00017810012,0.00021648484],"domain_scores_gemma":[0.999228,0.00018885927,0.00029280107,0.0001949692,0.0000262799,0.0000690801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001383024,0.00018307894,0.00030636913,0.00009361784,0.00013688413,0.000009215662,0.00022723425,0.00006466076,0.00008435763],"category_scores_gemma":[0.000050981598,0.00012058804,0.00007662973,0.00020596899,0.0009264126,0.00009411835,0.00011187909,0.00013630588,0.000005393759],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042170696,0.0100313425,0.21296863,0.000015115606,0.000073688,0.000008462182,0.006256854,0.0000046291343,0.7643434,0.000043545508,0.00014344056,0.0018938129],"study_design_scores_gemma":[0.035921406,0.0038926739,0.50736713,0.000021356685,0.000012496205,0.0000015651102,0.0007937584,0.000011569933,0.45187253,0.000028823322,0.000034552413,0.000042151092],"about_ca_topic_score_codex":0.000018930717,"about_ca_topic_score_gemma":0.000066713554,"teacher_disagreement_score":0.31247088,"about_ca_system_score_codex":0.000035320387,"about_ca_system_score_gemma":0.000021522508,"threshold_uncertainty_score":0.49174377},"labels":[],"label_agreement":null},{"id":"W2806664837","doi":"10.1002/hup.2663","title":"Why meta is better: A reply to Linden‐Carmichael et al. (2018)","year":2018,"lang":"en","type":"letter","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Coffee research and impacts","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Psychology; Art","score_opus":0.15986085811209466,"score_gpt":0.5090624449756187,"score_spread":0.34920158686352404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806664837","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15757446,0.0024990302,0.0000042986944,0.83454025,0.0019211102,0.001228697,0.000114978866,0.0001073227,0.0020098658],"genre_scores_gemma":[0.0082056895,0.0004500804,0.00030784123,0.9757238,0.008058278,0.0002857008,0.00021691316,0.00013266908,0.0066190483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947065,0.0005882027,0.0012171995,0.0016887159,0.00070352014,0.0010958781],"domain_scores_gemma":[0.9971673,0.00039970732,0.00024872107,0.0008607898,0.00014877557,0.0011747244],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010180938,0.00073272263,0.0017991209,0.000375913,0.00024862128,0.00009287921,0.00044511794,0.00088103465,0.01365181],"category_scores_gemma":[0.00010820249,0.0005857384,0.0008819365,0.00017544664,0.0010916704,0.00011549935,0.0004789786,0.003647551,0.00079651416],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021861533,0.0006508047,0.00033343714,0.0000602472,0.0031418754,0.00088304695,0.00029038094,4.862938e-9,0.00889331,0.0000016153181,0.98312116,0.00043798072],"study_design_scores_gemma":[0.009398321,0.005845587,0.00037770998,0.000071977774,0.0010815267,0.0002321898,0.000031418465,0.000003966583,0.002815692,0.000068889065,0.97954255,0.00053016894],"about_ca_topic_score_codex":0.0001114528,"about_ca_topic_score_gemma":0.000005951367,"teacher_disagreement_score":0.14936876,"about_ca_system_score_codex":0.000079267826,"about_ca_system_score_gemma":0.00016226123,"threshold_uncertainty_score":0.99998146},"labels":[],"label_agreement":null},{"id":"W2810359220","doi":"10.1002/hup.2659","title":"Pharmacogenetic evaluation of a <i>DISP1</i> gene variant in antidepressant treatment of obsessive–compulsive disorder","year":2018,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health; Ontario Ministry of Research, Innovation and Science; Canadian Institutes of Health Research; Ontario Mental Health Foundation; Genome Canada","keywords":"Paroxetine; Fluvoxamine; Genome-wide association study; Sertraline; Antidepressant; Pharmacogenetics; Citalopram; Serotonin reuptake inhibitor; Fluoxetine; Psychiatry; Single-nucleotide polymorphism; Psychology; Genetic association; Medicine; Internal medicine; Oncology; Clinical psychology; Genotype; Genetics; Anxiety; Gene; Biology; Serotonin","score_opus":0.06361174518063484,"score_gpt":0.46323750119478074,"score_spread":0.3996257560141459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810359220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850803,0.0081803035,0.000022549808,0.0001280436,0.0021597096,0.0011908308,0.000043607593,0.000023809253,0.003170864],"genre_scores_gemma":[0.99845433,0.00031288926,0.00016456403,0.00025700632,0.00043387516,0.00025013895,0.000029066568,0.000039027123,0.00005910149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99585426,0.001129135,0.0013661449,0.00087414955,0.00032856406,0.00044773583],"domain_scores_gemma":[0.9984443,0.0002500785,0.00057510275,0.0003728656,0.00018702468,0.00017061864],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005766936,0.0003649114,0.0008604305,0.00023223797,0.00011713628,0.000008429817,0.00027252076,0.0002148857,0.0051735677],"category_scores_gemma":[0.000020485772,0.00033242235,0.00023348756,0.00025487554,0.0017404128,0.000077403034,0.000092972376,0.00017754466,0.00004734995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010178021,0.03162518,0.5163906,0.0000436849,0.0020154417,0.00018833824,0.011765414,0.00006797784,0.3844885,0.001161421,0.0018514744,0.040223934],"study_design_scores_gemma":[0.14408562,0.012684022,0.7110201,0.00008273904,0.0011118094,0.00010912198,0.004389628,0.0019704602,0.12058074,0.0018687018,0.0010759137,0.0010211237],"about_ca_topic_score_codex":0.00023014775,"about_ca_topic_score_gemma":0.000046910325,"teacher_disagreement_score":0.26390776,"about_ca_system_score_codex":0.00006267733,"about_ca_system_score_gemma":0.00007452944,"threshold_uncertainty_score":0.9999128},"labels":[],"label_agreement":null},{"id":"W2902851430","doi":"10.1002/hup.2684","title":"Effect of <scp>GAD1</scp> genotype status on auditory attention and acute nicotine administration in healthy volunteers","year":2018,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; University of Ottawa","funders":"Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada","keywords":"P3a; P3b; Nicotine; Psychology; Audiology; Placebo; Event-related potential; Neuroscience; Medicine; Cognition","score_opus":0.014594835185020453,"score_gpt":0.4073445277404722,"score_spread":0.3927496925554517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902851430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702847,0.00069207256,0.0000048396437,0.000056195066,0.0012697552,0.00043678368,0.000013519116,0.000011970652,0.00048638508],"genre_scores_gemma":[0.99777615,0.00037756338,0.000057604695,0.00047231227,0.0009991123,0.00004068741,0.00006504785,0.000021020662,0.00019051012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810266,0.00038624724,0.000556182,0.00055524835,0.000105410516,0.00029422104],"domain_scores_gemma":[0.9993454,0.00010863736,0.00017203816,0.00016625994,0.000035529552,0.00017210326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054144784,0.00020673273,0.00033353918,0.00006135897,0.00010648345,0.000008330066,0.00009924506,0.0002469567,0.000045383324],"category_scores_gemma":[0.00005871128,0.00019030397,0.00008255555,0.00005847103,0.0006283237,0.0000071280183,0.00010221346,0.00022896187,0.000015603144],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005523677,0.0008728434,0.0665921,0.00002569515,0.00016105625,0.0000013383572,0.00013749,3.8305146e-7,0.91642064,0.000017620945,0.008913744,0.0013334003],"study_design_scores_gemma":[0.03288023,0.08363562,0.057103302,0.00003789039,0.00013741452,0.000022457853,0.00028625914,0.00007238749,0.8149356,0.000012956616,0.010621968,0.00025390042],"about_ca_topic_score_codex":0.000011136366,"about_ca_topic_score_gemma":0.00002174174,"teacher_disagreement_score":0.101485044,"about_ca_system_score_codex":0.000017765338,"about_ca_system_score_gemma":0.000037407804,"threshold_uncertainty_score":0.77603704},"labels":[],"label_agreement":null},{"id":"W2945477786","doi":"10.1002/hup.2693","title":"Effects of olanzapine during cognitive and emotional processing in schizophrenia: A review of functional magnetic resonance imaging findings","year":2019,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Olanzapine; Functional magnetic resonance imaging; Psychology; Schizophrenia (object-oriented programming); Cognition; Brain activity and meditation; Neuroscience; Cingulate cortex; Anterior cingulate cortex; Psychosis; Striatum; Neuroimaging; Clinical psychology; Dopamine; Psychiatry; Electroencephalography; Central nervous system","score_opus":0.056630614775938094,"score_gpt":0.4471669234584478,"score_spread":0.39053630868250966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945477786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1704998,0.82776105,3.0841824e-7,0.000036964524,0.00013917497,0.0014838433,0.000022039683,0.000009339896,0.00004744764],"genre_scores_gemma":[0.025426207,0.9736986,0.00013247736,0.00014299552,0.00017289071,0.00023654923,0.000072394476,0.000031046646,0.00008680526],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99741507,0.00026705448,0.001152604,0.0006350722,0.0002672361,0.00026299484],"domain_scores_gemma":[0.9989881,0.00035163556,0.00029312226,0.00010667608,0.00007620994,0.00018428039],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033724518,0.0003455433,0.0020138784,0.00026094305,0.00006802061,0.000006906922,0.000075332486,0.00017316209,0.0003233129],"category_scores_gemma":[0.00009167483,0.0002750781,0.00030116492,0.00019685093,0.0006317523,0.0000616008,0.00013132245,0.0006257684,0.000009112595],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016281988,0.002549699,0.0038802742,0.26055422,0.00026484366,0.00032769513,0.000060608578,8.002742e-9,0.0006271036,0.00007453351,0.00027626014,0.71510273],"study_design_scores_gemma":[0.13555753,0.0038172225,0.1526879,0.6951867,0.003803144,0.0011966672,0.000058020694,0.000023383483,0.000443782,0.00008163547,0.0062948503,0.00084917754],"about_ca_topic_score_codex":0.000003570628,"about_ca_topic_score_gemma":6.785505e-7,"teacher_disagreement_score":0.71425354,"about_ca_system_score_codex":0.00004967805,"about_ca_system_score_gemma":0.00028351677,"threshold_uncertainty_score":0.99997014},"labels":[],"label_agreement":null},{"id":"W2968380560","doi":"10.1002/hup.2711","title":"A randomized placebo‐controlled trial examining the effects of escitalopram on neuroticism and state anxiety in a nonclinical sample","year":2019,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Treatment of Major Depression","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Lundbeckfonden; Københavns Universitet","keywords":"Escitalopram; Neuroticism; Psychology; Anxiety; Placebo; Clinical psychology; Psychoticism; Randomized controlled trial; Psychiatry; Sample (material); Medicine; Extraversion and introversion; Big Five personality traits; Personality; Internal medicine; Alternative medicine; Social psychology","score_opus":0.037259737583929746,"score_gpt":0.41616726252952746,"score_spread":0.3789075249455977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968380560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990045,0.0006926002,0.0000014222767,0.00028154248,0.001397843,0.006998346,0.0000025160682,0.000028355844,0.00055234676],"genre_scores_gemma":[0.9974315,0.00028579732,0.0000999125,0.001191279,0.00018790239,0.00053391187,0.0000050840927,0.000022804805,0.00024178752],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966702,0.0011614674,0.0011252046,0.0005691628,0.00021836425,0.000255611],"domain_scores_gemma":[0.9897225,0.0095615005,0.00028597083,0.00024069767,0.000017116396,0.00017224104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014064984,0.00025455395,0.0015678765,0.00009228116,0.00007382939,0.000013502558,0.00009776397,0.00017438432,0.00017088982],"category_scores_gemma":[0.0006294217,0.00014955737,0.00025732067,0.00006109921,0.00073117565,0.000047737034,0.000106297135,0.00053222146,0.00001114489],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9689888,0.0026636051,0.013004625,0.000042749136,0.0002911414,0.000031977852,0.00045900955,0.0000012483224,0.013050001,0.00004927,0.00018249617,0.0012351281],"study_design_scores_gemma":[0.9763627,0.008407055,0.012805224,0.000119073615,0.00023462206,0.000009967867,0.0000709679,0.00031480697,0.0013609837,0.00013737807,0.000052754694,0.00012444396],"about_ca_topic_score_codex":0.000016005019,"about_ca_topic_score_gemma":0.0000016224499,"teacher_disagreement_score":0.0116890175,"about_ca_system_score_codex":0.000015334395,"about_ca_system_score_gemma":0.000028059761,"threshold_uncertainty_score":0.6098772},"labels":[],"label_agreement":null},{"id":"W2971484309","doi":"10.1002/hup.2712","title":"The effect of baseline antipsychotic status on the 12‐month outcome in initially stabilized patients with schizophrenia","year":2019,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Schizophrenia (object-oriented programming); Extrapyramidal symptoms; Antipsychotic; Brief Psychiatric Rating Scale; Positive and Negative Syndrome Scale; Anxiety; Rating scale; Psychiatry; Depression (economics); Medicine; Clozapine; Internal medicine; Psychology; Psychosis","score_opus":0.03235742957709797,"score_gpt":0.4060553820068312,"score_spread":0.37369795242973325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971484309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594384,0.00037529183,1.6625167e-7,0.0005482906,0.00036245384,0.0020671184,0.000015441181,0.000018274359,0.00066911726],"genre_scores_gemma":[0.9989976,0.000073540024,0.00004776305,0.0005523544,0.00008491656,0.000102251746,0.000022883582,0.000023730676,0.00009495328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973704,0.00073247217,0.0006929573,0.00043502776,0.00035818078,0.00041096666],"domain_scores_gemma":[0.99720407,0.0019981263,0.00014826246,0.000328186,0.000041479456,0.00027990446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095829985,0.00025024923,0.0005731151,0.000079736805,0.00015559954,0.000018369841,0.00015473932,0.000097949815,0.00077792635],"category_scores_gemma":[0.00013086438,0.00011068209,0.00014233249,0.000114448354,0.0006899673,0.000041231924,0.00005891821,0.00055588083,0.000055252607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26724157,0.0014629448,0.72705,0.000021236254,0.0002193301,0.00002952591,0.000065529144,7.739941e-7,0.0012859778,0.0001596479,0.00026938348,0.002194069],"study_design_scores_gemma":[0.1536765,0.024606178,0.81836504,0.000072804454,0.00008922821,0.000004884164,0.00011415023,0.000055197906,0.0026185822,0.000057545043,0.00018788863,0.00015202186],"about_ca_topic_score_codex":0.000017841201,"about_ca_topic_score_gemma":0.000025528512,"teacher_disagreement_score":0.11356509,"about_ca_system_score_codex":0.000040419385,"about_ca_system_score_gemma":0.00005880741,"threshold_uncertainty_score":0.8517748},"labels":[],"label_agreement":null},{"id":"W3005882383","doi":"10.1002/hup.2725","title":"Kava drinking in traditional settings: Towards understanding effects on cognitive function","year":2020,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Medicinal Plant Extracts Effects","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Health Research Council of New Zealand","keywords":"Kava; Test (biology); Cognition; Psychology; Medicine; Psychiatry; Ecology","score_opus":0.15658574671887057,"score_gpt":0.4293378840051202,"score_spread":0.2727521372862496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005882383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988518,0.0003906677,0.00006596833,0.0027813935,0.00091742014,0.00067575544,0.0000045311394,0.00007328658,0.0065730023],"genre_scores_gemma":[0.9661176,0.000029222516,0.00003605906,0.0322279,0.0014351346,0.00004629811,0.000060704104,0.000021348818,0.000025706857],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99824625,0.00022566189,0.00046890523,0.00054394966,0.00024677155,0.00026844614],"domain_scores_gemma":[0.9985923,0.0008383986,0.00010212109,0.000053797834,0.000014085229,0.00039925144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038066556,0.00021371739,0.00046320795,0.000105005434,0.00012688842,0.000013436526,0.000051006034,0.00018593845,0.0005473503],"category_scores_gemma":[0.00012704702,0.00019225305,0.00010043478,0.0001127745,0.000262012,0.00007686957,0.00002819331,0.00078157074,0.000059110414],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.104566,0.0071429466,0.07833758,0.0012747665,0.0015223906,0.006089432,0.0067638196,0.000006269696,0.6963675,0.007522421,0.068864755,0.021542145],"study_design_scores_gemma":[0.31187713,0.09429362,0.44900566,0.0057027694,0.0020001717,0.00085279817,0.010523156,0.0028567435,0.111369535,0.0057881624,0.003443809,0.0022864377],"about_ca_topic_score_codex":0.00000293254,"about_ca_topic_score_gemma":8.2266627e-7,"teacher_disagreement_score":0.58499795,"about_ca_system_score_codex":0.00006908999,"about_ca_system_score_gemma":0.000035957113,"threshold_uncertainty_score":0.7839852},"labels":[],"label_agreement":null},{"id":"W3110473772","doi":"10.1002/hup.2770","title":"Serum levels of neuropeptide Y in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the double‐blind randomized controlled PULSAR study)","year":2020,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcosine; Neuropeptide Y receptor; Positive and Negative Syndrome Scale; Internal medicine; Endocrinology; Psychology; Schizophrenia (object-oriented programming); Placebo; Medicine; Gastroenterology; Psychosis; Psychiatry; Neuropeptide; Chemistry; Receptor","score_opus":0.06532444905830072,"score_gpt":0.37220156706142854,"score_spread":0.30687711800312784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110473772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627507,0.00004263301,1.372626e-7,0.00013250153,0.00013252055,0.0032658288,0.000034890283,0.000013980702,0.00010241502],"genre_scores_gemma":[0.9993516,0.000021226537,0.000010125861,0.0003509665,0.000087275315,0.000116095754,0.0000018365962,0.000021964523,0.00003888715],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997131,0.00078302337,0.0010670626,0.00060344924,0.00019963432,0.00021584793],"domain_scores_gemma":[0.9988691,0.00027632655,0.0005580428,0.00016137856,0.000032097258,0.000103052625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015988002,0.0002568448,0.0011250662,0.00005212916,0.00012260654,0.000011654698,0.00020969391,0.00004403463,0.00009826848],"category_scores_gemma":[0.000033062446,0.0001348621,0.0001590364,0.0001697383,0.00080477126,0.000094341936,0.00010494684,0.0002124876,0.0000029980924],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56347036,0.0017142377,0.005755926,0.000008633644,0.00007605195,0.000009653139,0.00027466108,0.000057706264,0.4285302,0.000015864094,0.0000035034448,0.000083199135],"study_design_scores_gemma":[0.76474375,0.007782288,0.10175883,0.000020704803,0.00009585854,0.0000012083474,0.000047269798,0.000039519837,0.12538815,0.0000037048935,0.000004195295,0.00011451401],"about_ca_topic_score_codex":0.000015432995,"about_ca_topic_score_gemma":0.000009491309,"teacher_disagreement_score":0.303142,"about_ca_system_score_codex":0.000021881684,"about_ca_system_score_gemma":0.00003585423,"threshold_uncertainty_score":0.5499517},"labels":[],"label_agreement":null},{"id":"W3157303707","doi":"10.1002/hup.2791","title":"Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging study","year":2021,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Forensic Toxicology and Drug Analysis","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Baycrest Hospital; Toronto General Hospital; University Health Network; Centre for Addiction and Mental Health","funders":"","keywords":"Raclopride; Dopamine; Binding potential; Ventral striatum; Psychology; Striatum; Dopamine receptor D2; Medicine; Internal medicine; Narcolepsy; Endocrinology; Neuroscience; Neurology","score_opus":0.1174972655863866,"score_gpt":0.49828855409383455,"score_spread":0.3807912885074479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157303707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905,0.0012395385,0.0000030019992,0.0026270617,0.0036113856,0.00059199426,0.000023373732,0.00016874832,0.0012349297],"genre_scores_gemma":[0.9813105,0.00015127525,0.00005750039,0.015635438,0.00088821456,0.0001947709,0.000066057604,0.000056996432,0.0016392549],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9917678,0.0041351486,0.001503321,0.0015695693,0.00021417742,0.00080997165],"domain_scores_gemma":[0.99773264,0.00070067967,0.00027502424,0.00048756172,0.000100225036,0.0007038927],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00222008,0.00054337597,0.0009716145,0.00028965087,0.00071696576,0.00005727657,0.00038570695,0.00057723967,0.0051501873],"category_scores_gemma":[0.00012062068,0.00044929743,0.00024689888,0.000399317,0.0015642504,0.0003927892,0.0003739661,0.0022021653,0.00014182374],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008040771,0.033481505,0.6136323,0.00005768407,0.0010477542,0.0077844034,0.0096140895,0.00010590332,0.3002903,0.001186211,0.016768841,0.007990236],"study_design_scores_gemma":[0.24472733,0.013731453,0.25674388,0.00012007813,0.0026373584,0.0003705484,0.07950707,0.0047342735,0.2801799,0.005827279,0.10520268,0.006218166],"about_ca_topic_score_codex":0.00002734164,"about_ca_topic_score_gemma":0.0004931839,"teacher_disagreement_score":0.35688844,"about_ca_system_score_codex":0.000060558446,"about_ca_system_score_gemma":0.00010489544,"threshold_uncertainty_score":0.99979585},"labels":[],"label_agreement":null},{"id":"W3207497475","doi":"10.1002/hup.2821","title":"Melatonin and melatonin‐agonists for metabolic syndrome components in patients treated with antipsychotics: A systematic review and meta‐analysis","year":2021,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Melatonin; Metabolic syndrome; Internal medicine; Medicine; Antipsychotic; Schizoaffective disorder; Placebo; Endocrinology; Bipolar disorder; Schizophrenia (object-oriented programming); Psychiatry; Psychosis; Obesity","score_opus":0.1323927229962824,"score_gpt":0.4708268889891266,"score_spread":0.3384341659928442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207497475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07235519,0.920721,4.536089e-7,0.00008422134,0.00005105226,0.0066155083,0.00013387557,0.000025369902,0.00001334175],"genre_scores_gemma":[0.028531574,0.96748084,0.00030718156,0.00042719205,0.000024196768,0.0024226017,0.00059830537,0.00006644367,0.00014169127],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9951829,0.00094581454,0.0018161985,0.0012737635,0.00030011975,0.0004812439],"domain_scores_gemma":[0.99784416,0.0005036031,0.00051160133,0.00043669605,0.00009426986,0.0006096816],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006716217,0.00077584875,0.0113262255,0.00043858794,0.00017845925,0.000055296034,0.00014244975,0.0003662013,0.00022834342],"category_scores_gemma":[0.000033959903,0.00048516027,0.0012885346,0.00050963426,0.000507937,0.00006971987,0.00011899325,0.00058681914,0.000007371986],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005368423,0.006622492,0.0059537627,0.39829522,0.58095074,0.0008564348,0.00007586043,3.342109e-8,0.0000018348696,0.00023950293,0.0002266267,0.0014090971],"study_design_scores_gemma":[0.027293092,0.0025693802,0.0032459814,0.022160243,0.94196355,0.0004905269,0.000021069614,0.000005419664,0.000003999101,0.000009157113,0.0016146478,0.00062290963],"about_ca_topic_score_codex":0.000013385113,"about_ca_topic_score_gemma":0.000009407705,"teacher_disagreement_score":0.37613496,"about_ca_system_score_codex":0.000049003567,"about_ca_system_score_gemma":0.000084517924,"threshold_uncertainty_score":0.99976003},"labels":[],"label_agreement":null},{"id":"W3209897178","doi":"10.1002/hup.2824","title":"Potential processes of change in MDMA‐Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self‐transcendence, and therapeutic relationships","year":2021,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"MDMA; Social anxiety; Psychology; Psychotherapist; Context (archaeology); Shame; Anxiety; Clinical psychology; Psychiatry; Social psychology","score_opus":0.3000767527289443,"score_gpt":0.5327557203681698,"score_spread":0.23267896763922546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209897178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.068191245,0.92768645,0.000011538372,0.00015891826,0.0013725782,0.0018917633,0.0000824324,0.000040763727,0.00056432514],"genre_scores_gemma":[0.19860525,0.7982372,0.000057350993,0.00025748016,0.000586141,0.0019993251,0.00010403398,0.000047315378,0.00010589156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962386,0.00087873737,0.0014529199,0.00094485783,0.000121163626,0.00036375845],"domain_scores_gemma":[0.99848354,0.0005539201,0.0005686802,0.00018370102,0.00011386174,0.000096274336],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070495286,0.00046118555,0.0017685867,0.00017970805,0.00040065392,0.000024300176,0.00020631912,0.0007153094,0.000359612],"category_scores_gemma":[0.000017070824,0.00041031602,0.00039758193,0.0002850304,0.0005841154,0.00006529264,0.000045359982,0.00061601563,0.0000040973464],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011989406,0.005567113,0.0016128753,0.0031758733,0.0022948978,0.000008526544,0.014980667,5.1583275e-8,0.00015156664,0.00084563723,0.0018946666,0.96826917],"study_design_scores_gemma":[0.05751057,0.0029276437,0.017127864,0.0030541534,0.002839136,0.00013595224,0.011716076,0.00001226316,0.00011585883,0.0009887423,0.9006595,0.0029122424],"about_ca_topic_score_codex":0.000014916419,"about_ca_topic_score_gemma":0.000035192614,"teacher_disagreement_score":0.96535695,"about_ca_system_score_codex":0.00002402388,"about_ca_system_score_gemma":0.00010226538,"threshold_uncertainty_score":0.9998349},"labels":[],"label_agreement":null},{"id":"W4213037518","doi":"10.1002/hup.2836","title":"Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression","year":2022,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Treatment of Major Depression","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Major depressive disorder; Treatment-resistant depression; Ketamine; Depression (economics); Confidence interval; Medicine; Odds ratio; Antidepressant; Internal medicine; Randomized controlled trial; Logistic regression; Clinical trial; Depressive symptoms; Major depressive episode; Rating scale; Psychiatry; Psychology; Anxiety","score_opus":0.028732841043085884,"score_gpt":0.41228578593714255,"score_spread":0.38355294489405667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213037518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98662543,0.011467305,5.745562e-7,0.00027690936,0.0004922416,0.00093288237,0.000033909182,0.00004530683,0.00012542176],"genre_scores_gemma":[0.9969675,0.0015059701,0.0001446213,0.00033890916,0.00016137586,0.00026732343,0.00004157841,0.000036838446,0.0005358676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960564,0.0011541549,0.0012625967,0.00093482865,0.00029168557,0.00030036492],"domain_scores_gemma":[0.9980578,0.00084860326,0.0003297814,0.00031569417,0.000027556433,0.00042057296],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087805366,0.00034395276,0.0009013965,0.00024198227,0.00023833648,0.000010351379,0.00009303244,0.0002603538,0.0005585526],"category_scores_gemma":[0.0000935237,0.00026826956,0.00015276462,0.00011928848,0.00073743105,0.000097614065,0.0004820898,0.00051759445,0.0000015163885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08192083,0.003036462,0.67966425,0.000026802181,0.0001325923,0.00032855218,0.00051838765,6.8044636e-7,0.22848035,0.0000015405888,0.0004338766,0.005455643],"study_design_scores_gemma":[0.054409817,0.010149314,0.9215946,0.00017055364,0.00029813504,0.00015856395,0.00042684862,0.000119863485,0.010548548,0.000022893237,0.001866253,0.00023459681],"about_ca_topic_score_codex":0.000027014816,"about_ca_topic_score_gemma":0.0000041655285,"teacher_disagreement_score":0.24193034,"about_ca_system_score_codex":0.00009834901,"about_ca_system_score_gemma":0.000059163875,"threshold_uncertainty_score":0.99997693},"labels":[],"label_agreement":null},{"id":"W4239946193","doi":"10.1002/(sici)1099-1077(200004)15:3<199::aid-hup163>3.3.co;2-k","title":"The interaction between cytokines and neurotransmitters in depression and stress: possible mechanism of antidepressant treatments","year":2000,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Nucleus accumbens; Antidepressant; Psychology; Depression (economics); Psychiatry; Neuroscience; Dopamine; Anxiety","score_opus":0.0501237004069989,"score_gpt":0.399544832697158,"score_spread":0.34942113229015914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239946193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99836296,0.0005406206,0.0000011422223,0.00014620538,0.00017305436,0.0002636632,0.000014062738,0.000017548326,0.00048075453],"genre_scores_gemma":[0.9977266,0.0016846801,0.000012191041,0.0004146959,0.00005031874,0.000025010695,0.0000018362989,0.000010055812,0.00007460456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987068,0.00023108034,0.00038544709,0.0004161915,0.000083412,0.00017706888],"domain_scores_gemma":[0.9993801,0.00036023054,0.00007521709,0.00009198547,0.000003852354,0.00008862747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010890548,0.0001393373,0.00021181234,0.00004783125,0.00021836405,0.000029689843,0.0001032379,0.00007711672,0.000112319365],"category_scores_gemma":[0.000010340643,0.00009814751,0.000039673025,0.000056363777,0.00055490766,0.00012919563,0.000046953264,0.00017786688,0.000002045233],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022208064,0.00087694207,0.24161384,0.000021542744,0.000042421518,0.000032035685,0.00096735184,0.0000024935707,0.6976944,0.00024440934,0.00016458836,0.05611915],"study_design_scores_gemma":[0.016277075,0.0010479967,0.40063843,0.00007273183,0.00003920018,0.00003052906,0.00061341864,0.0002880791,0.5785677,0.0016401629,0.0005090677,0.00027563304],"about_ca_topic_score_codex":0.00002696997,"about_ca_topic_score_gemma":0.0000063374328,"teacher_disagreement_score":0.15902461,"about_ca_system_score_codex":0.0000041065664,"about_ca_system_score_gemma":0.0000039340857,"threshold_uncertainty_score":0.40023392},"labels":[],"label_agreement":null},{"id":"W4376616454","doi":"10.1002/hup.2871","title":"Can antidepressant use be associated with emotional blunting in a subset of patients with depression? A scoping review of available literature","year":2023,"lang":"en","type":"review","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Feeling; Depression (economics); Antidepressant; Systematic review; Psychology; Adverse effect; Psychiatry; Medicine; Clinical psychology; Psychotherapist; MEDLINE; Anxiety; Internal medicine; Social psychology","score_opus":0.17154310022330413,"score_gpt":0.4849100051008777,"score_spread":0.31336690487757357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376616454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0712724,0.9240567,9.537949e-7,0.000014792673,0.00070789555,0.00275817,0.00080850767,0.000057464094,0.00032313121],"genre_scores_gemma":[0.011763468,0.9851247,0.00007372738,0.0003168879,0.00014762986,0.000700271,0.0014001115,0.00013491651,0.0003382731],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99373126,0.0012612053,0.0024113264,0.0015051226,0.0005106224,0.0005804602],"domain_scores_gemma":[0.9948692,0.001707758,0.002312324,0.00046688956,0.00041244837,0.00023138485],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086953107,0.0007787975,0.0032313145,0.0006835776,0.00015900022,0.000036849888,0.0004190187,0.0006619657,0.0014793476],"category_scores_gemma":[0.0003525559,0.00054955017,0.00038284415,0.0015796421,0.00078418653,0.00020230851,0.00022551439,0.001016613,0.00001663345],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029101488,0.014793188,0.8154544,0.09847446,0.00513378,0.0002567462,0.0010407225,3.532966e-7,0.0000061827077,0.000037551108,0.019288246,0.04260422],"study_design_scores_gemma":[0.022326766,0.0020309195,0.048315443,0.9106337,0.0021782215,0.000029810184,0.00011869217,9.2594536e-7,0.000016138141,0.000024033072,0.013071219,0.0012541737],"about_ca_topic_score_codex":0.000045709436,"about_ca_topic_score_gemma":0.000034923676,"teacher_disagreement_score":0.8121592,"about_ca_system_score_codex":0.000060485785,"about_ca_system_score_gemma":0.00019494059,"threshold_uncertainty_score":0.9996956},"labels":[],"label_agreement":null},{"id":"W4395689370","doi":"10.1002/hup.2898","title":"Analysis of schizophrenia‐associated genetic markers in the HLA region as risk factors for tardive dyskinesia","year":2024,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Centre for Addiction and Mental Health Foundation; Brain and Behavior Research Foundation","keywords":"Tardive dyskinesia; Single-nucleotide polymorphism; SNP; Schizophrenia (object-oriented programming); Genotype; Human leukocyte antigen; Dyskinesia; Medicine; Psychiatry; Psychology; Internal medicine; Clinical psychology; Genetics; Biology; Gene; Immunology; Disease","score_opus":0.05832295645562774,"score_gpt":0.41232138129574136,"score_spread":0.3539984248401136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395689370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976506,0.00065072736,0.000011400214,0.00020807805,0.00060110475,0.00046056288,0.000040938558,0.00004085889,0.00033567759],"genre_scores_gemma":[0.9985878,0.00023560591,0.000015606296,0.0009007678,0.00007862234,0.00007290932,0.000013070188,0.000014968949,0.00008068444],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99791396,0.00056666404,0.0005495077,0.0005794173,0.00014844835,0.00024198889],"domain_scores_gemma":[0.9981089,0.0015196718,0.00013623404,0.00014875084,0.000011669986,0.000074728065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035618895,0.00017907628,0.0003767679,0.00025108302,0.00016785029,0.00003890559,0.00027517017,0.00014574706,0.00020763355],"category_scores_gemma":[0.00017340032,0.000126922,0.00037391915,0.0006030627,0.00060297153,0.000062949024,0.000045062974,0.00028265806,0.000006500512],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01952528,0.009559126,0.43179303,0.00016508333,0.0050700917,0.00054801727,0.024609486,0.00030776468,0.43719092,0.005868499,0.050083954,0.015278754],"study_design_scores_gemma":[0.022459766,0.0034783517,0.9206733,0.000061470244,0.0019520804,0.000018576775,0.0058475556,0.008500148,0.029021828,0.0044227857,0.0026511836,0.0009129266],"about_ca_topic_score_codex":0.000047032703,"about_ca_topic_score_gemma":0.000018911167,"teacher_disagreement_score":0.4888803,"about_ca_system_score_codex":0.00001736581,"about_ca_system_score_gemma":0.0000211509,"threshold_uncertainty_score":0.5175729},"labels":[],"label_agreement":null},{"id":"W4410564375","doi":"10.1002/hup.70006","title":"Clozapine Once‐Versus Multiple‐Daily Dosing Regimen: A Single‐Center, Retrospective, Cross‐Sectional Study","year":2025,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dosing; Medicine; Clozapine; Regimen; Adverse effect; Retrospective cohort study; Population; Internal medicine; Single Center; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.09763144311708988,"score_gpt":0.49327081293386876,"score_spread":0.3956393698167789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410564375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911263,0.001773094,0.0000037317145,0.000476819,0.002459061,0.0011434854,0.000014701147,0.000116431394,0.0028863521],"genre_scores_gemma":[0.9961142,0.000110845394,0.00032587926,0.00074395305,0.0007211727,0.00018768266,0.00003789217,0.000023454268,0.0017349239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973053,0.0002383332,0.00077744306,0.0009213774,0.00032608508,0.00043146353],"domain_scores_gemma":[0.99885386,0.00027038707,0.00011595203,0.00029585324,0.000100913705,0.00036302456],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040343523,0.00030003124,0.0005673327,0.00018453482,0.0004946912,0.000073755466,0.00014594129,0.00019140005,0.0010301389],"category_scores_gemma":[0.00008742908,0.00025946772,0.00024320876,0.00019553599,0.0007850786,0.00009875856,0.00018842785,0.00062512414,0.00005182397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13475609,0.014239844,0.8302803,0.000014121398,0.0011214835,0.00022428119,0.0001386882,2.9146165e-7,0.013842189,0.00018937499,0.00347733,0.0017160204],"study_design_scores_gemma":[0.19400337,0.008615474,0.7926534,0.00003342089,0.00013037473,0.000047061134,0.00034108857,0.00004229553,0.0021254988,0.00012326731,0.0016831317,0.00020160837],"about_ca_topic_score_codex":0.000041857653,"about_ca_topic_score_gemma":0.000039680126,"teacher_disagreement_score":0.059247285,"about_ca_system_score_codex":0.0002601652,"about_ca_system_score_gemma":0.00009309329,"threshold_uncertainty_score":0.99998575},"labels":[],"label_agreement":null},{"id":"W7117739282","doi":"10.1002/hup.70031","title":"Anxiolytic Medication Use in Low‐ Middle‐ and High‐Income Countries: A World Mental Health Surveys Report","year":2025,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Sleep and related disorders","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Executive Agency for Health and Consumers; Pfizer Foundation; U.S. Public Health Service; Bristol-Myers Squibb; Eli Lilly and Company; Ministerio de Salud de la Nación; Pan American Health Organization; Fundação de Amparo à Pesquisa do Estado de São Paulo; Universidad CES; European Commission; World Health Organization; GlaxoSmithKline; Fogarty International Center; National Institute of Mental Health; Pfizer","keywords":"Anxiolytic; Anxiety; Medical prescription; Anti-Anxiety Agents; Mental health; Pharmacotherapy; Intervention (counseling); Antidepressant","score_opus":0.04443655691560618,"score_gpt":0.44293738271774574,"score_spread":0.3985008258021396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117739282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832818,0.005941753,0.000015938753,0.0033808874,0.0044589383,0.00068428885,0.000016363865,0.00007255562,0.002147473],"genre_scores_gemma":[0.9893686,0.0007314237,0.000036478385,0.0058104554,0.00012444308,0.00011685714,0.00007525184,0.000020547754,0.0037159007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964047,0.0009381549,0.0012511025,0.00083040824,0.00013809546,0.00043750583],"domain_scores_gemma":[0.99878913,0.00040581476,0.0002562418,0.00027572497,0.000022534998,0.00025054396],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016987085,0.00025901434,0.00054064614,0.0003679472,0.00027694326,0.000036135327,0.00015535345,0.00029205764,0.001482365],"category_scores_gemma":[0.000026477512,0.00024303388,0.00007993089,0.0002896554,0.0010081615,0.000118155505,0.00010247918,0.00056019815,0.000047197103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026660443,0.0039746277,0.92162263,0.00008512007,0.0011362681,0.00030596388,0.0031601707,0.0000013435164,0.0004052464,0.0054010283,0.057692323,0.0035492587],"study_design_scores_gemma":[0.043948658,0.0007889745,0.93699336,0.00026384095,0.00010186724,0.00010857114,0.001747027,0.00007602715,0.00008410377,0.0007828393,0.01457594,0.00052877865],"about_ca_topic_score_codex":0.00063831377,"about_ca_topic_score_gemma":0.0003927577,"teacher_disagreement_score":0.043116383,"about_ca_system_score_codex":0.00007269531,"about_ca_system_score_gemma":0.000065912725,"threshold_uncertainty_score":0.9994304},"labels":[],"label_agreement":null},{"id":"W865674970","doi":"10.1002/hup.1189","title":"Add‐on mirtazapine improves depressive symptoms in schizophrenia: a double‐blind randomized placebo‐controlled study with an open‐label extension phase","year":2011,"lang":"en","type":"article","venue":"Human Psychopharmacology Clinical and Experimental","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mirtazapine; Placebo; Schizophrenia (object-oriented programming); Positive and Negative Syndrome Scale; Psychology; Randomized controlled trial; Depression (economics); Psychiatry; Major depressive disorder; Psychosis; Internal medicine; Antidepressant; Medicine","score_opus":0.12834789893637277,"score_gpt":0.4855986779447769,"score_spread":0.35725077900840413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W865674970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857954,0.0011314185,0.0000014563406,0.00014532723,0.00029266707,0.011706502,0.0000068155505,0.00006734882,0.0008530895],"genre_scores_gemma":[0.9940066,0.00006820017,0.00068835786,0.00068584905,0.00025575515,0.0039674765,0.000041436564,0.000054540178,0.00023182093],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957487,0.0009474745,0.0011611816,0.0012544633,0.00035236563,0.0005358398],"domain_scores_gemma":[0.9978098,0.0003978622,0.00027974593,0.0006402302,0.00009424617,0.0007781046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012137138,0.00051037257,0.002053242,0.00030337498,0.0002798721,0.00006645281,0.00041525817,0.00021199301,0.00087530015],"category_scores_gemma":[0.000069641734,0.00031904402,0.00015473911,0.00016885104,0.00087552774,0.00024464814,0.00027481216,0.00074652047,0.00003443713],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92181796,0.058888964,0.0011440481,0.000008179688,0.0016715328,0.001205225,0.00074938964,1.6982996e-7,0.011222526,0.00017918277,0.00021264942,0.0029001741],"study_design_scores_gemma":[0.92917514,0.062000033,0.0032932097,0.00007258178,0.0006252335,0.00006456667,0.00048431035,0.00021144436,0.0035448968,0.00021666705,0.0000050925405,0.00030685513],"about_ca_topic_score_codex":0.00014519614,"about_ca_topic_score_gemma":0.00013204492,"teacher_disagreement_score":0.008211189,"about_ca_system_score_codex":0.000055177992,"about_ca_system_score_gemma":0.00014141158,"threshold_uncertainty_score":0.99992615},"labels":[],"label_agreement":null}]}